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Sammendrag på norsk 
Bakgrunn: Hoftebrudd er en viktig årsak til sykdom og død med 1.3 millioner brudd årlig i verden og en 
fortsatt stigende insidens. Risikofaktorer er høy alder, osteoporose og skrøpelighet, og de fleste 
bruddene skyldes lav energitraumer på grunn av fall. Høy alder, nedsatt funksjon før bruddet og mannlig 
kjønn øker risiko for et uheldig resultat, mens fall utendørs er prognostisk gunstig. 
Utvikling av såkalt ortogeriatriske behandlingsmodeller for hoftebrudd som bruker teknikker og 
prinsipper utviklet i geriatrien er en måte å bedre prognosen for pasientene. Det er utviklet flere 
modeller: 
1. Konsultasjonsmodeller der pasienten på vanlig måte behandles i en ortopedisk avdeling, men får 
tilsyn og vurdering av geriater eller et geriatrisk team under oppholdet, og der teamet deretter 
foreslår tiltak til ortoped. 
2. Modeller med felles ansvar der geriater og ortoped inngår i et team som utreder og behandler 
pasienten og legger en felles plan for videre oppfølging. 
3. Geriatrisk team modeller der utredning og behandling (med unntak av selve kirurgien)foregår i 
en geriatrisk avdeling tilpasset bruddbehandling, og der ortopeder ansvarlig for operasjon, men 
ellers kun konsulteres ved behov. 
Målsetninger for studien: Overordnet mål for studien var å undersøke om bred geriatrisk utredning og 
behandling (CGC) ga en tilleggsgevinst sammenlignet med tradisjonell ortopedisk behandling (OC).  
 
Målsetninger for denne avhandlingen er: 
1. Å beskrive bakgrunn, utvikling og prinsippene bak de orthogeriatriske modellen og hvordan den 
skiller seg fra vanlig behandling (Artikkel I).  
2. Å presentere kliniske resultat (Artikkel II): 
a. Mobilitet fire måneder etter bruddet (primært endepunkt)  
b. Sekundære  endepunkt: 
i. Mobilitet etter en og 12 måneder, og p- i-ADL, kognisjon, frykt for å falle, 
stemningsleie og livskvalitet en, fire og 12 måneder etter bruddet,  
ii. Bruk av helsetjenester første året etter bruddet 
 
3. Finne ut om effekten på mobilitet, p- og- i-ADL og kognisjon var avhengig av alder, kjønn, 
bruddtype og funksjon før bruddet (Artikkel III). 
 
Metode: Hoftebruddsstudien i Trondheim er en randomisert kontrollert studie basert på ortogeriatri-
modell 3 ovenfor. Studien sammenligner standard ortopedisk behandling (OC) med ortogeriatrisk 
behandling i en egen enhet (CGC). Hjemmeboende pasienter 70 år eller eldre som klarer å gå minst 10m 
og som har et lavenergibrudd kunne inkluderes, mens pasienter fra sykehjem, høy-energi brudd, 
patologisk fraktur eller annen sykdom med forventede leveutsikter på mindre enn 3 måneder ble 
ekskludert. Behandlingen er basert på bred geriatrisk utredning (CGA) og gjennomføres av et tverrfaglig 
team bestående av geriater (overlege eller lege i spesialisering), sykepleier, fysioterapeut og 
ergoterapeut; teamet har regelmessige møter der det lages individuelle behandlingsplaner og settes mål 
for opphold og klargjør videre behov etter utreise samt behandlingsmål. Behandlingen er helhetlig og 
fokuserer på tidlig mobilisering, gjennomgang av den enkelte pasient med tanke på bakenforliggende 
sykdom, medisingjennomgang og diagnose og behandling av komplikasjoner. 
Primært endepunkt i studien var mobilitet etter fire måneder testet med SPPB. Pasientene ble også 
testet på femte postoperative dag, etter en , fire og 12 måneder. Sekundære endepunkt var personlige 
(p-) og instrumentelle (i-)aktiviteter i daglig livet(ADL) med Barthel Index (BI; 0-20)) og Nottingham 
Extended ADL Skala(NEAS; 0-66), kognisjon ble testet med Mini Mental Status (MMSE; 0-30) og klinisk 
demens vurdering (KDV;0-18, 0 best), livskvalitet ble målt med EuroQol 5 dimensjoner (EQ-5d; -0.594-1), 
depresjon med Geriatrisk depresjonsskala (GDS;0-15), frykt for å falle med Falls Efficacy Scale 
International (FESI; 7-28) og bruk av tjenester inklusive liggetid sykehus og kommunale tjenester. Vi har 
også gjort eksplorerende analyser med undergrupper basert på alder, kjønn, brudd type og funksjonsnivå 
før bruddet. 
Analysene er utført som en 2-veis longitudinell mixed model analyse med tid siden brudd og 
behandlingsgruppe som uavhengige faktorer i analysen og funksjon testet som avhengig faktor. Alder, 
kjønn og bruddtype er brukt som kovariater. I analysene av undergrupper ble modellen utvidet til en 3-
veis interaksjonsanalyse og undergrupper basert på alder, kjønn, bruddtype og funksjon ble lagt inn. 
Bakgrunnsdata er analysert med kji-kvadrat test og Nevcombes test for forskjeller mellom proporsjoner. 
Resultat: 397 pasienter ble rekruttert til studien, 198 til CGC og 199 til OC. Kvinner utgjorde 74 % av 
materialet, og 60 % bodde alene. Det var ingen signifikante forskjeller I bakgrunnsdata mellom gruppene 
 Primært endepunkt mobilitet gikk i favør av CGC med SPPB-skår på 5.12 og 4.38 i henholdsvis CGC og OC 
(CI 0.18 til 1.30; p=0.010). Forskjellen har klinisk betydning. Andre viktige sekundære endepunkt i favør 
av CGC etter fire måneder var NEAS på 33.59 og 27.42 (CI 2.57 til 9.78; p=0.001); FESI 11.31 og 12.57 (CI -
2.27 til -0.27;p= 0.013) og til slutt EQ-5d 0.54 og 0.46 (CI 0.01 til 0.15; p=0.033). 
Resultatene ble opprettholdt etter 12måneder og var fortsatt i favør av CGC. SPPB var 5.30 og 4.61 
(CI0.10 til 1.28; p=0.023); NEAS 35.20 og 28.81 (CI 2.59 til 10.19; p=0.001); FESI 10.81 og 12.01(CI -2.24 til 
-0.18; p=0.021) og til slutt EQ-5d 0.52 og 0.45 (CI0.02 til 0.16;p=0.015). 
Liggetid (LOS) for index-oppholdet var lenger I CGC med 12.6 i forhold til 11.0 døgn (CI 0.2 til 2.94; 
p=0.025), men dette ble kompensert med færre liggedøgn påfølgende år 5.63 mot 8.35 (CI -5.48 til 0.04; 
p=0.053). Bruk av tjenester indikerer mer bruk av institusjonssenger etter behandling i OC, og mer bruk 
av hjemmebaserte tjenester etter CGC. 
Analyser innenfor undergrupper viser en positiv effekt av CGC på etter eller flere delmål i alle 
undergrupper. Effekten er mest uttalt hos pasienter under 80 år, kvinner, pasienter med intra-kapsulære 
brudd og pasienter som var i hovedsak funksjonelt uavhengige før bruddet. 
Analyser mellom undergrupper viser at pasienter med intra- kapsulære brudd hadde mer nytte av CGC 
enn pasienter med ekstra- kapsulære brudd etter 4 måneder for p-ADL; BI (gruppeforskjell= 1.51; 
p=0.037) og med en trend for mobilitet med SPPB (gruppeforskjell =0.93; p=0.07). Forskjellene ble 
opprettholdt etter 12 måneder for BI (GD=1.49; p=0.045) og økte for SPPB (gruppeforskjell=1.25; 
p=0.021). 
Konklusjon: I denne randomiserte studien har vi utviklet og testet et nytt behandlingsopplegg for 
hoftebruddpasienter. Våre resultater viser en overveiende positiv effekt av CGC med forbedrete kliniske 
resultat på en rekke funksjoner og samtidig reduksjon i bruk av helsetjenester. Effekten er til stede i alle 
pasientgrupper, selv om pasienter med ekstra-kapsulære brudd synes å ha mindre nytte av CGC enn de 
andre pasientgruppene. 
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Summary in English 
Background: Hip fractures are an important cause of morbidity with 1.3 million fractures per year world 
wide, and the incidence is still increasing. Risk factors for fractures are advanced age, osteoporosis and 
frailty, and most fractures are a consequence of low energy traumas due to falls. A hip-fracture may have 
serious consequences for a patient, with loss of mobility, independence including inability to live in own 
home and even death as the most feared results.  Patients being old, with reduced pre-fracture function 
and male gender have increased risk of an adverse outcome, while patients with out-door fractures have 
a better chance of recovery. 
In orthogeriatric treatment models principles for assessment and treatment of frail elderly patients 
developed by geriatricians are applied on hip-fracture patients. Several models are developed:  
1. Consultation based models where the patient receives treatment in an orthopaedic ward, where 
a geriatrician or a geriatric multidisciplinary team assess the patient and make recommendations 
for further treatment. 
2. Models of joint care where the geriatrician shares responsibility with the surgeon and treatment 
is delivered by a multidisciplinary team. 
3. Geriatric team models where the patient receives all treatment, except surgery, within a 
geriatric ward designed for fracture patients, and the orthopaedic surgeon is responsible for 
surgery and later consulted on demand. 
Aims: The overall aim of The Trondheim Hip Fracture Trial was to investigate if comprehensive geriatric 
care (CGC) was beneficial as compared to conventional orthopaedic care (OC).  
 
Aims of this thesis are: 
1. To describe the background, development and principles for the experimental orthogeriatric 
treatment model and how it differed from conventional orthopaedic treatment (Paper I).  
2. To present the main clinical results of the study (Paper II): 
a.  mobility at four months after the fracture (the primary end point)  
b. the following secondary endpoints: 
i.  mobility at one and 12 months, and  p- and i-ADL, cognition, fear of falling, 
mood and quality of life at one, four and 12 months after the fracture ,  
ii. use of health care services during 12 months of follow-up 
 
3. To study whether efficacy of CGC on mobility, p-and i-ADL and cognition were dependent of age, 
gender, pre-fracture function and type of fracture in the two groups (Paper III). 
Method: The Trondheim Hip fracture trial is a randomized clinical trial (RCT) based on orthogeriatric 
model 3 comparing standard orthopedic care (OC) in a trauma ward with comprehensive geriatric care 
(CGC) in a geriatric ward. Home-dwelling patients 70 years or older and able to walk at least 10m 
suffering from a hip fracture due to low-energy trauma could be included, while patients in nursing-
homes, with high-energy trauma, pathological fracture or other disease causing a reduced life 
expectancy of less than 3 months were excluded. The model is based on a multidisciplinary team 
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consisting of geriatrician (consultant or resident), nurse, physical therapist and occupational therapist. 
The team has regular meetings designing an individual care plan including short- and long-term 
treatment goals for each patient and a plan for discharge. The assessment and treatment is systematic 
and comprehensive focusing on somatic health including comorbidities and medication, mental health, 
function and social situation. Early mobilization was important. After discharge from hospital the primary 
health care had responsibility for the treatment in both groups. 
Primary end point of the study was mobility assessed by the Short Physical Performance Battery (SPPB) 
(0-12) at four months. Secondary end points were personal and instrumental  Activities of Daily living (p-
ADL and i-ADL) by using the Barthel Index (BI) (0-20) and Nottingham Extended Activities of daily living 
Scale (NEAS) (0-66), respectively, cognition assessed by using Mini Mental Status Examination (MMSE) 
(0-30) and Clinical Dementia Rating (CDR) (0-18), quality of life as measured by using the EuroQol-5 
dimensions (EQ-5d) (-0.594 -1), mood by Geriatric Depression Scale (GDS) (0-15), fear of falling by Falls 
Efficacy Scale International (FESI) (7-28) and, use of health care services. Assessments were made at one, 
four and 12 months; in addition SPPB was made on the fifth postoperative day.  
In order to investigate if impact of CGC on SPPB, BI, NEAS and MMSE differed between subgroups of 
patients, we made post-hoc analyses based on age (70 to 79 or ≥80 years), gender, fracture type (intra- 
or extra-capsular) and pre fracture function (pre-fracture NEAS <45 or ≥45). 
We used two-way longitudinal mixed models analyses with time and group allocation as independent 
factors and the outcome investigated as dependent factor. Age, gender and fracture-type were co-
variates. In the sub-group analyses we did 3-way mixed models analyses with age, gender, fracture type 
or function added as a factor. Background data where analyzed by chi-square analysis combined with 
Newcombe´s test for confidence intervals for proportions. 
Results: We recruited 397 patients to the study, 198 in CGC and 199 in OC group. There were 74% 
females and 60% were living alone. Mean age was 83 years. There were no significant differences in 
background variables between the study arms. 
 The primary end-point mobility at four months was in favor of CGC with a  mean SPPB score of 5.12 in 
CGC and 4.38 in OC group (CI 0.18 to 1.30; p=0.010). At four months NEAS was 33.59 and 27.42 (CI 2.57 
to 9.78; p=0.001); FESI 11.31 and 12.57 (CI -2.27 to -0.27; p= 0.013) and EQ-5D 0.54 and 0.46 (CI 0.01 to 
0.15; p=0.033) in the CGC and OC group respectively. For GDS and MMSE there were no differences 
between groups. 
At 12 months the results were maintained in favor of CGC. Mean score for SPPB was 5.30 and 4.61 (CI 
0.10 to 1.28; p=0.023); NEAS 35.20 and 28.81 (CI 2.59 to 10.19; p=0.001); FESI 10.81 and 12.01(CI -2.24 
to -0.18; p=0.021), MMSE (CI 0.12-2.77; p=0.033) and EQ-5d 0.52 and 0.45 (CI0.02 to0.16; p=0.015) in the 
CGC and OC groups respectively. For GDS there was a trend in favor of CGC (CI -1.46 -0.02; p=0.06) 
Mean Length of stay was longer in CGC with 12.6 and 11.0 days (CI 0.2 to 2.93; p=0.025), but more 
patients were discharged directly to home after CGC; 47 (25%) against 20(11%); (CI 6.3%-21.4%; 
p=0.001). The following year after the index stay mean number of days in hospital was 5.63 and 8.35 (CI -
12 
 
5.48 to 0.04; p=0.053) in CGC and OC respectively. There were more overall use of services indicating 
more use of institutions such as nursing home and institutionalized rehabilitation in OC, and more use of 
home-based services in CGC. 
Sub groups analysis: Within-group analyses indicate positive effects of CGC in all sub-groups for one or 
more functional outcomes. The results are most pronounced among patients aged 70 to 79, females, 
patients with intra capsular fractures and well-functioning patients before fracture. 
Between-group analyses at four months show that patients with intra-capsular fractures respond better 
to CGC than patients with extra-capsular fractures for  BI (GD= 1.51; p= 0.037) and a trend for SPPB 
(GD=0.93; p=0.07). These results are maintained at 12 months for BI (GD=1.49; p=0.045) and increased 
for SPPB (GD=1.25; p=0.021).  
Conclusion: In this RCT we have developed and tested a new clinical treatment program for hip-fracture 
patients. Our results indicate an overall positive effect of CGC with improved functional outcomes, 
quality of life and reduction in use of services. The effect is present in all patient groups, but patients 
with extra-capsular fractures seem to benefit less of the intervention than others. 
13 
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1. Introduction: 
Fragility fractures are common and serious events affecting mainly elderly people. Osteoporosis and falls 
are the underlying conditions, and many patients are frail and have co-morbidities and use several 
drugs.(1) Fragility fractures are a major cause of loss of independence; disability and death of old age.(2-
4) Patients with fragility fractures are major consummates of public health services including nursing 
home beds.(5) 
The hip fractures are the most feared of the fragility fractures, because they dramatically affect 
autonomy and quality of life. (6, 7) Consequences of hip fractures are disturbance of gait and balance, 
fear of falling and chronic pain. Almost all patients need a walking aid after the hip fracture, a rollator or 
crouches, and many are permanently dependent of assistance. (8) 
New methods to prevent fractures and to improve surgical outcome and the long term result after 
rehabilitation are developed, but despite such efforts, prognosis is still poor. 
1.1 Background: 
1.1.1 Epidemiology of hip fractures 
World wide there are more than 1.3 million hip fractures every year.(9) The incidence of hip fractures 
varies considerably between regions and populations. The risk is highest in Scandinavia, with a sevenfold 
increased risk in comparison with Mediterranean countries. (9) The risk is lowest in China where most 
fractures occur in men.(9) Data from mixed populations suggest that Africans have a reduced risk 
compared to other populations, probably due to differences in bone size.(10) More than 50% of hip 
fractures occur in industrialized countries today, while, due to ageing of populations, a considerable 
increase is expected in Asia, and by 2050 the majority of fractures will occur there.(11)  
 There has been a steady increase in the incidence of hip fractures until the mid-nineties. The increase is 
parallel to the increase in longevity. The average life-span has increased  steadily the last 200 years,(12) 
now reaching 87 years for women and 81 for men in the leading countries (Japan and Iceland).(13)The 
mean age  of the first hip-fracture have increased from 73 years in the 1960s to 79 from in 2008, is 
expected to increase  with 1 year every 5 year period.(14) Even if recent analyses indicate a decline in 
the incidence of hip-fractures, an increase in the prevalence is expected in the years to come due to the 
aging of population.(11) As no fracture is better than a well treated fracture, initiatives as “Capture the 
Fracture” aim to identify patients at risk in order to prevent hip- and other fragility fractures.(15) 
 
Several risk factors for hip fractures have been identified through epidemiological research. Age is the 
most important risk factor which may be related to many of them being frail, using many drugs and with 
high prevalence of dementia and osteoporosis.(16)  
Osteoporosis is a prerequisite for hip fractures caused by low energy trauma. The definition of 
osteoporosis is a measured bone mineral density (BMD) T-score below 2.5 SD of normal. (17) The BMD, 
however only accounts for 40% of the fracture risk in each patient, while the remaining risk is related to 
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structural attributes of the skeleton. (18) These attributes are not available for regular clinical 
investigation. Most algorithms to assess fracture risk, use epidemiological factors to improve 
estimates.(18)Risk factors for primary osteoporosis are  advanced age, female gender, Caucasians, low 
weight, early menopause, sedentary lifestyle, smoking and excess use of alcohol, low serum vitamin-D 
and  little sun-exposure.(19) Secondary osteoporosis are caused by a range of disorders including 
endocrine (hyperthyroidism, hyperparathyroidism and hypercortisolism), and metabolic disorders 
(coeliac disease, anorexia nervosa), cancers(lymphomas), drugs(steroids, antidepressants and anti-
diabetic drugs) and a range of other disorders.(19) In both primary and secondary osteoporosis there is 
an imbalance with higher resorption than formation of bone.(20) 
 Risk factors for osteoporosis and hip fractures are similar, and treatment of osteoporosis protects 
against hip fractures even if treatment is probably less effective in protecting against hip fractures as 
compared to other fragility fractures. (17) Calcium and Vitamin-D supplementation is likely to reduce 
fracture risk, at least in patients living in institutions, (21) while anti- resorptive treatment have failed to 
show any effect on hip-fractures in patients >80 years of age even if the effect on vertebral fractures is 
similar to younger patients .(17) 
Gender and ethnicity is important. Three out of four hip fracture patients are women.(10) At any given 
age the risk of a hip fracture are twice in women, but women also have a longer life expectancy than 
men and are exposed for a longer time. Caucasians have an increased risk of hip-fractures, while the risk 
is reduced in Africans.(22) Caucasian women have a life-time risk of a hip-fracture of 17%.  
Finally, frailty is a strong risk factor for hip fractures. The frequency of frailty varies considerable 
between studies, but in a large study of women over 65 years approximately one in six was frail.(23) A 
study in men over 65 years showed that four percent suffered from frailty.(24) Patients with frailty had a 
14% risk of hip fracture over 10 years as compared with eight percent for robust women. Frailty will be 
described in more detail in chapter 1.3. 
1.1.2 Epidemiological risk factors for fall 
A fall may be defined as an event where a person is coming to rest inadvertently on the ground or floor 
or other lower level.(25) There is some evidence that a fracture may cause a fall, (26, 27) but in most 
cases the fall seems to be the causative event.(28) Some risk factors for falls are similar to those of 
fractures, for instance age and frailty. More than 50% of women aged 75 years or older have had one or 
more falls over a year period, and 13% of these falls caused a fracture.(29) One study showed that 13 of  
308 falls suffered a lower extremity fracture (of which hip fractures are most common in this age 
group).(29)  
Comorbidity is an important risk factor for falls which can be related either directly to disorders causing 
falls or to side-effects of pharmacological treatment.  Disorders affecting balance or muscle strength 
such as neurological disorders, including stroke and Parkinson’s disease increase the risk of falling. Falls 
among patients with a heart disease may be due to arrhythmia or to side effects of medication, for 
instance orthostatic hypotension. Drugs affecting the central nervous system including drugs used for 
psychiatric disorders and insomnia such as antipsychotics, anti-depressants and sedatives are also 
associated with falls.(30) Recreational substances as alcohol increase risk of falls, and the risk is related 
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to number of units per week.(31) Acute illnesses, as intercurrent infections, are also important risk 
factors. 
Impaired vision is a risk factor for falls. Disturbances of contrast sensitivity and perception of depth may 
be important.(32) It is possible that treatment of visual disturbances, for instance by cataract surgery 
may be beneficial, but further research is needed.(33, 34) 
Weather and icy roads and pavements are often mentioned as important factors for falls, and there is an 
association with low temperature and winter.(35, 36) Most falls causing a fracture are however 
happening indoors both for community dwelling and for patients in care facilities.(37) 
 
1.1.3 Consequences of a hip fracture 
1.1.3.1 Loss of mobility  
Mobility is affected in several ways by a hip-fracture. Initially pain and instability of the fragments limits 
mobility. After surgery the fracture is in general stabilized, and allows for some weight load, but most 
patients limit the load of the fractured hip as compared to uninjured hip to 50 % immediately after the 
fracture increasing to 85% after 12 weeks. (38) Most patients suffer from some degree of impairment in 
mobility even after longer time of observation. This may be due to loss of muscle due to inactivity, nerve 
damage due to the initial trauma or surgery and reduction of stability of the joint due to biomechanical 
changes. Studies have shown that 40% loose the ability to walk independently, and in a large study from 
New York, 14% completely lost the ability to ambulate.(11, 39) In a Swedish study, patients’ walking 
abilities were classified by a 10m walk test as good (able to walk independently <15s with or without a 
cane), average (able to walk with assistance or walking aid within 30 s) or poor (more than 30s).(40) Only 
16% of patients had good walking ability one year after a fracture, and 50% needed a walking aid.(40) In 
a Norwegian study it was shown that 43% of patients lost the ability to move outdoors from their own 
home. (8) Mobility is also essential in personal (p-) and instrumental (i-) activities of daily Living (ADL). 
1.1.3.2 Activities of daily living 
Activities of daily life (ADL) have been measured since the mid-50ties. It is customary to differentiate 
between personal (or basic) activities (such as personal hygiene or eating) and instrumental activities (or 
complex) activities (such as outdoor walking, shopping or handling of own economy).  Home-dwelling hip 
fracture patients are likely to have some  decline in i-ADL as 55% receive some kind of assistance ,(8) 
while they had a relatively preserved p-ADL before the fracture.(41) Reduced pre-fracture p- and i-ADL 
are known risk-factors for adverse outcomes after a fracture.(42) A majority of hip-fracture patients  
have  long-term reduced ADL.(43) Functional outcomes such as improved ADL are essential for 
independent living and important to evaluate as a potential effect of an intervention. 
 ADL has a hierarchy where i-ADL tend to be affected before p-ADL, but reduction in either affects risk of 
falling (44, 45) thereby increasing the risk of a hip fracture. (46) After  a hip fracture, decline in both p-
ADL and i-ADL have been shown, and 60% of patients need assistance in p-ADL one year after a hip 
fracture, while  80% report need of assistance in i-ADL.(11) Home-dwelling patients often suffer from 
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physical rather than cognitive decline, (47) and the need for assistance is partly related to reduction of 
mobility and p- and i-ADL. A majority of nursing home patients have dementia,(48) and this might affect 
both p- and i-ADL. Most i-ADL tasks such as ability to prepare a meal, house cleaning or control over own 
money is no longer performed by nursing home patients and decline is not necessarily perceived as a 
problem, while reduction of p-ADL as incontinence of urine or feces is more troublesome. 
1.1.3.3 Cognition 
Diseases affecting cognitive function are associated with dependency, risk of falling and hip 
fractures.(49, 50) Cognitive impairment may result in loss of muscle strength and balance due to 
inactivity, increased risk of falling due to risk behavior (walking without necessary aid) and increase of 
osteoporosis due to malnourishment. Cognitive impairment is the most important risk factor for lost 
ability to live in own home, (51) and 80 % of Norwegian nursing home residents suffer from dementia. 
The most important risk factor for cognitive impairment is age.(52) Cognitive Impairment is found to be 
more important than the fracture itself when family members evaluate care-giver stress.(53)  
There are several theories why hip fracture patients often suffer from cognitive impairment after 
treatment. A large proportion of patients suffer from cognitive impairment before treatment, and the 
observed reduction in cognition is actually the natural course of a dementia disorder. In a delirium study 
from Oslo, 42.6% of patients suffered from cognitive decline before suffering a hip fracture.(54) The 
surgical trauma may cause structural damage to the brain  for instance by fat-embolism, (55)and also 
choice of anesthetic technique may have an impact on the risk of delirium and dementia.(56) . In a study 
in New York, however, Koval found no difference in outcomes regardless of anesthetic technique.(57) 
There is increasing evidence of a strong relation between dementia and delirium in a post operative 
setting.(58) Acute post operative delirium is a strong predictor of long-term cognitive impairment after 
hip surgery.(59) Fifty per cent of patients with hip fracture suffer from delirium,(48)and there is an 
association between delirium and subsequent long-term cognitive impairment after hip fractures.(60-62) 
Delirium during initial treatment of the fracture with or without known cognitive impairment is 
associated with increased length of stay (LOS), institutionalization after the fracture and worse functional 
outcomes.(63)Evaluation of cognition would therefore be an important endpoint when doing 
longitudinal evaluation of an orthogeriatric hip fracture intervention. 
 1.1.3.4 Other 
Hip fracture patients have a high mortality rate, with a one-year mortality rate after hip fractures up to 
30%and a five year mortality-rate >70% for men  and almost 50% for women.(4, 64, 65) The difference is 
probably reflecting a difference in comorbidities and health between genders.(66) One-year mortality 
varies from >50% for male nursing home patients to < 2% for fracture patients below the age of 70.(67, 
68) Patients acquiring the fractures outdoors or related to falls on slippery roads have a reduced 
mortality.(64) Although mortality risk is lower among those below 70 years, the relative risk of dying is 
increased as compared to people of the same age without fracture.(69, 70) The risk of dying is largest 
during the first 3 months after the fracture, but is still increased decades later.(71) In a material from 
Southern-Norway , overall mortality was 21% after one year and 59% after five years.(72) Cardiac 
infarction, stroke and cancer are the most important causes of death, but pneumonia and urinary tract 
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infections are common complications and reasons for in-hospital mortality.(70) In-hospital mortality 
varies between different studies, from 1.5% to almost 5%.(73, 74) Differences in LOS and discharge 
practices may explain some of these differences, while differences in treatment strategies also may 
cause different mortality. 
Many patients develop chronic pain after a fracture.(8)Pain affects quality of life and is associated with 
inactivity and further deterioration in function with  increased risk of dependence.(75) 
Anxiety and depression are common and affect functional outcomes and quality of life after hip 
fractures. (52, 76-79) People having moderate or severe depression at the time of  a hip fracture had a 
three-fold risk of loss of independent walking, institutionalization and death as compared to other 
patients.(78) Fifteen per cent of patients develop depression after a hip fracture.(77) It is likely that 
inactivity and malnourishment due to depression may contribute to an adverse outcome after a 
fracture.(78) Psychiatric liaison service may reduce LOS, (80) but otherwise there is limited evidence of 
improved outcome after a hip fracture by treating the depression.(81) On the other hand use of anti-
depressants may contribute to increased fall risk, and an association between anti-depressants and 
vertebral, but not hip-fractures has been reported.(82) 
Fear of falling is a debilitating symptom in many hip-fracture patients. It is associated with pain and 
depression, but is also independently associated with poor outcome.(83) Patients with severe fear of 
falling tend to reduce physical activity as do patients with depression and anxiety. (84) Patients with 
frailty who experience a fall are more likely to have fear of falling than robust fallers. (85)Fear of falling 
may also stimulate the patient to develop compensatory walking strategies such as increasing stride 
width and shorter steps and thereby worsen walking ability.(86) Consequences of inactivity and change 
in walking pattern may create a downward spiral with increasing functional decline that subsequently 
reduce independent living and reduce quality of life.(87, 88) Strategies to identify and reduce fear of 
falling after a fracture may therefore be important to improve functional outcomes and improve quality 
of life. 
Hip fractures affect quality of life.(3) A Swedish study reported that the average hip fracture patients had 
an EuroQol 5-dimension score (EQ-5d) of 0.78 before the fracture and 0.59 four months afterwards.(89) 
In a time trade-off study of elderly women, loss of independence due to a bad hip fracture(unable to 
maintain independent living after the fracture) was considered to influence  quality of life more than 
breast cancer or a cardiac infarction.(88) 
Hip fracture patients are major consumers of public health services; however there are considerable 
international and interregional differences.(8, 65, 90) Need for health services depend on age, gender, 
available informal care and organization of health care.(91) In Norway nursing homes are the main 
institutional service provided by municipalities. They are publicly funded and administered. The level of 
care in most cases is similar to a skilled nursing facility. In smaller municipalities, one institution may 
offer both short- and long term nursing home beds and rehabilitation. In larger cities, as Trondheim, a 
limited number of large institutions provide rehabilitation, while most of the other institutions have 
primarily short- and long term nursing home facilities. Sheltered housing where patients live 
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independently, but have easy access to home care and nurse services is used more frequently and to 
some degree replaces nursing homes.In a study on hip fracture patients from Malmø, Sweden 61.7% 
lived in their own home before the fracture, 21.5% had some form of sheltered housing and 9.5% lived in 
nursing homes.(92) The remaining patients lived in various types of institutions at the time of the 
fracture.(92) Four months after the fracture 44.7% were still able to live in their own home, 17.4% had 
sheltered housing and the number in nursing homes had increased to 14.4%. In the Oslo Orthogeriatric 
Trial one third of patients lived in nursing homes at the time of fracture.(48) After the fracture 16% of 
previous home-dwelling patients lived in a nursing home. 
As for institutions, there is a considerable variation in home-based services. Home nursing services offer 
medical assistance within the patients´ home, while home-care services offer assistance as house 
cleaning. Other services are typically safety patrols and meals-on-wheels. There is a considerable 
increase in use of home-based services and informal care after a fracture.(8)Fifty-five per cent of home-
dwelling patients still living at home with no assistance prior to the injury did receive assistance 
afterwards, and in those who had assistance previous to the injury >50% needed more help afterwards. 
There are several estimates of cost of hip-fracture treatment, but the majority only consider hospital 
service and primarily measuring length of stay.(93-97) An American publication from 2003 estimated a 
total cost of 81300$, with 44% occurring the first year.(65) In this model 11% of cost was related to the 
initial stay (8900$) while 44% (35400$) was related to nursing home stays. Studies from other countries 
with a different organisation of health care may differ considerably, with long stays related to in-hospital 
rehabilitation or other elements shifting cost between different levels of care.(6) Development of new 
clinical pathways such as Fast Track Models are likely to reduce costs related to the initial stay, but may 
generate a cost-shift from hospital to other areas of the health care system.(98)  
 
1.2 Good clinical practice 
There are a several guidelines defining good clinical practice in relation to hip fractures. The actual 
practices still differ between hospitals and nations depending on tradition and available resources. Over 
the  recent years the evidence for adequate treatment has improved due to research , especially  audits 
and national registers have increasing importance in controlling quality of treatment offered.(99, 100) A 
recent British publication found reduced 30-day mortality from 11 to 8.5% and one-year mortality from 
34.1 to28.7% between 2007 and  2011, which is likely related to implementing The UK National Hip 
Facture Database The consequences are saving of 1000 lives since the database was established. .(101, 
102)  
“The Blue Book” by the British Orthopedic and Geriatric Societies has been a standard of good clinical 
practice, and recently a British national guideline based on the same sources has been established.(103, 
104) Even if quality is improving, there is still lack of evidence regarding many aspects of hip-fracture 
treatment. 
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1.2.1 Surgery 
There is an agreement that surgery is the treatment of choice for a hip fracture, and there are very few 
situations where conservative treatment might be considered acceptable.(105, 106) The Girdlestone 
operation where the femoral head is removed is sometimes used when regular surgery is 
contraindicated.(107) 
There is increasing evidence that time to surgery is essential, (108) and recent guidelines recommend 
surgery during the same day or next day, if possible.(104, 109) Serious comorbidities including cardiac 
arrhythmias, electrolyte disturbances, serious disturbances of blood sugar and infections should be 
treated as soon as possible after admission and sometimes surgery has to be postponed to avoid 
unnecessary per- and post-operative complications. (104, 110)Complications associated  with delay of 
surgery are infections, including urinary tract infections and pneumonia, pressure ulcers, delirium, deep 
vein thrombosis and increased mortality.(111) 
In recent years, so-called Fast Track Models have been introduced.(112, 113) The key element in these 
models is standardization of treatment to reduce pre-operative waiting time and total length of stay. 
Elements of a fast track protocol may for instance be standard blood tests and x-ray, standard 
intravenous infusions, analgesic treatment, direct transfer to a ward without delay in emergency 
department and dedicated operating theaters for hip fracture patients. By implementing protocols and 
delegating simpler tasks to the nursing staff, patients receive surgery sooner and may be discharged at 
an earlier stage. 
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Figure 1 Classification of hip fractures (114)
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1.2.1.1 Intra-capsular fractures 
Fractures of the proximal femur are classified as intra- and extra-capsular fractures. Intra-capsular 
fractures are divided into displaced (Garden III and IV) and non-displaced (Garden I and II) fractures 
depending of the angle of the fractured proximal part of the femur and the dislocation of the fragment. 
The blood supply of the femoral head may be compromised in displaced fractures causing caput 
necrosis. Therefore current recommendations suggest arthroplasty for displaced fractures ,(115) and 
internal fixation for non-displaced fractures, especially in younger patients.(103) The surgical trauma is 
more extensive with arthroplasty, and if the patients are very frail internal fixation may be considered  
even with a displaced fracture.(115) Occasionally, even the Girdlestone procedure may be an alternative 
either permanently or temporarily as pain relief for instance where there is strong suspicion of a 
systemic infection. 
Figure 2 Classification of femoral Neck Fractures (116) 
 
 
Classification of femoral neck fractures into Garden I-IV or dichotomized into Non-displaced or displaced 
© Orthopaedics & traumatology, surgery & research 2012 
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1.2.1.2 Extra capsular fractures 
Extra capsular fractures are fractures in the trochanter region or the sub-trochanter region comprising of 
the 5 cm area distal to the lesser trochanter in the femur. Trochanteric fractures may be stable or 
unstable, often comminute. Sub-trochanteric fractures are often unstable and the prognosis is poor with 
increased risk of a profound and lasting deterioration of musculoskeletal function.(117). Current 
guidelines suggest sliding hip screws as t treatment of trochanteric fractures, while for sub-trochanteric 
fractures  sliding hip screws and/or  medullary nails are most commonly used.(103) 
1.2.2Anesthesia 
Both general anesthesia and local anesthesia are acceptable options during treatment of hip 
fractures.(104, 118) A Cochrane analysis concluded that  local anesthesia had lower short term 
mortality,(118) but the difference was small. In a retrospective non-randomized study from Turkey  
combined peripheral nerve block was shown to be beneficial, especially for reducing preoperative 
waiting time as compared to general anesthesia which required more time for medical stabilization 
before surgery.(119) A Danish group used epidural anesthesia from the diagnosis of a hip fracture until 
fourth postoperative day as part of their Fast Track model, and report excellent results .(120)  
1.2.3 Treatment of pain 
Hip fractures are painful, and effective treatment of pain is probably essential for a good outcome.(121) 
Uncontrolled pain is one of several factors associated with development of delirium; therefore studies 
focusing on reducing delirium are often focusing on optimal pain management.(122, 123) Even if pain 
treatment is considered important, evidence is lacking regarding the optimal analgesic regimen.(124) 
1.2.3.1 Paracetamol (Acetaminophen) 
Paracetamol is considered a safe and relatively effective drug in acute pain management. Most recent 
studies have paracetamol in the standard pain regimen offered.(124) There are no current evidence 
showing superiority as compared to other regimes, but most alternatives have more obvious 
disadvantages. 
1.2.3.2 Non-Steroid Anti-inflammatory drugs (NSAIDS) 
NSAIDs are potent pain relieving drugs, with a well documented effect as analgesic treatment in an acute 
setting. They also have a well documented list of potentially dangerous side-effects, especially in the 
elderly, limiting their use.(125) The most important side-effects are gastrointestinal bleeding, worsening 
of heart failure and renal failure. New NSAIDs (COX-2 inhibitors) were developed to reduce risk of 
gastrointestinal bleeding, but were found to increase risk of heart disease.(126) 
Despite the risk, some authors advocate more use of these drugs, and report positive effects in studies 
on control of pain and reducing the need of postoperative opiates.(127, 128) 
1.2.3.3 Opiates 
Opiates have been the cornerstone of pain treatment for centuries, both chronic and acute. They are 
widely used, but their equally well known side effects such as chronic constipation, nausea, sedation, 
delirium, increased risk of falling and urinary retention restricts their use. There are few contra-
indications to opiate therapy, and most are relative. Opiates cause respiratory depression, and patients 
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with respiratory failure should be monitored. Renal failure is associated with increased risk of side-
effects to opiate treatment due to accumulation of metabolites.(129) Some patients may develop 
dependency, but in cases of temporarily strong pain as with a fracture this is hardly a problem. Delirium 
as a result of pain is more frequent than delirium as a cause of opiate treatment.(130)  
There is no strong evidence that regular morphine is inferior to other opiates despite its lower price. 
Pethidine have clearly more side effects, especially in older patients and should be avoided.(131) It also 
has a toxic metabolite with serotonergic effects and may cause serotonergic syndrome and interactions 
with MAO-inhibitors. Tramadol should be avoided in patients with an increased risk of seizures.(132) It 
also has the indication of moderate pain, and is therefore most likely to be insufficient during the acute 
phase of hip fracture treatment. Tramadol has its main effect through opiate receptors, but also inhibits 
the reuptake of serotonin and nor-epinephrine. It may cause serotonergic syndrome, especially when 
used with antidepressants. (133)Inhibitors of CYP3A4 may affect metabolism of tramadol and its 
metabolites.(134) Codeine is frequently used in combination with paracetamol (as oral combination 
drugs for moderate pain) and is metabolized to morphine by CYP 2D6. Eight percent of the Caucasian 
population has a genetic polymorphism making them poor metabolizers and having no analgesic effect 
of codeine.(129) Rapid metabolizers have an increased conversion rate of codeine to morphine and may 
develop toxic levels of morphine by standard doses of codeine.(135) This mutation is relatively rare in an 
Caucasian population (3%), while as many as 30% of Arabic or North- African origin may have this 
mutation of CYP2D6. 
1.2.3.4 Nerve block 
Use of nerve block and local anesthesia can be administered both pre-, per- and post-operatively. It is 
widely accepted as an alternative to general anesthesia during surgery, and is often used as a safe and 
effective alternative/supplement to systemic pain medication and. Femoral nerve block is commonly 
used and is reported even better than standard care regimens, (124) another option is a so-called fascia 
iliaca block reported to be easier and safer with similar effect.(127)  
1.2.4 Medical complications following hip-fractures 
Medical complications may develop during the course of a hip fracture. These may be a direct effect of 
the trauma (for instance anemia due to bleeding), a consequence of treatment (as pneumonia due to 
immobilization) or other causes (as delirium in frail patients that have multiple potential causes). 
Standardization of treatment, preventive measures and good routines for follow-up are essential to 
reduce the risk of complications. Research and identification of best practice is necessary and ongoing, 
and traditional treatment is revised every year. 
1.2.4.1 Delirium 
Delirium is defined in the Diagnostic and Statistical Manual of Psychiatric Disorders version 5 ( DSM 
5)(136) as: 
A) Disturbance in attention 
B) Impairment in cognition or perception that is not better accounted for by a preexisting dementia  
C) The disturbance develops over a short period (hours to days) and tends to fluctuate during the 
course of the day 
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D) Disturbances in A and C must not be occurring in the context of a severely reduced level of 
arousal, such as coma 
E) There is evidence that the disturbance is a direct physiologic consequence caused  by a medical 
disorder, medication, intoxication or withdrawal of substances 
If the diagnostic criteria above are only partially met, the term sub-syndromal delirium is frequently 
used.(137, 138) As a rule delirium is reversible, but a protracted course with persisting delirium is 
common. A meta-analysis found that in patients with delirium during hospital stay, 44% had symptoms 
at discharge and 26 % had persistent delirium at 3 months.(138) The studies included, however, were in 
mixed populations and not only hip-fracture patients. 
Risk factors for delirium may be divided in predisposing (“The vulnerable patient”) or precipitating 
factors (139) Other authors have chosen to divide these factors in modifiable (intercurrent disease) or 
non-modifiable factors (for instance age).(140) The mechanisms creating delirium is not fully explained, 
but a state of reduced acetylcholine and excess dopamine is suggested and sometimes combined with a 
inflammatory cascade affecting the central nervous system.(136) 
Delirium affects a large proportion of hip fracture patients, in some materials over 50%.(48, 60) The 
frequency of delirium after a hip fracture is similar to delirium after surgery for aortic aneurisms or 
coronary bypass.(141) In patients without known dementia, delirium during hospitalization for a hip 
fracture is associated with increased risk of dementia during follow-up.(60) It is also associated with 
increased LOS, reduction in ADL and increased use of nursing homes.(142) 
Clinically, delirium may present as hyper active where the patient is agitated, unable to find rest and may 
even be aggressive to care-givers; hypoactive where the patient is quiet with a fluctuating consciousness, 
often bed-resting; or a mixture of these (143) Hallucinations may be present in both hyper and 
hypoactive delirium. The hyperactive delirium is fairly easy to recognize, while hypoactive delirium may 
go unattended. Several assessment tools to diagnose delirium such as CAM (Confusion Assessment 
Method) have been developed and are used extensively in different settings.(144) 
Treatment of the underlying disease is important to prevent delirium. Maintaining physiological 
homeostasis by ensuring oxygen saturation, preventing anemia, control of temperature and blood-
pressure did reduce the frequency of delirium in a Swedish study, but failed to identify an effect of one 
single element.(123) Several studies have shown an effect of pain reduction on the frequency of 
delirium.(130, 145) Opiates are in general recommended (except pethidine).(130, 146) Other elements 
proven to be effective is environmental adaptions of the ward by systematic orientation of patients, 
mental stimulation by access to papers or news, assistance of eating and drinking if necessary, ensuring 
vision and hearing by access to glasses or hearing aid/ speech enhancer and finally ensuring sleep by 
adapting the environment (dimmed lightning, reduction of noise) or access to sedatives.(147) Some 
authors advocate prophylactic use of antipsychotic drugs as haloperidol in high-risk surgical patients.(63) 
Finally, recent guidelines also address the need to focus on elimination to avoid constipation or urinary 
retention.(148) 
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1.2.4.2Anemia and transfusion 
Transfusion of blood between a donor and patient has been a medical option since the middle of the 19th 
century.(149) Arguments for treatment in hip-fracture patients have been patient welfare and reduced 
risk of delirium when correcting anemia,(122) while arguments against transfusion have been religious, 
risk of infection (for instance HIV and hepatitis B and C), unnecessary immunization, cost and little 
evidence of actual benefit of the treatment.(150) Isolated transfusion as a prophylactic treatment of 
delirium has failed to show any effect.(151) Persistent anemia have been used as an argument of failure 
to reach mobilization goals, but correction of anemia have not been shown to improve functional 
outcome in short-term or long term studies.(152, 153) There are reports indicating effects on 
complication and mortality by a liberal transfusion strategy with a treatment goal for hemoglobin (HgB) 
above 10 g/dl, (152) and a recent publication found effect on p-ADL but not on QoL by transfusion with a 
liberal threshold of 11.3 as compared to 9.7 for HgB.(154) Currently the question of when to transfuse 
remains unanswered. 
1.2.4.3 Prophylactic antibiotic therapy 
The benefit of prophylactic antibiotic therapy is well documented in hip fracture surgery,(155)  and 
especially in joint replacement. It reduces infections in implants and also protects against urinary and 
respiratory infections. Any regimen can be used as long as Minimum Inhibitory Concentration (MIC) is 
maintained from start of surgery to the final closing suture. Single dose regimens are not inferior, and 
oral treatment is as effective as other methods of administration.(155) The risk of complications seems 
low, but use of prophylactics may influence resistance pattern of bacteria.(156) 
1.2.4.4Anti-thrombotic therapy 
Hip fractures are associated with increased risk of deep vein thrombosis and pulmonary embolism 
related both to the trauma, surgery and immobilization. There is evidence that prophylactic treatment 
with heparin or low molecular heparin (LMWH) reduces the risk of thrombosis.(157) Studies comparing 
LMWH with other agents (vitamin-K antagonist, Factor Xa inhibitors and Direct Thrombin 
inhibitors)indicate a slightly increased risk of bleeding with LMWH, but the level of evidence is 
limited.(158) For mechanical devices as stockings, there is currently no evidence of effect.(159) 
1.3 Geriatric care  
The term geriatric medicine was suggested by an Austrian Immigrant to the USA, Ignatz Leo Nascher, 
who also suggested for the making of a new specialty.(160) In 1947 the British Geriatric Society was 
founded, first under the name “The medical society for the care of the elderly”, with the purpose to 
improve research in the field of geriatrics. At this time several clinics and hospitals in UK had started 
programs for improving outcome for old people with complex disorders.(161) Several important aspects 
were addressed early in the process: 1. atypical presentation of common disorders in elderly; 2. a holistic 
approach; 3. interdisciplinary treatment and teams; 4. rehabilitation; 5. focus on caregiver stress; 6. 
education. These six elements are still the baseline of geriatric medicine. 
1.3. Geriatric patients 
Geriatric patients are generally old, but age is not the most important factor when identifying the 
geriatric patient. The typical geriatric patient is frail, has multiple comorbidities and is functionally 
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declined.(162) Due to their comorbidities, polypharmacy is common, but also underutilization of 
treatment. The functional decline often involves impairments in mobility, cognition and p- and i-ADL. 
These characteristics are often also found among hip fracture patients that in many ways may be 
characterized as geriatric patients. An earlier publication have identified three hip fracture populations, 
1: home dwelling outdoor fallers (healthy),2: home-dwelling indoor fallers (at risk) and 3: nursing-home 
patients.(41) It is customary to consider population 2 and 3 as “geriatric”, but the evidence for this 
assumption is limited.(41) 
Frailty is an important concept in geriatric medicine and can be defined as a state of increased 
vulnerability to stress due to reduced physiological reserves and physiological dysregulation in multiple 
systems.(162) Each component of frailty may be subclinical, but the accumulation of physiological 
reduction may cause the clinical entity of frailty.(162) Frailty is associated with age, female gender, 
functional disability and comorbidities, but is a separate entity. Clinically, frail patients often presents 
with weight loss, loss of muscle strength, sarcopenia, fatigue, reduced physical activity and reduced gait 
speed. (162) Frailty increases the risk of a poor outcome after a stressful event and is associated with 
fear of falling, increased risk of falls.(23)and increased risk of a fracture after a fall. Associated factors as 
low BMI are important, because low BMI and frailty increases risk of fracture more than eight times. (23) 
Frail patients are often complex,(163) with functional decline and comorbidities. Specialized care and 
guidelines focusing on single diseases or single functions often fail to address the complexity. An 
interdisciplinary, holistic approach as given in geriatric medicine is often necessary to obtain clinical 
improvements. Even if each intervention may seem small, the accumulated effect of this whole person 
approach may improve health and increase the patient’s capacity to overcome perturbations. 
1.3.2 Comprehensive geriatric assessment 
The comprehensive geriatric assessment is the fundament of all geriatric treatment and care.(163) This 
consists of a systematic investigation of physical, psychological, functional and social status performed 
by a multidisciplinary team consisting at least of a geriatrician, a geriatric nurse and a physical therapist 
working together and creating a joint plan for the patient. Other members in a team may be an 
occupational therapist, social worker or a dietician. Use of standardized tests for investigations over a 
range of domains is common. Early discharge planning in close collaboration with the patient and next of 
kin and the primary health care is important, as is early mobilization and rehabilitation. This assessment 
should generate a management plan defining short- and long term goals including hospital care, a plan 
for rehabilitation and the need for follow-up after discharge. The comprehensive geriatric assessment 
often includes an ambulatory follow-up when returning home.(164, 165) In Norway, ambulatory follow-
up is mostly done by a team from the municipality. This model have been examined in several studies 
and meta-analysis, and is found to reduce mortality, morbidity and reduce need for institutional 
care.(165) 
1.3.3 Orthogeriatric treatment 
Patients with fragility fractures and especially hip fractures share many features with geriatric patients. 
In orthogeriatric treatment methods developed in geriatric medicine are applied on patients suffering 
from fragility fractures. Today, the key element is comprehensive geriatric assessment combined with 
focus on optimal surgical timing and treatment of the fracture.  
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 The special needs of hip fracture patients have been recognized for a long time. The first 
orthogeriatrician was Lionel Cosin, a surgeon working with rehabilitation. He was present at the founding 
of the geriatric society at St Johns Hospital, London,  in 1947,and thereby recognizing hip- fractures as a 
geriatric disease.(166) Later Devas (orthopedic surgeon) and Irvine (geriatrician) developed an acute care 
model with shared care between orthopedic surgeons and geriatricians where early surgery was 
followed by a geriatric intervention and focusing on early mobilization.  
Different models of orthogeriatric care for hip fractures have been developed, but so far the evidence of 
effect has been limited and to some degree conflicting. There are few publications presenting long term 
outcomes and economic considerations. (167-169) Today, literature describes three to five different 
models for orthogeriatric care, (170-172) with some overlap between the models. An overview of 
models, interventions and results are given in Table 1, section a, b and c. 
1. Geriatric consultations  in an orthopedic ward 
a) Liaison service 
The simplest model is the orthogeriatric liaison service. In this model the surgeon, by demand, 
contacts the geriatrician for a consultation while the patient is in hospital.(173) The geriatrician 
makes a formal investigation of the patient, identifies problems and suggests a solution. Changes 
in treatment and follow-up are then performed by the surgeon or GP, if indicated. This model is 
simple, and needs little extra resources if a geriatric ward is present at the hospital. However, no 
study has shown any effect in regard of improved results so far. 
b) Regular consultations 
In this model, a geriatric team investigates all patients as a part of the routines of the orthopedic 
ward. The consultation may take place once or repeatedly during the stay. It may or may not 
include a multidisciplinary investigation. An RCT performed in Glasgow showed that patients 
who were offered geriatric consultations as a part of the daily routine had more diagnoses at 
discharge, but the treatment did not affect outcome or length of stay.(174) As many as 20% of 
the control patients were also investigated by geriatricians. Education of surgeons during the 
study may also have affected outcome. A study in Canada evaluating a multidisciplinary team 
doing regular rounds twice a week found no significant effect on death, ambulation, transfers  
from bed to chair or ability to stay in own home.(175) The study also included nursing home 
patients which may have affected the outcome and the potential for improvement
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2. Models of multidisciplinary care in an orthopedic ward 
a) Co-managed care  
Models where orthopedic and geriatric doctors have shared leadership over the orthogeriatric unit, is called a 
co-managed model.(185, 186) Decisions regarding the patients are taken by the multidisciplinary team, with 
both medical professions present. Some units with co-managed care treat patients from the emergency room to 
discharge from the hospital , while others are in-hospital rehabilitation units with focus on post-operative care 
and early rehabilitation.(187) 
There are a limited number of reports on evaluation of co-managed care. The group in Rochester comparing 
their data with a national average found reduced length of stay without increasing number of readmissions and 
reduced number of complications.(188) Tarazona-Santabalbina reports a low readmission rate, but is only 
comparing with previous publications from other countries.(189) 
b) Clinical pathway  
A clinical pathway is a model fairly similar to the co-managed model where geriatricians, surgeons and the 
orthogeriatric team share responsibility for the patient.(190) However, the unit is organized as an assembly line 
with stations that administer different elements of treatment. Each profession involved has full responsibility for 
their station. The pathway has predefined standards which limits individualized treatment. In the end, all 
information is collected in a united, multidisciplinary report. 
Again, the evidence of improved results is limited. The NYU Hospital for Joint disease has had a clinical pathway 
for hip fractures since 1990. In 2004 they published results based on comparison with historical controls 
indicating reduced length of stay (21.6 to 13.7days) and a surprisingly low in-hospital mortality (5.3 to 1.5%) and 
one year mortality (14.1 to 8.8%), but found no effect on ambulation, need of surgical revision or discharge 
status.(190) 
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3. Models of multidisciplinary care within a geriatric environment 
a) Geriatric care with orthopedic consultations  
In this model, geriatricians and the orthogeriatric team organize the entire care pathway, with 
orthopedic surgeons performing surgery, and assess fracture specific problems, but otherwise 
have limited responsibility for the treatment.(218, 219) This model recognizes the fact that 
except for the surgical treatment of the fracture, the hip fracture patients have mainly geriatric 
problems which probably are most optimally handled by geriatricians and a geriatric 
multidisciplinary team.  
This model has been evaluated with a pseudo-randomized design where patients entered the 
experimental model or standard care depending of available beds. Improved functional 
outcomes, survival and cost-effectiveness have been shown. (169, 220)
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1.3.4 Rehabilitation after a hip fracture 
The concept of orthogeriatric care has to a large extent been invented in rehabilitation facilities, and 
some of the studies on postoperative in-hospital orthogeriatric services described above may more or 
less be considered as rehabilitation.(93, 235) Several approaches to organize and also minimize the 
period of rehabilitation have been proposed, but the evidence for what is the better is limited.(111) The 
conclusion in a Cochrane review on multidisciplinary rehabilitation is that at least it is not harmful. (240) 
The routines for rehabilitation depend on traditions and available funding more than evidence. Early 
mobilization and physical therapy is found to be beneficial.(241, 242)  The treatment chain of hip 
fractures include the initial therapy including surgery followed by in-hospital rehabilitation, sometimes  
in the ward where patients were admitted for the fracture, or the patients are transferred to an in-
hospital rehabilitation unit shortly after surgery.(230) Other options are specialized rehabilitation 
facilities doing hip-fracture rehabilitation or rehabilitation in a skilled nursing facility depending on 
availability of organization and competences.(243) Most patients in Norway are treated either in a post 
acute specialized rehabilitation center or receive general rehabilitation in an institution similar to a 
skilled nursing facility. 
A third option is home based rehabilitation where the patients receive physical therapy at home or in an 
out-patient clinic.(244) The content of rehabilitation may vary, but most programs focus at improving 
muscle strength, balance and other aspects of mobility. Norway has a public health care system, and 
rehabilitation is available for all patients in principle regardless of economy or insurance.  
This thesis focuses on acute orthogeriatric assessment and care with just initiation of rehabilitation as 
part of the process. Therefore, the more detailed aspects of geriatric rehabilitation will not be presented. 
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1.3.5 Orthogeriatric treatment in Trondheim 
The Geriatric Department in Trondheim was established in April 1994. Between October 31, 1994 and November 13, 
1995, a large RCT comparing outcome of geriatric patients treated in a nine-bed geriatric evaluation and management 
unit with similar patients in a general medical ward. (245) The results were in favor of the geriatric unit with 
improved survival and increased possibility of living at home. The unit now consists of 15 beds and an out patient 
clinic. The unit employs four senior consultants in geriatric medicine, and four residents as well as a multidisciplinary 
staff with nurses, assistant nurses, occupational- and physical therapists. Over time the geriatricians at our hospital 
had the idea to establish an orthogeriatric ward. The opportunity was given during a period of building a  new 
hospital forcing the trauma unit temporarily to reduce their capacity with five beds due to lack of space. These beds 
were established in the geriatric ward with funding from the Orthopaedic Department. This gave the opportunity to 
assess model 3 (known as “The Sheba-model”) in a RCT. This was also based on a literature review as described 
previously, the most promising model for orthogeriatrics that needed to be evaluated through a randomized 
design.(218) 
Details on the rationale for and development of the treatment in the orthogeriatric ward are described in paper 1.  
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2. Aims of the thesis 
 
The overall aim of The Trondheim Hip Fracture Trial was to investigate if comprehensive geriatric care (CGC) 
performed in an orthogeriatric ward was beneficial as compared to conventional orthopaedic care (OC) in an 
orthopaedic ward.  
 
Aims of this thesis are: 
 
1. To describe the background, development and principles for the experimental orthogeriatric treatment 
model and how it differed from conventional orthopaedic treatment (Paper I).  
2. To present the main clinical results of the study (Paper II*): 
a.  mobility at four months (the primary end point)  
b. the following secondary endpoints: 
i.  mobility at one and 12 months, p- and i-ADL, cognition, fear of falling, mood and quality of 
life at one, four and 12 months ,  
ii. use of health care services during 12 months of follow-up 
 
3. To study whether efficacy of CGC on mobility, p-and i-ADL and cognition were dependent of age, gender, pre-
fracture function and type of fracture in the two groups (Paper III). 
 
*) Results from cost- and health economic analysis are covered more thoroughly in another thesis by Gunhild Hagen. 
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3. Methods 
The Trondheim Hip Fracture Trial was a parallel group RCT. The trial was planned according to CONSORT-criteria for 
RCTs.(246-248) 
3.1 Study design 
3.1.1 Planning of the study 
The planning process was in principal divided into two separate parts and took place autumn 2007 and spring 2008. 
The core research group involved researchers experienced in planning and conducting large clinical trials, with 
scientific competences both in geriatric medicine, orthopaedics, health economics, and gait and falls research. We 
also engaged international capacities in clinical research and statistics. Locally, the research group collaborated with 
the Unit of Applied Clinical Research at the NTNU on data management and a web-based, computer-generated 
randomization service. At a later stage health economists and statisticians from NTNU were involved. 
The summer 2007 an application for funding was submitted to the Norwegian Research Council, later offering a grant 
which only partly covered running costs and salaries. Agreement was signed in January 2008. Complete funding was 
received at a later stage with funds from The Central Norway Health Authority; The Department of Neuroscience, 
NTNU; The St Olav Trust; the SINTEF and St Olav Fund for Science and Innovation and also the Municipality of 
Trondheim. The study protocol was approved by the Central Norway Ethics Committee by spring 2008, and the study 
was registered in ClinicalTrials.gov in April 2008. The original study protocol was published as a journal paper in 2011. 
(219) 
A parallel process focused at the clinical care pathway that was developed based on previous routines in the geriatric 
ward for comprehensive geriatric assessment and management, a literature review on evidence for treatment of hip 
fracture patients, visiting Diakonhjemmet hospital in Oslo, and teaching from the Departments of orthopaedics and 
anesthesiology. The assessment and treatment program was continuously adjusted to changes in Best Clinical 
Practice during the study, and was published as a separate paper (Paper I) after finishing the enrollment period.(249) 
3.1.2 Randomized controlled trial 
The design chosen for the study was a prospectively randomized parallel group design. After the orthopedic surgeon 
on call had diagnosed a proximal hip fracture and found the patient to be eligible, the nurse in charge of the patient 
asked her or him to participate, and collected a written informed consent. After the patients had given their informed 
consent they were randomized by the same nurse in the Emergency Room. If a patient was unable to give consent, 
for instance due to acute delirium, written or oral consent from next of kin were collected. Whenever possible, a 
regular consent was collected from the patient retrospectively. If next of kin was unavailable, the Regional 
Committee of Ethics in Medical Research allowed patients unable to give informed consent  to be included as  it was 
considered  unlikely that CGC would harm the patient as compared to standard care, but a written consent had to be 
collected retrospectively.  
 The scientific staff controlled the admission list for the Department of Orthopedics every day to identify hip fracture 
patients not randomized in the Emergency Room. These patients were included and randomized up to 24 hours after 
admission or until receiving surgery using the same procedure as in the Emergency Room. Patients already operated 
and returned to OC were not included. Patients allocated to CGC were either transferred immediately or stayed in OC 
until surgery and transferred to the geriatric ward immediately afterwards.  
We used a web-based computer-generated randomization system prepared by the Unit of Applied Clinical Research, 
NTNU. The participants were randomised in a 1:1 ratio with blocks of unknown size.  After randomization the patients 
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were transferred to their allocated ward. Except for surgery, all patient treatment would be delivered in the allocated 
ward.  
Patients not eligible or not willing to participate in the study were registered with initials, gender and date of birth 
and reason for ineligibility. 
3.1.2.1 Study related assessments 
Patients were assessed at the 5th postoperative day (± 1 day), at 1 month (±1 week), 4 (±2 weeks) and 12 months (±1 
month). Some patients not able to attend a scheduled appointment (for instance due to travel or disease) were 
assessed per telephone. 
3.1.3 Blinding 
It was considered impossible to blind participants and staff including surgeons for patient allocation. It was also 
impossible to blind assessors the 5th postoperative day when assessing patients at the hospital ward. Even if assessors 
did not receive any information of allocation, assessments during follow-up were only partly blinded as they might 
remember the patient from the index stay. In order to check if this influenced the final scores we controlled if scores 
deviated when assessors were the same at index stay and follow-up as compared to different assessors. 
3.2 Study population 
The St. Olav University Hospital serves the county of Sør-Trøndelag with a population of 290 000 inhabitants in 2008. 
The population is relatively homogeneous mainly consisting of Caucasians. Approximately 1/3 of the population is 
served by a community hospital in Orkdal and was not eligible for the trial. At the study start we selected participants 
from four municipalities; Trondheim, Melhus, Klæbu and Malvik with 179000, 15000, 6000 and 13000 inhabitants, 
respectively. These municipalities were chosen because they were in close proximity with the hospital, and would 
give a mix of urban- and rural population. The proximity with the hospital was considered important to achieve a high 
participation at follow-up and to diminish the patient stress of having to go to the hospital. The area of recruitment 
was extended to the entire county after some months due to slow recruitment rate and difficulties for the emergency 
staff to comply with these criteria.  
Patients were eligible for participation if they were 70 years or older, home-dwelling and able to walk at least 10 m. 
They were ineligible if they had a pathological fracture (due to cancer), late-stage malignant disease, other disease 
with an expected survival of less than 3 months, had suffered a high-energy trauma or were already included in the 
study.(219)  
3.3 Delivery of patient treatment  
Detailed checklists, assessment procedures and delivery of treatment are presented in Paper I.(249) This paper 
presents treatment in the experimental and the control groups and gives information on similarities and 
discrepancies between the treatment arms. 
3.3.1 Facilities 
The St. Olav University Hospital is a modern university hospital with a wide range of facilities. It is the community 
hospital for Trondheim and surrounding municipalities. It is also a tertiary university hospital for the three counties 
Sør-Trøndelag, Nord-Trøndelag and Møre & Romsdal. During the study the entire hospital was renewed and the 
building process was finished in 2013. The geriatric ward had been transferred to new facilities at study start and 
consisted of 15 single bed rooms organized in two bed clusters connected to a work station. Five beds for hip fracture 
patients were gathered in one cluster with a total of seven beds. In periods of high activity, the remaining two beds 
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were used for hip fracture patients as well. In periods of low activity, the fracture beds were used by patients 
suffering from other fragility fractures or acute geriatric conditions.  
The ward was constructed to facilitate orientation in older persons with light colors of walls with clear contrasts in 
doors or other obstacles, good lighting in rooms and hallways. The environment was enriched with clocks and 
calendars in every room to support orientation. Patients had access to papers, and there was radio, television and 
internet access in each patient room. The ward had one dining room, and patients were in general encouraged to 
have their meals in the dining room to get social stimulation and as part of mobilization. The ward had wide corridors 
and there was abundant space for walking with any aids and thereby stimulating mobilization. 
At study start the orthopedic ward was located in the old part of the hospital with two- or four bed rooms in light 
colors without any elements specially added to facilitate orientation. Meals were served in the patient rooms. 
September 1st 2009, the orthopedic ward was moved to a new center with wards that were equivalent to the geriatric 
ward. 
3.3.2 Standard treatment in the groups 
Regardless of treatment allocation, all patients were admitted to the Emergency Room and examined by the junior 
orthopedic surgeons on call. Surgery was performed by the orthopedic team on call, a junior surgeon on call with 
adequate experience in trauma surgery or the senior surgeon if considered necessary. Similarities in treatment are 
shown in Paper I, table 3. All patients received intravenous fluid at arrival, anti- thrombotic prophylaxis, paracetamol 
and femoral nerve block as baseline pain treatment and prophylactic antibiotics related to the surgery in most cases. 
Early removal of urine catheter and focus on prevention of pressure ulcers were standard in both arms. All patients 
had access to physical therapy. 
There was no difference between groups with respect to choice of surgery which was decided by the operating 
surgeon using recommendations as described in Chapter 1.2. Before surgery all patients were examined by the 
anesthesiologist on call who evaluated if the patient was fit for surgery and the choice of anesthetic method.  Almost 
all patients received spinal anesthesia. In the CGC arm patients were also examined by the medical resident on call 
between 1600 and 0800 and during weekends, and by a geriatric resident/consultant between 0800 and 1600. If 
indicated, the geriatric/medical doctor would discuss per operative risk with surgeon or anesthesiologist, for instance 
the risk of arthroplasty in patients who were unlikely to tolerate low blood pressure during installation of cement. 
Occasionally surgery was postponed until the patient was deemed sufficiently fit. 
3.3.3 The intervention arm (experimental) 
The main element in the intervention was comprehensive geriatric care (CGC). This method is summarized in Table 2, 
Paper I. It consists of a multidimensional assessment of somatic and mental health, general function and social 
situation. The evaluation was performed by an interdisciplinary team consisting of a consultant or resident in geriatric 
medicine, nurses, a physical therapist, an occupational therapist. Other medical specialists were requested when 
indicated. Each team member had dedicated responsibilities. The team used established and validated tests for 
individualized treatment planning including an early plan for discharge and necessary follow-up. We had a defined 
intention to discharge patients directly to their own home without institutionalized rehabilitation if possible.(244) We 
did not establish any strict criteria for this, but the decision was made at the interdisciplinary team meeting in 
understanding with the patient and her next of kind, and the municipality. Early discharge planning was emphasized 
including if patients needed extra care or aids after returning home. To facilitate discharge to own home, patients 
were introduced to this concept at an early stage of rehabilitation. Patients received written information at discharge 
to own home. If discharged to an institution they received only oral information to avoid later confusion in respect of 
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drug regimen or treatment plans, while the responsible institution received a full medical report including lists of 
drugs and instructions for further treatment. 
Differences of treatments are summarized in Table 3, Paper 1. The number of staff per bed is higher in the CGC than 
the OC and includes more nurses (1.67 and 1.48), more doctors (0.13 and 0.11) more physical therapists (0.13 and 
0.11) and occupational therapists (0.13 versus none). Physical and occupational therapists in CGC were integrated in 
the ward, and were involved as a routine practice with the patient from admission without referrals. There was a 
more vigorous follow-up of fluid intake and nutrition, assessment of pain by the use of a verbal rating scale and focus 
on adequate treatment of pain in the experimental group.(250) Delirium was evaluated using CAM. If saturation was 
below 95 percent, extra oxygen was administered with nasal catheter or mask. Blood transfusion was given with an 
HgB <10.(152) Patients were screened for constipation and urinary retention.  Laxatives were administered 
prophylactically in nearly all patients. Among cognitively impaired patients frequency and amount of defecation was 
registered and necessary actions taken if there were signs of constipation. Patients were screened for urinary tract 
infections by using urinary sticks at admission and by withdrawals of catheters, and urinary retention by using a 
bladder scan. Intermittent catheterization was performed if signs of urinary retention. Most patients in the 
experimental group were screened for osteoporosis either during the hospital stay or were referred to such screening 
after discharge. If untreated before and expected to live long enough to benefit, treatment with calcium and/or 
bisphosphonates should be initiated during the hospital stay, in the out-patient clinic of the Department of 
Endocrinology or by the general practitioner. 
Early mobilization was an essential part of CGC. If possible all participants were therefore mobilized the 1st 
postoperative day by a physical therapist and a nurse, and a plan for the mobilization of each patients was made 
based on pre-fracture function and the current medical situation. The ward was designed to facilitate mobility as 
described under facilities. The physical therapist participated in mobilization of all patients and supervised the staff in 
mobilization methods. However, she had her main focus on patients with the most challenging mobility problems 
while other patients were encouraged to ambulate and were assisted by other staff members to ensure activity. 
Supportive equipment as walkers and rollers was always available in the ward. The occupational therapist ordered 
the correct aid at discharge, and the appropriate aid was present when returning home or in a rehabilitation facility. 
The Cumulated Ambulation Score (CAS) was used the first three days after surgery to assess  mobility.(251) 
The drug regimens were evaluated for all patients. Before surgery we identified drugs considered unnecessary or 
potentially harmful that should be discontinued permanently or temporarily in relation to the surgery. ACE-inhibitors 
and diuretics given against hypertension were generally stopped. Drugs that should be administered before surgery 
were specified (for instance beta-blockers in patients with known cardiovascular disease), either orally if possible, or 
as injections. Extra steroids were administered in patients with possible adrenal insufficiency (mainly due to corticoid 
treatment). A specific focus was given to anticoagulants (vitamin-K antagonists) and novel anti-platelet drugs (for 
instance clopidogrel). For vitamin K-antagonists we considered INR level which should be below 1.8 in case of spinal 
anesthesia. This was achieved by drug cessation and/or administration of K-vitamin. In some cases coagulation 
factors were administered intravenously. For potent platelet inhibitors surgery was postponed or platelets were 
transfused (due to the risk of spinal hematoma) depending mainly on the choice of the anesthesiologist.  
After surgery a comprehensive evaluation of the drug regimen with respect to indication for treatment, doses, 
possible side-effects and under-treatment of medical conditions was performed. There was a specific focus on drugs 
associated with falls such as CNS-acting drugs including sedatives, and drugs affecting the cardiovascular system. A 
special attention was given to drugs with potential anticholinergic side effects. The START and STOP criteria were 
applied to a certain extent, although not systematically.(252) In patients using diuretics the diuretic was removed if 
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the treatment indication was weak or absent, or if the patients suffered from side-effects as orthostatic hypotension 
and/or urinary incontinence. If indicated, patients with long-lasting anxiety or depression could be offered specific 
treatment of their disorders if considered potentially beneficial. In most cases, however, this decision was left for the 
patient’s general practitioner (GP) as a post acute surgical setting is not optimal for a correct diagnosis. Cognitive 
impairment was common, but in a postoperative setting it would not be appropriate to diagnose dementia and 
therefore treatment with cholinesterase inhibitors was not started during the hospital stay. If indicated, the patient’s 
GP was recommended to initiate evaluation of tentative cognitive impairment and depression when the clinical 
condition had stabilized after the trauma (i.e. 3 months). 
 
3.3.4 Traditional orthopedic Care (Control) 
The orthopedic ward followed standards of orthopedic care in Norway. Patients were evaluated in traditional ward 
rounds with nurse and surgeon and being mobilized the 1st postoperative day. Meals were served in the patient´s 
room. All patients were formally referred to physical therapy if not considered unfit. Pain medication was 
administered as baseline paracetamol and long- or short-acting opioids if indicated. There was no systematic review 
of patient drugs during hospital treatment (the routine for vitamin-K antagonists and platelet inhibitors were similar 
as for the intervention), and during the study period no clinical pharmacologist was employed at the department. A 
comparison of treatment in the geriatric intervention ward and orthopedic ward is given in table 3, Paper I. 
There was no structured and team-based discharge planning, but discharge was ordered by the responsible surgeon. 
The patients received information from the surgeon, responsible nurse and physiotherapist if indicated. As for the 
intervention, patients only received written information when discharged to own home. The patient’s GP and 
institutions receiving the patient after discharge received a written report as standard. 
September 1st 2009 the orthopedic ward changed facilities from the old ward with two- and four-bed rooms, to a new 
building with single-bed rooms with modern facilities. At that time 219 of 397 patients had been included in the 
study.  
3.4 Outcomes 
The Trondheim Hip Fracture Trial has used a variety of different outcome measures.(219) Most of our tools are 
validated for the group studied and are recommended for use in frail populations. Performance based tools are used 
when available and eligible, and especially for the primary outcome, while e interviews with patient or caregiver are 
used if appropriate for some secondary outcomes. This section contains a presentation of each outcome and a 
summary of each tool describing: 
x Measured outcome, and associated tests 
x Description of the different elements of the test 
x Strengths and weaknesses 
x Definitions of clinically important change 
3.4.1 Mobility 
Mobility at 4 months was the primary outcome. Both assessment instruments were performance based and testing 
lower extremities function. 
3.4.1.1 Short Physical Performance Battery (SPPB) 
SPPB has three domains: Balance (0-4 points), sit to stand (0-4 points) and gait speed (0-4 points) scoring a total of 12 
points.(253) It is found appropriate in frail and old populations. It has a ceiling effect in very healthy and mobile 
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individuals, but in a hip-fracture population this is not a problem. The possibility of a nil score for patients unable to 
walk prevents a floor effect.(254) A change in scores of 0.5 points for the individual patient is found to be clinically 
meaningful, while a difference of 1 point is substantial.(255)  
3.4.1.2 Timed Up and Go (TUG) 
TUG measures time used for a  patient sitting on a chair to stand up, walk 3 meters, turning, and walk back and sit 
down again.(256)The main strength of the method is its widespread use in studies of old in general and in hip fracture 
studies. The main weakness is a pronounced floor effect as many patients are unable to get a score if unable to walk, 
and it does not discriminate between different difficulties of walking (for instance difficulties in standing up from a 
chair as compared to slow walking speed). 
There are no studies evaluating clinical meaningfulness of changes in TUG scores.(257) There are, however, data on 
normal scores and scores associated with adverse outcomes as falls. In a healthy population a normal score is less 
than 10 seconds, while spending more time than 16 seconds is associated with increased risk of falling.(258, 259)In 
hip fracture populations, a TUG score >24 seconds is associated with increased risk of falling after discharge from 
hospital.(260)  
3.4.2 Activities of daily living (ADL) 
3.4.2.1 Barthel Index (BI) 
BI is a measurement of p-ADL.(261) It is a 10 item questionnaire with a maximum score of 20. The items of BI are 
feeding (0-2 points), bathing (0-1 points), personal hygiene (0-2 points), dressing (0-2 points), bowel control (0-2 
points), bladder control (0-2 points), use of toilet (0-2 points), transfer between chair and bed (0-3 points), mobility 
(0-3 points) and stair walking (0-2 points).  Maximum score of each item is 1 to 3 points. 
 An advantage of BI is that it is well established and widely used both in clinical practice and research. It may be used 
both as a questionnaire or in interview both face to face or by telephone and still have acceptable precision.(262) BI is 
found to have an acceptable sensitivity to change that is valuable in a longitudinal study, but it may have a floor 
effect in very frail populations and a ceiling effect in populations with better functional capacity.(263)  
Depending of methods used, Minimal Clinical Important Difference (MCID) is between 1.49 to 1.85 points. 
(264)Impairment in BI would be a strong indicator of dependency, increased  LOS and in many cases indicates need 
for 24 hours care or at least need for rehabilitation.(265)  
3.4.2.2 Nottingham Extended Activities of Daily Living (NEAS) 
NEAS is a measurement of i-ADL. It was developed primarily as a measurement of i-ADL in stroke patients,(266) but 
has previously been used in hip fracture and hip replacement populations.(42, 267) It consists of four domains with 
22 items scoring 0 to 3 points giving a maximal score of 66: Mobility with six  items: outdoor walking, stair walking, 
getting in- and out of a car, walking on uneven ground, ability to cross roads and use of public transport. Kitchen 
activities with five items: independent feeding, ability to make a hot drink, ability to transport a hot drink between 
two rooms, dishwashing and cocking a meal. Domestics with five items: managing own money, hand-washing of 
clothes, housework, shopping and laundry. Leisure time activities with six items: Reading books or papers, use of 
telephone, writing letters, going out socially, gardening and driving.  
It is used in hip fracture studies,(268), but is less sensitive to change in a healthier population (osteoarthritis 
patients).(269) It has no obvious floor effects, while a ceiling effect has been observed in high functioning hip 
replacement patients.(267) 
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In stroke populations, MCID is found to be between 2.4 up to 6.1 points making differences within this interval likely 
to be relevant and higher values certainly relevant.(270) Specific data for hip fracture patients have not been found. 
3.4.3 Cognition 
Cognitive function can be tested with performance-based methods, and with questionnaires. Tests by questionnaires 
are necessary to gain any pre-fracture data. We have therefore used both methods. 
3.4.3.1 Clinical Dementia Rating (CDR) 
CDR is an established questionnaire-based method to evaluate cognitive function. (271) It has been used to screen for 
dementia since 1982. It consists of six domains; memory, orientation, judgment, community affairs, home and 
hobbies and personal care. Each item scores 0=normal; 0.5= slightly reduced; 1= mild cognitive failure; 2=moderate 
cognitive failure and 3= severe cognitive failure. We have used the sum-of-boxes approach for scoring, where the 
scores of each item are summarized into a total score which is used to categorize the patient into four categories; 
normal (0 points), possibly reduced (0.5 to 4 points), mild dementia;(4.5 to 9.5 points), moderate dementia (10-15.5 
points) and severe dementia (16 to 18 points.(272) 
CDR allows for all sources of information to be used in scoring the patient even if it is primarily designed for carers 
and next of kin(273) It allows for information to be collected in retrospect,(274) making a pre-fracture estimation of 
cognitive function possible. It has a strong focus on memory (in the original test by Hughes it was the main category, 
with the five other categories used as adjustment) making it primarily a test for Alzheimer’s disease and not the more 
general group with cognitive impairment. It is not sensitive to change, and we have not found any data on MCID even 
if the sum-of boxes approach may make such analyses more feasible than the standard approach.(272) The 
Washington University Alzheimer's Disease Research Centre who created the test recommends that users take an 
online seminar to ensure reliability of scoring. 
3.4.3.2 Mini Mental Status Examination (MMSE) 
The MMSE is an extensively used performance based screening test for cognitive impairment.(275) It is designed for 
repeated testing with specified instructions when retesting the patients. Time between tests affects reliability, and 
test intervals of less than six months have an uncertain value. (276) MMSE consists of 20 items in five groups; 
orientation (10 items 10 points), registration (1 item 3 points), calculations and attention (1 item 5 points), recall (1 
item 3points) and higher functions (language and constructional praxis; 7 items 9 points).(277) The maximum score is 
30 points. Traditionally between 24 and 30 points was considered normal, mild cognitive impairment from 22-24 and 
dementia below 22 points, but most clinicians treat these thresholds with caution as they are influenced by 
educational level and age. A person with an academic degree or profession are likely to score better in an early stage 
of dementia, and a candidate with only primary school or less may have a normal cognitive function with a score of 
22.(277)  
It has a better sensitivity to change than the CDR, but it is not very sensitive.(276) A change in MMSE of 2-3 points is 
considered to be of importance.(277)  
3.4.4 Mood 
3.4.4.1 Geriatric Depression Scale (GDS) 
GDS short-form with 15 questions was used to evaluate depression in our study.(278) This is a generic questionnaire 
with a dichotomous yes/no option developed for an old population, and it has also been used in hip fracture 
studies.(279-281) GDS has a factor structure of five groups within the domains; sad mood, lack of energy, positive 
mood, agitation and withdrawal.(282) Each of the answers indicating depressive symptoms is scored one point. There 
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is a cut-off for probable depression at 7 points. It may be less sensitive for depression in institutionalized 
patients,(283) and there is conflicting evidence regarding sensitivity to change.(284, 285)  
3.4.5 Fear of falling 
3.4.5.1 Falls Efficacy Scale International –short (FESI-s) 
We have used the FESI-s to assess fear of falling. (286) This is a 7-item scale based upon  the original 16 item FESI 
developed by the Prevention of Falls Network Europe (ProFaNE).(287) The seven items are: dressing or undressing- 
taking a bath- getting in or out of a chair- walking stairs- reaching for something above your head or on the floor- 
walking a slope- participating in a social event. Each item may be scored 1-4 points, spending from: Not at all 
concerned to very much concern with possible sum scores from 7 to 28. Compared with the original FESI, it is easier 
to perform and less exhausting for frail patients. The short-FESI has showed good validity regardless of cognitive 
function.(288) When used in populations with risk of falls or recent falls it has no ceiling effect, and there is no floor 
effect in frail populations.(289) 
 It is found to be reasonable sensitive to change.(288) Trials have identified cut-off values correlating with low (7-8 
points), moderate (9-13) and high risk (14-28) of falling for FESI-s.(289) 
3.4.6 Quality of life (QoL) 
Tools for estimating QoL  may be disease specific or without connection to the disease studied.(290) The latter 
instruments are necessary to perform cost-utility analysis. 
3.4.6.1 EuroQol  
EuroQol is one of the most widely used generic instruments to estimate QoL.(291) We have used the EuroQol 5 
dimensions (EQ-5d) instead of the original with six dimensions .(292) The five domains  are mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression and each item scoring  from 1 to 3, no problem to unable to 
perform or maximal problem. This generates a 5-digit code between 11111 (no problem in any field) and 33333 
(worst quality of life imaginable). Each combination of digits gets a decimal value between -0.594 (worst possible 
quality of life and 1 (perfect life). Death has a defined score of 0 indicating that some states are considered worse 
than death.  
A separate part of the instrument is the EQ-5d scale (“thermometer”) scoring between 0 and 100 were 100 is perfect 
health, whereby the patients score their health on a VAS scale between 0 and 100. 
3.4.6.2 QALYs (Quality adjusted life years)  
QALYs are used in cost-utility analyses. The general expression for QALYS can be written as follows: 
 1 1 1
0
T
2
n
t t t
t
Q Q T
QALY
T
 
 
ª º u« »¬ ¼¦   
 The numbers of measurements are n, T is the time of the study period and Q is the utility measurement. Qt is the utility value at 
time t. (293) 
QALYS are calculated from the difference in a generic utility value, for instance EQ5-d over a given period of time. 
One QALY equals one year in perfect health.(294) A treatment improving the EQ-5d score with 0.1 point over one 
year gives a benefit of 0.1 QALY. If the extra cost of the treatment is 5000€, the cost utility result will be 
50000€/QALY. As cost utility analyses are not a part of this thesis, this will not be discussed any further. 
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3.4.7 Baseline registrations 
3.4.7.1APACHE II 
The APACHE-II is a system to evaluate and estimate preoperative risk. (295) It is a complex algorithm containing a 
series of clinical variables as well as information of chronic and acute disease. This generates a score that gives an 
estimate of risk related to surgery. It consists of 12 physiological measurements: Temperature, mean arterial 
pressure, heart rate, respiratory rate, oxygenation, pH, s-sodium, s-potassium, s-creatinine, hematocrit, white blood 
count and Glasgow Coma Scale (GCS). We calculated hematocrit from hemoglobin and did not measure hematocrit 
separately.(296) Each measurement is given a score from 0 (normal) to 4 (highly abnormal- low or high). The APACHE 
II score is the sum of A+B+C.The sum of values of the physiological score generates value A. Value B is deduced from  
the patient age; <44 years 0 points; 45-54 2 points; 55 to64 3 points; 65-75 5 points and >75 6 points. Chronic 
diseases are scored under C and give 5 points for emergencies or non-surgical patients (for instance a septic infection) 
having terminal liver, lung, renal or heart failure or immunodeficiency (related to drugs or disease). Elective surgical 
patients get 2 points for the same disorders. In our study minimum APACHE II score is 5 due to age. 
We assumed that missing physiological variables were normal if not registered at admission. GCS, heart rate and 
blood pressure were in general well documented, while respiratory frequency was occasionally missing. To affect 
APACHE II it had to be above 25. Earlier studies have shown that approximately 35% of patients have minor 
abnormalities at admission, but most of these were laboratory anomalies that were routinely done in the ER in our 
study and few patients had deviations in physiological variables. (297)  
3.4.7.2Charlson Index 
Charlson index of comorbidities  consists of 17 different diagnostic groups scoring from 1 to 6 points.(298) Diagnosis 
of cardiac infarction, heart failure, peripheral vascular disease, cerebrovascular disease, dementia, pulmonary 
disease, connective tissue disease, peptic ulcer, liver disease and diabetes scores 1 point. Complicated diabetes, 
paraplegia, renal disease and cancer scores 2 points. Metastatic cancer and severe liver disease scores 3 points and 
HIV-infection scores 6 points. Only diseases identified at admission were used.  
3.4.7.3 Type of fracture 
All fractures included in the study were coded according to the ICD10 as proximal femoral fractures. The fractures 
included are femoral neck (S72.0), per- trochanteric (S72.1) and sub-trochanter fractures (S72.2). The fractures are 
registered both with their respective code, and collapsed and dichotomized as intra-capsular fractures (S72.0) or 
extra-capsular fractures (s72.1 and S72.2). 
3.4.7.4 Surgical procedures 
There is a variety of surgical procedures available for hip fracture patients. We have registered surgical codes as 
specified in the surgical description, and we use The Nordic Medico-Statistical Committee Classification of Surgical 
Procedures (NCSP) for coding. All codes are in Chapter N for movement apparatus and F for proximal femur. In the 
analyses we have not differentiated between hemi-arthroplasty and total arthroplasty as very few patients were 
offered the latter alternative. 
When presenting data in regard of procedures, we have collapsed surgical codes into four groups: arthroplasty, 
screws, plates and other. Even in the collapsed form, patients may have more than one procedure. 
3.4.7. 5 Other 
We registered, if available, demographic characteristics of marital status (married, widowed), living arrangements as 
living alone or with family members (co-habitants) and residing in sheltered housing. Prescribed drugs and regular 
use of prescription free drugs such as NSAIDS or paracetamol were also registered.  
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3.4.8 Clinical registrations  
Clinical variables were registered manually by extraction from medical records including notes, charts, surgery, forms, 
imaging reports and laboratory data.   
3.4.8.1Complications 
We have registered a number of complications during the index stay. We had a specific focus on infections, especially 
urinary- , pneumonia and wound infections. We also registered other major complications as they were documented 
in the patient´s medical records: heart attack, stroke, surgical complications, thromboembolic complications as deep 
venous thrombosis or pulmonary embolus and complications due to failure of an arthroplasty. For identifying 
infections we used notes in medical records or start of antibiotics indicating an infection if information in medical 
notes were lacking. Delirium was not registered as part of the study, even if it was identified as part of the clinical 
treatment program in the CGC arm. 
To identify bleeding we have used notes in medical records in combination with information of transfusion. We have 
registered information of transfusion pre, per- and postoperatively including number of units of blood or erythrocytes 
administered. 
Serious complications after discharge may lead to readmissions, but a majority of readmissions are for non-surgical 
complications which are difficult to differentiate from new disease.(299) Readmissions are therefore described in 
3.4.9. 
3.4.8.2 Mortality 
Data on mortality are registered one year after fracture. Date of death is collected from The National Registry. The 
last registration of death was made January 2012 as the finally enrolled patient finished one year follow-up. We 
therefore possess complete data of death during follow up. Data of death is presented as death before surgery, one 
month, four  months and as 12 months mortality. We have not specified in-hospital mortality. 
3.4.9 Use of health care services   
We have registered use of health care services during one year after the fracture. The registration includes use of 
both in-hospital resources and use of services in the municipalities. Data from the index stay and readmissions were 
collected from National Patient Registry (NPR) and hospital registries, while data from the municipalities were 
collected from The National Registry for Statistics of Individual Care and Nursing (IPLOS). Data were registered one 
year after the initial admission. 
NPR delivered data on LOS and readmissions based on a patient file with identifiable data including date of birth and 
admission. Data form the municipalities were collected in two ways. A research assistant (physiotherapist) was 
granted access to the registries of the municipality of Trondheim and registered the available data directly in the 
database. For the remaining municipalities, forms for the individual participant was sent and filled in by staff in the 
municipality. The forms were then returned and registered in the database by a secretary at the Department of 
Geriatrics. 
All services that include a stay at a treatment facility are registered as LOS in hospital, rehabilitation and nursing 
home care. A patient is registered as admitted the day she arrives regardless of time of the day until and including the 
day of discharge. When use of resources overlap (for instance at discharge between two levels of care), the highest 
level take precedence.  
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3.4.9.1 In-hospital use of health services 
In-hospital resources include facilities, personnel resources and consumer goods used by the individual patient. Table 
1, Paper I gives an overview of type of resources used in each arm of the study. Personnel resources are defined as 
staff per bed and are a constant for each ward. The number of staff per bed is higher in the CGC than the OC as 
described under Methods section 3.3.3. Facilities are described in Methods section 3.3.1.LOS times the constant for 
each ward is the actual use of health services within the ward. Consumer goods consists mainly of resources used 
during surgery, and is not discussed any further in this thesis as it is independent of allocation as defined by 
randomization.  
3.4.9.2 Rehabilitation 
We registered rehabilitation as LOS in a rehabilitation facility. This includes rehabilitation as registered in NPR in 
specialized rehabilitation facilities (similar to in-hospital rehabilitation), District Medical Centers which are inter-
municipal rehabilitation facilities and rehabilitation wards (similar to a skilled nursing facility) in single municipalities 
often located in a nursing home. These data were collapsed before final analyses into one group. 
3.4.9.3 Use of health services in the municipalities 
Care provided by the municipalities is registered in for all patients receiving any form of care. We have also used data 
from NPR for medical consultations and for consultations with PT paid over NPR. We have not registered informal 
care or care provided by private suppliers. 
Table A2 (appendix paper 2) gives a detailed list of services including nursing homes. Services are listed dichotomized 
(have/have not) or as a volume with an appropriate measure (days, hours, minutes). Data of start and stop of a 
service is also registered. Services are registered as intended use (decision), not as actual use.  
3.5 Statistics 
In addition to a description of the methods used to analyze data in a study, statistics also includes a comprehensive 
description of handling of data including analysis, efforts to avoid missing data and the quality process in registration 
and controlling the data files. Transparency in data handling is important to achieve quality during the entire process. 
The principles used to handle data in our study are described in our analysis plan (Appendix).(300)  Elements to 
ensure quality are patient relevant outcomes, realistic test schedules at follow-up, efforts to reduce participant 
attrition and finally a multi-level quality control system with independent and repeated controls of quality, evaluation 
of types of missing data, imputation when appropriate and use of robust pre-specified analytical methods to avoid 
“shopping for p-values”. 
3.5.1Types of data 
Our data are in four groups, nominal data as type of fracture or choice of surgery, binomial data as gender or group 
allocation, discrete variables as the SPPB, FESI-score or number of drugs and finally continuous data as TUG-score in 
seconds, age or LOS. Due to the size of the scales of the discrete data, they are treated analytically as continuous 
data.(301) 
Most data in our study are repeated measurements allowing for use of methods for longitudinal analysis. Data from 
the index stay and background data are measured once and analyzed by methods appropriate for single 
measurements. 
3.5.1.1 Distribution 
Most outcomes are normally or close to normally distributed. Most baseline data are binomially distributed. 
Distribution is checked for by manually inspecting distribution curves and Q-Q plots 
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3.5.2 Missing data 
Missing data is a challenge in all clinical trials, but especially important in studies of frail elderly persons.(302) Missing 
data may be due to attrition, mortality, intercurrent disease or missing attendance due to other causes. Predefined 
strategies on how to handle different types of missing data, and systems for evaluation of missing data is important. 
We can divide missing data in three categories, missing completely at random (MCAR), missing at random (MAR) and 
missing not at random (MNAR).(303) MCAR is in principle completely independent of outcome and subject tested and 
happens by chance alone. MAR exist if “the probability of dropout is conditionally independent of the unobserved 
measurements given the observed measurement” or that no confounder may explain the missing data, only the 
information already present.(304) MNAR has a clear correlation between missing data and a factor with the subject. 
An example of MCAR is loss of data due to a technical error with equipment while an example of MAR may be a 
patient failing to attend a test due to intercurrent disease (related to decline of health).In MNAR there is a correlation 
between the missing data and the patient. For instance, when comparing to regimes of cancer treatment, one 
regimen may have more missing data due to more side effects than the other regimen. 
3.5.2.1 Type and handling of missing data 
In our study the following categories of missing data was identified and handled as described. We have analyzed all 
data as intention to treat (ITT) including patients with missing data or incomplete follow-up in the analyses. 
Missing items are the most common kind of missing data. In our study missing items were present, but to a moderate 
degree (<5%). We used simple imputation by the Expectation Maximation (EM) algorithm for imputation of single and 
double missing items on questionnaires and performance tests, using scores from the same time-point as predictors. 
(304) If the algorithm created an impossible value, the result was corrected to the closest possible value for the actual 
item. Imputed values including a decimal number were used even if the regular items only included integers. Multiple 
imputation were used to a limited extent in our study.(305) In paper II, multiple imputation was used on EQ-5d as a 
part of the cost utility analysis.  
Missing forms are not unusual, and at each scheduled appointment 10% of participants had one or more missing 
forms. This could be related to patients being unable to attend, but still being able to answer some of the 
questionnaires for instance by telephone. Forms with >2 missing items were considered missing. Missing forms are 
handled by mixed models which are a way of reducing the consequence of missing data in longitudinal studies. It uses 
available data, and does not need complete datasets to do an analysis.(306) It is sensitive to NMAR and a careful 
evaluation of the cause of missing data should be performed before using mixed models.(307)  
Missed appointments were registered to a limited degree and are presented in the flow chart, Paper II. We have 
differentiated missing appointments due to absence and death were the data is not missing, but do not exist (except 
for EQ-5d with a score of zero). As for missing forms, missing appointments are handled by mixed models. 
To reduce the risk of absence, extensive measures were taken. Participants received written information of when to 
meet in advance of every visit to hospital for assessments. The day before tests, patients were reminded of the 
appointment by phone. Patients from the municipality of Trondheim were transported to the hospital by a dedicated 
taxi driver who assisted the patients from house to the test lab and back. The same driver was used during the entire 
project to increase comfort and feeling of safety for the patients. 
3.5.2.2 Withdrawn 
Participation in the study was voluntary and some patients withdrew. Most patients withdrew from further 
assessments, but accepted that data was collected from registries, only one patient refused both further assessments 
and collection of any data from registries. 
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3.5.3 Data analyses with mixed models 
All analyses of repeated measurements in our study were done by longitudinal mixed models. This method has 
several advantages. It is considered the preferred method when there are missing data, when the pattern of missing 
is CMAR or MAR, when the study population is large or moderately large, and when data is collected over time with 
irregular time intervals.(307) Mixed models are in general more robust to violation of assumptions as compared to 
other methods of analyzing longitudinal data.(308)  
The analyses in our datasets are done on total scores for each test at each time point. We have performed simple 
imputation as described above to increase precision of our estimates, and to use as much of available information as 
possible. Outcomes are dependent variables, with time and group allocations as factors. 
3.5.3.1 Co-variates 
A key element of mixed models is to increase precision of the analysis by using co-variates as a controlling 
element.(308) This reduces errors and standard deviations. We have chosen our covariates in this study based on 
clinical judgment because the selected covariates are likely to be of importance. In the present papers, gender, age 
and fracture type are covariates as all are shown to affect outcome.(92, 309) 
3.5.3.2 Interaction analyses  
An interaction analysis are a mixed model were additional factors are added to the analyses, evaluating the effect of 
each factor of the total effect and if the factor significantly affect outcome. In paper III we present 16 two-way 
interaction analyses where age, gender fracture-type and function by NEAS are used as factors when analyzing SPPB, 
BI, NEAS and MMSE. 
3.5.3.3 Sensitivity analyses 
Sensitivity analyses are used to evaluate if a change in assumptions affect a result of an analysis. An example is to 
perform analyses of both intention to treat and per protocol analysis to see if conclusions differ, or perform analysis 
with and without outliers in a dataset. It is customary to use the same methodology in a sensitivity analysis as in the 
regular analysis. We have used two-way interaction analyses in mixed models with treatment in old orthopedic ward 
as a dichotomized factor. The analysis was performed for SPPB, BI and NEAS.  
3.5.4 Other analysis 
Most analyses in this study are mixed models on longitudinal data. However, some data from the index stay and also 
background data are not longitudinal. We have used linear regression to evaluate LOS during the index stay.  We 
wanted to use similar methods including the same co-factors as were used in mixed models, but without longitudinal 
data.(301) Chi- square tests were used to compare groups in cross tabulations of baseline values. We have used the 
methodology developed by Newcombe to compare proportions and create confidence intervals for proportions in 
the study.(310) The results from Newcombe`s test for differences between proportions are presented together with 
chi-square analysis. 
4. Ethics 
Research in humans is regulated by national laws in line with the Helsinki Declaration. (311, 312) All research on 
humans has to be approved by the Regional Committee of Ethics in Medical Research before collecting any data. 
Participation in research on humans is voluntarily, and written informed consent is in general mandatory. In cases 
where written informed consent is impossible (for instance due to reduced consciousness), consent has to be given 
by next of kin or a legal guardian. When patients are not legally competent (for instance children, patients with 
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severe mental disorder or dementia), permission to participate are given by their legal guardian. The patient might 
still refuse to participate. The research should be possibly beneficial for the patient, and it should be terminated 
immediately if the method investigated is proven inferior to standard care. The research should also be stopped if the 
novel method during the study is proven superior. The Regional Committee of Ethics in Medical Research is 
responsible for other permissions related to the research as permission to create a bio-bank or applications for the 
Norwegian Data Protection Authority. Human Research in Norway is by law open for inspection by the Regulatory 
Authority and this includes access to data. 
This study was approved by the Regional Committee of Ethics in Medical Research (REK4.2008.335), the Norwegian 
Social Science Data Services (NSD19109) and the Norwegian Directorate of Health (08/5814).It was registered at 
ClinicalTrials.Gov with registry number NCT00667914. 
4.1 Ethical considerations 
Focus on evidence-based medicine has created a demand for evidence even for treatment of elderly, and methods to 
reduce the challenges for elderly recruited to research are wanted. Old patients are considered more vulnerable, and 
need extra protection in respect of research.(313) They may have changes in physiology making them more 
vulnerable for side-effects of treatment, they have more comorbidities including dementia and considerable 
proportions of patients are frail.(162) Complications, mortality and attrition increase risk of missing data.(314) 
Outcomes and tests should be validated both for the condition and for old patients.  
As described in section 3.1.2 we collected written consent for our participants. If patients were unable to give their 
consent due cognitive impairment, we collected written consent from next of kin or oral consent from next of kin if 
they were not present on admission. When next of kin was unavailable, we had permission from the Regional Ethics 
Committee to include patients as the study was considered not to represent any extra risk for patients. In cases of 
lack of written consent or consent from next of kin we aimed at collecting written consent from the patient if he or 
she was able to give it later (for instance after a delirium). 
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5. Results and summary of papers 
5.1 Paper I 
Background: Hip fractures often have serious consequences on function, mobility and mortality. Studies have shown 
that interdisciplinary geriatric treatment may be beneficial compared to traditional treatment, and several models of 
orthogeriatric treatment have been developed.  
Aim: Describe the theoretical basis of the model used in the Trondheim Hip Fracture Study and outline the treatment 
programs delivered in Department of Geriatrics and Department of Orthopedic Surgery (DOS), respectively. 
 
Findings:  
Basis for the experimental treatment: 
Model: We performed a literature search exploring available orthogeriatric models and decided to evaluate a model 
with treatment within a geriatric ward with orthopedic consultations.  
 
Comprehensive geriatric assessment (CGA):  
CGA is shown to improve outcome in acutely sick elderly patients. It should be systematic and multidimensional. 
Treatment should be delivered in a dedicated unit. It should be based on protocols and assessment tools and focus 
on communication with caregivers and patients. Discharge planning should start as early as possible. Early 
mobilization and rehabilitation should be emphasized. 
 
Developing a treatment program for hip fracture patients in a new clinical pathway: 
The Department of Geriatrics (DG) had extensive experience in CGA on medical patients, but very limited experience 
in hip-fracture treatment. The new clinical pathway was based on previous routines of the DG, the existing peri-
operative routines of DOS  and the Department of Anesthesiology (DA) at our hospital and a literature review.  As 
part of the development a group of clinicians visited the orthogeriatric ward at Diakonhjemmet Hospital in Oslo. The 
interdisciplinary team  had input from DOS and DA through teaching and also visited the orthopedic trauma ward. 
The treatment program was piloted during four months before starting the study.  
Program elements: 
- Patient flow: Pre-and postoperative treatment were delivered in DG. 
- Organization of wards: The orthogeriatric unit consisted of five beds that were added to the existing 10-bed 
geriatric unit. The team consisted of a medical doctor/geriatrician, nurse, physiotherapist and occupational 
therapist. The staffing per bed was higher in DG than in DOS. 
- Standard care: Standard care was specified and according to national standards, including focus on hydration, 
femoral block as pain relief, prevention of pressure ulcers and early removal of urinary catheter. 
- Treatment in the experimental group: Comprehensive geriatric care (CGC) should be based on an 
interdisciplinary multidimensional and systematic assessment of all patients focusing on each patient's 
capabilities and limitations as well as development of individual care plans. Discharge planning should start as 
early as possible similar to the approach used for geriatric patients without fractures. 
- Medical assessment and treatment: The new program based on CGA included identification and treatment of 
comorbidities, pain relief, hydration, oxygenation, nutrition, elimination, prevention and management of 
delirium, assessment of falls and osteoporosis, and I early mobilization. 
 
Discussion: 
 A new treatment program for hip fracture patients (CGC) was developed, introduced and run in the DG. The program 
is to be evaluated in an RCT with DOS as control.   
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5.2 Paper II 
Background: Existing literature indicates that orthogeriatric interdisciplinary treatment of hip fracture patients is 
beneficial, but the evidence from large randomized clinical trials is limited. A promising model is the orthogeriatric 
unit managed by geriatricians with orthopaedic surgeons being consultants (except for the surgery).  
Aim: to evaluate the effectiveness of comprehensive geriatric care (CGC) provided throughout the entire hospital stay 
as compared to standard care in orthopaedic trauma ward (OC).  
Methods: The study was a prospective randomised clinical trial (RCT) with two parallel groups, but not blinded. 
Randomization was computer-based and performed in the emergency-room  
We included home-dwelling patients 70 years or older and able to walk at least 10m. They should not suffer from a 
pathological fracture, have an expected survival shorter than three months and should not be the victims of high-
energy trauma. The intervention took place during the entire hospital stay with no specific follow-up. 
The primary outcome was mobility at four months measured by Short Physical Performance Battery (SPPB; 0-12, 12 
better) , and the following secondary outcomes: mobility, p- and i-ADL, cognition, fear of falling, mood, quality of life, 
use of health care services and cost. Pre-fracture variables included personal activities of daily living (p-ADL) 
measured by Barthel Index (BI; 0-20, 20 better), instrumental activities of daily living (i-ADL) measured by Nottingham 
Extended ADL Scale (NEAS; 0-66, 66 better), cognition measured by Clinical Dementia rating (CDR; 0-18, 0 better) and 
early post-operative mobility measured by SPPB was collected at the 5th postoperative day. At one month mobility 
was assessed by SPPB and the Timed Up and Go (TUG; time in seconds). ADL was measured by BI and NEAS.  Mini 
Mental Status Examination (MMSE; 0-30, 30 better) was performed for cognition, depression was evaluated by 
Geriatric Depression Scale (GDS; 0-15), fear of falling was investigated by Falls Efficacy Scale International (FESI; 7-28, 
7 better) and quality of life was investigated by EuroQol –five dimensions (EQ-5d, -0.594-1, 1 better). The same test 
battery including CDR was used at four and 12 months. At 12 months we also collected data on use of health services 
from both the hospital and municipalities over one year after the fracture. In-hospital services included the index 
stay, readmissions and out-patient consultations, while use of institutions including rehabilitation facilities and 
nursing homes as well as home based services as home nursing, home care, safety patrol and meals on wheels were 
registered from the municipalities. Qualys were calculated as a part of the cost-utility analyses. 
Mixed models were used to analyse repeated measurements, where as linear regression was used when analysing 
continuous data without repetition. Results are presented as mean (standard error (SE)). Discrete data was analysed 
with chi-square test and Newcombe`s test for differences between proportions. 
Results: 397 out of 1077 patients were found eligible and included in the study, 198 in CGC and 199 in OC. 547 did 
not fulfill the inclusion criteria, and 54 patients refused to participate. Only 79 potential participants were not 
included due to other reasons.  
Characteristics of the study population: 74% were women, mean age was 83 years, mean pre-fracture BI was 18 
points and the mean NEAS was 41 points. 
The primary outcome as mean score of SPPB at 4 months was 5.12(0.20) in CGC and 4.38(0.20) in OC. (Group 
difference (GD) = 0.74; CI 0.18 to 1.30; p= 0.01). 
Index stay: SPPB at 5th postoperative day was 1.61 (0.19) in CGC and 1.04 (0.20) in OC. (GD= 0.56; CI 0.20 to 1.10; 
p=0.042). 
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One month: FESI was 12.73(0.35) and 13.97(0.37) in CGC and OC; (GD=-1.24; CI-2.24 to -0.24; p=0.015). Outcomes 
not referred at one, four and 12 months were not significantly different between the groups. Scores are referred as 
mean for CGC and OC respectively. 
Four months: BI 16.31(0.29) and 15.30(0.29);(GD 1.01; CI 0.21 to 1.81; p=0.013), NEAS 33.59 (1.29) and 27.42(1.31); 
(GD 6.17; CI 2.57 to 9.78; p=0.001), FESI 11.31 and 12.57;(GD=-1.27;CI -2.27 to -0.27; p=0.013);EQ-5d 0.54(0.03) and 
0.46 (0.03); (GD=0.08; CI 0.01 to 0.15; p=0.033).  
12 months: SPPB 5.30(0.21) and 4.61(0.22); ( GD=0.69; CI 0.10 to 1.28;p=0.023), MMSE 24.13(0.46) and 22.69(0.49); 
(GD=1.44; CI 0.12 to 2.77;p=0.033), BI 16.46 (0.29) and 15.33 (0.30) (GD=1.13; CI 0.31 to 1.96; p=0.007), NEAS35.20 
(1.33)and 28.81(1.41); (GD=6.39; CI 2.59 to 10.19; p=0.001), FESI 10.81(0.36) and 12.03(0.39; (GD=-1.21; CI -2.21 to -
0.18; p=0.021), EQ-5d 0.52(0.03) and 0.45(0.03); (GD=0.07; C! 0.02 to 0.16; p=0.015) and quality adjusted life years by 
QALYs 0.49 (0.02) and 0.42(0.02);(GD 0.07; CI 0.01 to 0.13; p=0.019).  
LOS was 12.6 (0.43) and 11.0 (0.54); (GD= 1.6; CI0.20 to 2.93; p= 0.025); the number discharged to own home in CGC 
and OC was 47/198 and 20/199; p=0.001). Time in hospital after index stay 5.63(11.76) vs 8.35 (15.90) days; (GD=-
2.72; CI -5.48 to 0.04;p=0.05), use of rehabilitation 21.82 (24.44) vs 25.94 (29.46) days; (GD=-4.12; CI-9.52 to 1.29; 
p=0.14) and in nursing homes 51.74 (104.88) vs 65.38 (114.64); (GD= -13.65; CI -35.36 to 8.06; p=0.22).The use of 
home- care services 103.91(168.83) vs 63.70(130.38) hours;( GD= 29.50; CI 9.72 to 69.28; p=0.0095).   
The results of the cost utility analysis reported in Paper 2 found the intervention cost-effective*.  
Discussion: CGC was superior to OC being more clinically effective than standard treatment. The effects were present 
already during the index stay, and were maintained for one year. The differences for use of health care services were 
overall in favour of CGC, except more use of care services at home, although not significant. The cost utility analyses 
found the intervention cost-effective. 
* Cost and the cost utility analysis published in this paper is a part of another thesis and will therefore not be discussed any further. 
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5.3 Paper III 
Background: Observational studies in prognosis of hip-fracture patients indicate that patients with a low pre-fracture 
function (mobility, personal and instrumental activities of daily living (p- and i-ADL) and cognition), men, patients with 
extra-capsular fractures and old patients do worse. There are limited data from large randomised clinical trials (RCT´s) 
on the overall effect of orthogeriatric treatment, and even less on effect in sub-populations of hip fracture patients. 
In an RCT, we found an effect on mobility, p- and i-ADL and cognition of Comprehensive geriatric Care (CGC) as 
compared to standard orthopaedic care (OC). 
Aim: To study if there is differences in efficacy of orthogeriatric care within- and between subgroups based on age, 
gender, fracture- type and pre-fracture function. 
 Methods: The study population is the same as in Paper 2.We investigated if pre-fracture function by NEAS (high 
function defined as NEAS≥45), gender, type of fracture (intra (ICF) - or extra (ECF)-capsular) and/or age (dichotomized 
as 70 to 79 or >80) may influence the effect of CGC on mobility by SPPB, p-ADL by BI, i-ADL by NEAS, and cognition by 
MMSE. Clinically important differences are defined as SPPB > 0.5 points, BI > 1.49 points (264), NEAS > 2.4 points) , 
and MMSE > 2 points .  
Collection of data and methodology is similar to Paper 2. Analyses are performed by mixed models as a three-way 
interaction analyses with group allocation, time and the respective subgroups created by function, gender, type of 
fracture or age as factors.  
Results:  
Within group effects:  
4 months: Patients <80years had an effect in favour of CGC on SPPB (6.4 and 5.3; p=0.017), NEAS (39.2 and 27.7), 
p<0.0001), BI (17.2 and 15.3; p=0.003). Patients above 80 had an effect on SPPB (4.5 and 3.9; p=0.039). 
Women had an effect in favour of CGC on SPPB (5.1 and 4.1; p=0.001), NEAS (33.6 and 27.6; p=0.0001) and BI (16.5 
and 15.4; p=0.005). We found no effect of CGC in men.  
Patients with ICF had an effect in favour of CGC on SPPB (5.6 and 4.5; p=0.001), NEAS (35.0 and 28.1; p=0.0001), BI 
(17.0 and 15.5; p=0.001). We found no effect in ECF. 
Patients with pre-fractureNEAS≥45 had an effect in favour of CGC on SPPB (6.6 and 5.7; p= 0.006) and NEAS (44.8 and 
37.4; p<0.001). Patients with NEAS<45 had an effect of CGC on BI (14.1 and 12.6; p= 0.005). 
Except for the difference observed for BI in women, these statistically significant differences are even clinically 
important. For cognition there were no clinically or statistically significant differences at four months  
12 months: Participants<80 years had an effect of CGC on NEAS (39.0 and 31.3; p=0.003) and on MMSE (25.1 and 
22.9; p=0.035). Participants ≥ 80 had an effect of CGC on SPPB (4.6 and 3.9; p=0.027), NEAS (31.8 and 26.6; p=0.003) 
and BI (16.2 and 15.1; p=0.011). 
Women had an effect of CGC on SPPB (5.1 and 4.2; p= 0.001), NEAS (34.1 and 28.2; p=0.0003) and BI (16.6 and 15.4; 
p= 0.003). For men we only found effect of CGC for MMSE (24.0 and 21.4; p=0.027). 
There was an effect of CGC in ICF on SPPB (5.6 and 4.4; p= 0.0003), NEAS (35.1 and 28.8; p=0.0004) and BI (17.0 and 
15.3; p= 0.0004).Patients with ECF had an effect of CGC on NEAS (31.7 and 27.1; p=0.045).  
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Among Patients with pre-fracture NEAS≥ 45 CGC had an effect on SPPB (6.8 and 6.0; p=0.016), NEAS (47.1 and 38.4, 
p<0.0001), BI (18.7 and 17.7; p=0.031) and MMSE (26.3 and 24.4; p=0.015). 
Effects were clinically significant for all differences in SPPB and NEAS, and most results for MMSE, while the effects on 
BI were below the suggested threshold of clinical importance for all subgroups.  
Between group effects: 
Age: There is a significant effect of CGC in favour of patients aged 70 to 79 years as compared to patients ≥80 years 
for NEAS at 4 months (Group difference (GD) 8.50: p=0.004). The effect disappears at 12 months. 
Gender: There are no between group effects between men and women at four or 12 months. 
Fracture-type: There is a significant effect in favour of ICF at four months for BI (GD= 1.51; p= 0.037) and a trend for 
mobility by SPPB (GD=0.93; p=0.07). These results are maintained at 12 months for both SPPB (GD=1.25; p=0.021) 
and BI (GD=1.49; p=0.045). 
Function: There are no significant between group differences at 4 months, while there is a significant effect in favour 
of patients with pre-fracture NEAS≥45 at 12 months for NEAS (GD=6.83; p=0.012). 
Discussion:  
Our results indicate that there is a beneficial effect of CGC across the subgroups of age, gender, fracture-type and 
pre-fracture function. All subgroups have significant effects of one or more outcomes, and most observed effects are 
even clinically important.  
The between group analyses show that especially patients with ECF has less benefit of CGC as compared to ICF for 
both mobility and p-ADL. For NEAS we registered an effect of CGC in patients 70 to 79 years at 4 months and in 
patients with pre-fracture NEAS≥45 at 12 months.  
Interpretation:  We believe that our strategy of identifying short and long time goals for patients for functional results 
might support recovery even if it takes time. The results for ECF might indicate that the larger trauma and following 
surgery is more determinative, and the benefit of CGC is insufficient to cover the difference. 
To conclude, our results indicate a widespread beneficial effect of CGC, but the results seem to be better in patient 
subgroups with a known good prognosis while there is need of further research, especially on ECF, of males, and 
patients with  functional decline before the fracture. 
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6. Discussion 
The overall aim of the Trondheim Hip Fracture Trial was to investigate if comprehensive geriatric care (CGC) 
performed in an orthogeriatric ward was beneficial as compared to conventional orthopaedic care (OC) in an 
orthopaedic ward. (315)We performed a randomized parallel group clinical trial to study if a model with a geriatrician 
led orthogeriatric ward (Model 3 in the introduction) improved outcome as compared to a traditional orthopedic 
treatment for home-dwelling patients over 70 years of age who had been able to walk before the fracture. CGC had a 
beneficial effect on the primary outcome of mobility at 4 months, and we also found an effect on several important 
secondary end points as p- and i-ADL, cognition, fear of falling and quality of life at four and 12 months. LOS was 
increased for the index stay in CGC, but the overall time in hospital over a year was reduced for CGC. More patients 
were able to be discharged home, and there fewer days in nursing homes and rehabilitation institutions. However, 
patients treated with CGC had more use of home-based services. In post hoc analyses we explored if age, gender, 
fracture type and pre-fracture function was of importance for efficacy of CGC. We found that patients in all sub-
groups had some effect of CGC. Patients with ICF had a significantly better effect than patients with ECF for mobility 
at 4 and 12 months ADL. Patients with pre-fracture-NEAS ≥45had significantly better i-ADL one year after CGC 
compared with patients with pre-fracture NEAS<45. 
 
6.1 Results 
In this section I will discuss the overall results in Paper II and the subgroup analysis in Paper III. I will then try to 
compare our results with existing knowledge and especially against the results from the Oslo Orthogeriatric Trial as 
these two studies were fairly similar in respect of clinical methodology, but to some degree differed in results. 
6.1.1 Mobility 
Mobility at 4 months by SPPB was the primary outcome of the study, and the difference of 0.74; p=0.010 was in favor 
of CGC. The difference is clinically meaningful and probably important to achieve independence in mobility after the 
fracture. The result is maintained at 12 months. The intervention is therefore effective in improving mobility in a 
population of home dwelling elderly hip fracture patients.  
There are several elements in the intervention that was aiming at improving mobility as described under methods. 
We focused on early mobilization, and activity monitoring during the index stay show that patients were mobilized 
more frequently and for a longer period in CGC as compared to OC.(316)The orthogeriatric intervention started 
immediately after transfer from the emergency room, and it is possible that early intervention and increased 
detection of medical problems besides  the hip fracture may have improved patients’ general health status and well 
being, allowing for early mobilization. Effective pain management and focus on pain during activity was probably also 
important. The multidisciplinary team allowed for an early identification of patients with slow recovery after surgery, 
undiagnosed medical disorders and evaluation of the patients’ drug regimens, and allowed for an immediate extra 
effort when needed. Optimal devices for supporting ambulation and function were adjusted by physical and 
occupational therapists. The structure of the team and the regular meetings may also reduce the risk of conflicting 
information from different members of staff, increasing patient confidence during single contacts with team 
members.  
There are limited data on effect of orthogeriatric care on mobility from earlier studies. Models  with geriatric 
consultations report improved walking ability after the treatment program, (179)and a British group reports better 
ambulation after implementing an orthogeriatric care pathway within an orthopedic ward.(198) An Israeli study of 
treatment of hip fracture patients in a geriatric ward found no significant improvement of mobility as compared with 
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standard orthopedic care followed by rehabilitation, but patients in the geriatric group needed less time in institution 
to achieve their mobility.(317)There are publications indicating detection of more complications in orthogeriatric 
units as compared to standard care, (217) but we have no data supporting this as an explanation of improvement of 
mobility  in our trial. In the Oslo Orthogeriatric Trial, that also included nursing home patients, there was an overall  
one point difference in SPPB, and among the home-dwelling patients they report a 2-point difference of median SPPB 
score 4 months after surgery (p=0.04),both  in favor of the intervention group,(48) . The differences reported in the 
Oslo trial are quite large and within the range of clinical significance despite the lack of statistical significance.  Based 
on these two studies we conclude that mobility is improved when home-dwelling patients are treated with CGC. 
 
6.1.2 ADL 
CGC had a beneficial effect on p-ADL with BI scores of 1.01 and 1.13 points better than OC at 4 and 12 months 
respectively. This statistically significant difference is below both suggested thresholds for MCID of 1.45 and 1.85 as 
suggested by Hsieh. (264) There were several aspects of CGC that aimed to improve p-ADL. Daily training in p-ADL 
with focus on patient participation in daily routines by all members of staff was a defined part of the program, and 
more nurses per patient in CGC as compared to OC made this occasionally time consuming process possible. There 
was focus on discharge planning and especially aspects of p-ADL necessary to return to own home, for instance stair-
walking with physiotherapist if the patient had stairs in- or outside their residence. Half of the patients have a close to 
normal BI score at the end of the study indicating  that BI had a ceiling effect making it less suitable to identify effect 
of an intervention in a home-dwelling population, which may explain why the effect was relatively small on a group 
level. 
Other studies have shown improvement or maintaining of p- ADL by orthogeriatric intervention both in consultation 
services and multidisciplinary orthopedic care,(95, 181, 200) but only Shyu have previously reported a positive long 
term-effect. (168) Our results are similar to these studies with small effects on p-ADL with uncertain clinical 
significance. Similar results were also reported from a Swedish postoperative intervention program. (235) The Oslo 
Orthogeriatric Trial reported ADL by BI, but found no difference between the intervention and control groups.(48) 
The effect of CGC on i-ADL assessed by NEAS was large with a difference of 6.2 at 4 months and 6.4 at 12 months in 
favor of CGC. This difference was highly statistically significant (p=0.001). It was also clinically meaningful and well 
above the level of MCID between 2.6 and 6.1 as suggested by Wu.(270) The reasons for the improvement of i-ADL are 
not obvious. An improvement of general health in CGC as compared to OC may allow for more activity. Elements of p-
ADL, such as stair walking are also a part of i-ADL, and will benefit from training. To our knowledge this is the first 
time an orthogeriatric intervention shows an effect of i-ADL. The Oslo Orthogeriatric Trial also reported on i-ADL, but 
their population with many nursing home patients made a measureable effect unlikely. In their home-dwelling 
population they report a difference in favor of the acute geriatric ward of 4.5 points, but this was not statistically 
significant (p=0.35).(48) 
If we summarize all elements of ADL, there are some common factors. It might be a direct result of improved mobility 
as shown by SPPB because 3/10 items in the BI, and 6/22 items in NEAS measures aspects of mobility. Since we have 
an effect on mobility, this will improve ADL as well. The effect on cognition was less obvious, as discussed below, but 
would also improve ADL and especially i-ADL. Finally, focus on motivation and the importance of ADL to return to 
previous place of residence might have a positive effect.  
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6.1.3 Cognition 
There was a small overall effect of treatment with CGC on cognition. At 12 months the patients treated with CGC had 
1.4 points better average score of MMSE which is statistically significant, but below the 2-points threshold suggested 
as a clinical effect on an individual level.(277) Except for Alzheimer populations there are no reference data on a 
group level even in geriatric patients, but the difference found in our study is likely to represent a clinical effect on 
difference of cognition between groups. For CDR there was a difference in favor of CGC, but this was not statistically 
significant neither at 4 nor 12 months. CDR is not very sensitive to change, and is generally more useful to stage 
dementia than to follow response of treatment or progression.(318) 
It is unlikely that the difference between the groups may be explained by difference in pre-fracture cognition. The 
pre-fracture CDR was 2.7 in both CGC and OC indicating no baseline difference. Theoretically differences in type of 
fracture and surgery could create a different strain on the brain in the acute phase of fracture, but there were no 
such differences between the groups. The CGC, however, focused on clinical aspects that can theoretically prevent 
and/or improve delirium. 
 It might therefore be hypothesized that the difference in cognition at 12 months may be explained by frequency, 
duration and severity of acute post-operative delirium.(63) However, we have not collected data on delirium that 
could help us to verify this hypothesis. Other possibilities are removal of potentially harmful drugs in CGC or 
improvement in general health including the trend towards less depressive symptoms that could affect the score of 
MMSE in CGC. A study from Boston investigated acute cognitive function after hip fracture and found less delirium 
after geriatric consultations (1 case of delirium avoided for every 5.6 consultations), (122) but this study did not try to 
show improvement of long-term effects. In the Oslo Orthogeriatric Trial the frequency of delirium was very high, 
more than 50% of patients in both arms had delirium during the index stay, but they also included nursing home 
patients who might be at a particular high risk, (54) and more than 50% of their participants had a diagnosed 
dementia at admission. However, they failed to show any difference in delirium or improvement of cognition during 
follow-up.  
There are few studies reporting long-term effect on cognitive performance by orthogeriatric treatment, only Shyu 
found improved long-term cognition as compared to standard care. (177)The Oslo Orthogeriatric Trial had cognition 
after four months as their primary outcome, but failed to show any short- or long term effect on cognition. Our 
results are promising, but more research is needed to conclude if CGC or other orthogeriatric treatment models 
improve long time cognition. 
 
6.1.4 Use of health care services 
The overall difference of in-hospital time was in favor of CGC although not significant. The increased LOS was 
unexpected as most previous studies indicate a reduction by CGC.(96, 200, 201, 203), but also the Oslo Orthogeriatric 
Trial had longer mean LOS in CGC.(48) An orthogeriatric consultation study from Canada (Table 1a) also reported 
increased LOS, but found no difference in overall time in institutions including rehabilitation after 6 months.(175) The 
clinical methodology in the two Norwegian studies is fairly similar even if the populations differed, suggesting that 
CGC per se may be more time consuming than standard care. CGC may improve detection of complications or 
underlying conditions that make further treatment necessary. Less time spent in hospital after CGC may support this. 
It is also possible that the intention to discharge as many patients as possible back to their previous place of 
residence may have caused increased LOS as one extra day in hospital allowed more patients to return home without 
further rehabilitation. In some cases it was concluded that they were unlikely to benefit from rehabilitation. These 
patients had to wait in hospital for discharge to a nursing home instead of being discharged to a rehabilitation facility 
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at an earlier stage . In the OC occasionally lack of beds may have forced surgeons to discharge patients early despite 
possible benefit of longer stay in hospital. 
Patients in CGC spent fewer days in rehabilitation institutions than patients from OC, but the difference was not 
statistically significant. It may be that patients with poor potential for rehabilitation were discharged directly to 
nursing homes. In addition to factors mentioned previously, this may also be related to better discharge planning, or 
better function reducing the need of rehabilitation in institution, and thereby an increased number of patients could 
be discharged directly home. There are limited reports in literature of rehabilitation after orthogeriatric treatment. 
Studies in stroke patients indicate a long term benefit of early supported discharge as compared to standard care, 
(319) but we have not identified such studies in hip-fracture patients. The results from studies of home-based 
physical therapy are so far inconsistent. (320) Our group is currently investigating the effect of individualized home 
based rehabilitation as compared to standard care in a new RCT.(321)  
The use of services in the municipalities showed more days in institutions after treatment in OC, and more use of 
home-based services after CGC. There were significantly more patients needing a short time stay in a nursing home in 
the OC population after the post acute phase, probably indicating increased functional challenges as observed for 
mobility and NEAS. Increased use of home-based services may indicate that the CGC identified more challenges for 
the patients prior to discharge, or at least provided better discharge planning and it is possible that this affected 
future need of institutions. 
 6.1.5 Other 
Quality of life was in favor of CGC at both 4 and 12 months. This difference was clinically and statistically significant 
and supports findings in previous studies of orthogeriatric treatment.(6, 322, 323) As both mobility and ADL was 
improved by CGC, this is likely to affect EQ-5d. We also had focus on treatment of pain, and in a paper currently 
under review we found more use of opiates in the CGC.(324)  
The mortality at 12 months was 30 (15.2%) and 37(18.6%) in CGC and OC, respectively. This difference was not 
statistically significant but is similar in a previous non-randomized study of geriatric managed orthogeriatric care 
(Table 1c).(220) On the contrary, the Oslo Orthogeriatric Trial had a higher mortality, 46(28.2%) in the intervention as 
compared to 43(25.9%) in the control group. The discrepancy between our results and the Oslo study most likely 
reflects differences in case-mix.  
There is very limited evidence from orthogeriatric trials that orthogeriatric treatment is effective in reducing 
depression, (178) although multidisciplinary rehabilitation as compared to standard care has been shown to improve 
depressive symptoms.(325) In our material there was a trend towards improved mood after CGC. A Dutch study 
found increased risk of depression after hip-fracture surgery in patients with delirium,(326) and as for cognition 
reduced frequency of delirium could result in better scores of GDS.  More research is necessary to prove an effect of 
CGC on mood disorders after hip-fractures. 
CGC significantly reduced fear of falling at both 4 and 12 months in our study. This could represent an important 
finding if patients changed behavior due to difference in fear of falling. Earlier studies have shown a strong 
correlation between FESI score and physical function in geriatric populations, (327) and it is likely that there is a 
similar relationship for FESI-s. On the other hand both CGC and OC had scores of FESI-s in the same level (9-13) 
indicating moderate risk of falling in both groups and therefore some degree of uncertainty of the clinical impact of 
our results.(289) FESI-s is sensitive in patients with low function, while it has a ceiling effect in high-function patients. 
It is possible that the effect we observe in our material reflects an effect in the frail part of our population, which our 
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other assessment methods may miss. We have not, however performed any sub-group analyses on FESI-s, so this 
question remains unanswered. 
6.1.6 Subgroup analysis 
There is very little, if any, evidence from previous orthogeriatric studies on which patients benefit from interventions. 
In Paper III potential subgroup effects of CGC have been analyzed in four subgroups (age, gender, fracture type and 
function by i-ADL). Old age, male gender, extra-capsular fractures and poor pre-fracture function are established risk 
factors for poor outcome (death or functional reduction).(309, 328) As for function previous studies have identified 3 
groups with different outcome; independent patients with normal or only slightly reduced i-ADL (“well- functioning”) 
that does well, patients with reduced i-ADL but  independent in p-ADL (“intermediate function”) and dependent 
patients with reduced p-and-ADL(“low function”) who do poorly. (41) Most home-dwelling patients will be in the first 
two groups, while most nursing-home patients will be in the latter. We postulated that CGC would mainly benefit 
those in the intermediate group, while well-functioning patients would recover after the hip-fracture regardless of 
allocation. The results from our sub-group analysis do not confirm our theory, as the well-functioning patients 
actually benefitted the most of our intervention. 
Patients aged 70 to 79 years seem to benefit more from CGC for i- and possibly also p-ADL at four months as 
compared to older patients. This effect disappears at 12 months. The between group difference for i-ADL might be 
affected of use of institutions after the index stay as all patients would have a low i-ADL score during an institutional 
stay. It is possible that older patients used more institutional services, which would affect i-ADL. This should not affect 
p-ADL to the same degree, but even for p-ADL there is a clinically important difference in BI of almost 2 points which 
also disappears at 12 months. One explanation is that patients ≥ 80 needs more time to recover, while patients <80 
improved earlier. The improved long term recovery in CGC might also be a result of better discharge planning 
including realistic treatment goals and programs to reach the goals at discharge. Improved general health might also 
play a part.  Based on our data CGC is superior to OC irrespective of age, but the magnitude of effect is largest in the 
younger age group where the differences are highly significant even in a clinical setting for all outcomes.  
Female patients have statistically significant benefits of CGC at 4 and 12 months. The effect on mobility and i-ADL are 
clinically significant, but not as impressive as for instance the effect of CGC on i-ADL for patients aged 70 to 79. Male 
patients, on the other hand, fail to show any benefit of CGC at 4 months, but have a clinically and statistically 
important effect of CGC on cognition at 12 months and a clinical effect even for i-ADL. The between-group interaction 
analysis did not confirm the gender difference suggested by the within group analyses, even if there is a trend in 
favor of women for mobility at 12 months. A possible explanation of both the within- and between group results are 
lack of statistical power as the minority of patients are men. The uneven size of the groups could create a type II error 
in respect of between group differences, while the small size increases the risk of type I errors as well for the within 
group differences. However, except for cognition, most results in OC and CGC are almost identical in males, making a 
type I error less likely. If men benefit less of CGC, there are several possible explanations for this. Some previous 
materials have suggested that men benefit more from active rehabilitation than females,(329) and more use of 
rehabilitation in OC may have closed the gap between arms seen in the overall material. Male hip fracture patients 
are less likely to live alone than female patients, and this may reduce the benefit of good discharge planning in 
respect of home care as the patient receive necessary assistance anyway. In either case this would reduce the benefit 
of CGC as compared to OC. Another possibility is that traditional hospital treatment actually is more suitable for men, 
and that the additional benefit of CGC is therefore limited. Further research is needed to improve hip-fracture 
treatment for men as they still have a worse prognosis compared to women. 
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Patients with intra capsular fractures have a clear clinical and statistical effect on mobility, p- and i-AD at both 4 and 
12 months, while patients with extra-capsular fractures only have a moderate effect of i-ADL at 12 months. The 
interaction analysis support this with statistically significant or trends of differences between the fracture types at 
both 4 and 12 months for mobility and p-ADL. One possible explanation is that the impact of the extra-capsular 
fractures on mobility and function is so determinative that the possible beneficial effect of CGC only marginally 
affects prognosis. Patients with extra capsular fractures have more soft tissue injury as a result of the trauma and also 
due to a larger surgical trauma, and it is possible that they benefit from a less intensive mobilization regimen 
especially in the early postoperative phase. Previous studies have shown that patients with extra-capsular fractures 
have a worse prognosis than patients with intra capsular fractures,(92) but there were indications from non-
randomized studies that orthogeriatric care was beneficial.(317) Our data do not support these findings, and further 
research is necessary to conclude with respect to CGC and extra-capsular fractures. 
The results from the analysis in subgroups based on pre-fracture NEAS showed that the well-functioning patients 
profited most from CGC. This is consistent with the results in the other analyses that patients with the best prognosis 
profited most, and undermines our theory that CGC would especially improve outcome in patients with functional 
limitations. Those with the highest function had a considerable clinical improvement that was statistically significant 
in all outcomes at 12 months and most outcomes at 4 months. Patients with pre-fracture NEAS <45 only had a small 
clinical effect of BI at 4 months and no clinically relevant long term effects. The between-group analysis supports the 
results in the individual tests with a significantly better effect of CGC in the well-functioning group after 12 months 
for NEAS. There might be several explanations to our finding.  Efforts to reduce cost and improve quality in care for 
the elderly have made it possible to stay at home longer, and home-dwelling patients may be more physically 
reduced before the fracture compared to previous studies and to some extent represent the low function population 
and not the intermediate. We divided our material by median pre-fracture-NEAS to get maximum power in the sub-
group analysis, but patients with a lower score in the well-functioning group might actually represent the 
intermediate group as defined by Ranhoff.(41) A clinically founded group based on NEAS, for instance of 60 points, 
would have eliminated that, but instead have created power issues.  A third explanation is of course that the patients 
with the best pre-fracture function has the greatest potential for recovery, at least with our assessment tools, and 
that CGC preserves their reserves in a superior way to OC. All hip-fracture patients have a limited expected life-span, 
but especially well functioning patients have years to live, and improvements in mobility, p- and i-ADL and even 
cognition could improve quality of life and reduce the needs for use of public services  in the remaining time after the 
fracture. 
6.2 Methods 
In this section I will discuss aspects of validity in respect of the methods used in our study. I will also discuss clinical 
methods, our use of outcomes and statistical methods. 
Internal validity is described as the degree of which the results are compromised by systematic errors (bias).(330) The 
four systematic errors that may compromise the result are errors of selection (patients with a better prognosis is 
selected for one arm) , performance (patients in one arm receive better care or follow-up), detection (biased 
assessment of outcomes) and attrition (biased occurrence and handling of protocol violations and loss of follow 
up).(330) Most journals uses the CONSORT criteria and checklist to ensure that internal validity is good, and that the 
research is transparent in respect of methodological weaknesses.(246, 331) 
External validity is the degree of which the results are valid not only in the study but in different settings as well. 
External validity can only be evaluated if internal validity is good.(330) 
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6.2.1. Internal validity  
This is a prospective RCT with parallel groups which is a robust and recognized scientific method. We used computer 
based randomization with unknown block size to eliminate the possibility of manipulation of the results.  In 
retrospect we learned that the blocks were fixed due to an error in the Unit of Applied Clinical Research, NTNU, but 
as this was unknown during collection of data and inclusion of patients, we do not believe that it will compromise our 
results .The inclusion rate was less than expected, and only37% of patients screened actually entered the study. The 
numbers of errors related to the randomization procedure are small, and should be divided equally between groups 
(patients not randomized at all).The limited numbers of beds in CGC occasionally generated a stop in recruitment to 
the study and all patients were admitted to the OC ward but did not participate in the study. We therefore believe 
that there was no risk of selection bias in this study. 
The treatment was not blinded and this is probably the largest weakness of our study. It would of course be 
impossible to blind participants, but we might have blinded at least the assessors.(219) Lack of blinding due to 
treatment could cause performance and selection bias. 
Differences in facilities could represent a potential performance bias during this trial. New and patient friendly 
facilities in CGC during the first half of the study could stimulate patients and staff to deliver the extra effort 
necessary to regain function. On the other hand, the OC received new facilities in the second part of the study with 
possibly a similar effect. Our efforts to investigate the possible effects did not show any significant effect of new 
facilities, but there was a trend to better CGC performance in the first half and OC performance in the second half. 
The CGC team and the OC team worked separately without any collaboration, and neither group would be able to 
influence treatment given by the other, and we find it likely that both teams would try to deliver the best possible 
care available. One possible exception would be surgery, where the responsible surgeon could choose surgery 
dependent of allocation, but there are no indications that this has happened. Patients not randomized into the trial, 
were admitted to OC, and in periods of high turnover this could create some degree of performance bias due to more 
patients per staff, but the effect is probably small as the hip fracture patients only are a part of the total trauma 
population. The overall risk of a performance bias in this study should be small. 
A detection bias is possible since the same group of assessors tested outcomes in both groups both at baseline and 
during follow-up. We have tested if there is any difference in scores from assessors who tested the participants both 
at index stay and during study assessments at 1, 4 and 12 months, compared to patients tested by different 
assessors, but found no difference.  The assessors collecting data from municipalities were blinded. Regarding 
collection of data on use of services from national registries, there should be no risk of detection bias. Testing outside 
the planned test period as defined under 3.1.2.1 Study related assessments, could represent a detection bias as the 
patients results to some degree depend on days since surgery. A limited group of patients were tested outside the 
the predefined test periods due to error or other reasons. We choose to use all results at the 5th postoperative day, 1 
month and 4 months as the deviations were very small and there was no difference between CGC and OC in number 
of patients tested outside at any test point. At 12 months data of one patient in each group was discarded as they 
were tested considerably outside the test period, and actually died before they entered the period. As results from 
clinical tests, questionnaires and the data from the municipalities show similar results, we find it likely that any 
detection bias at least is small.  
In most studies including ours there are deviations from protocol that could represent attrition bias. In the protocol 
paper, the number of included patients is 401, (219)and Paper I describes 398 included patients.(249) At the time of 
publication of the protocol, we had not started to look into any data, and the number of 401 was registered in the 
randomization engine. However, later inspection of the data revealed that 3 patients were randomized twice by error 
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in the emergency room leaving 398. One patient was later removed from the data analysis as she already had a 
permanent residency in a nursing home by the time of admission leaving 397 participants. Her data was removed 
before any analysis of outcomes was performed including her allocation and should not represent an attrition bias. 
There were more withdrawals in OC as compared to CGC (6 and 13 at 12 months). We consider these numbers to be 
small. Loss to follow-up at any time point was fairly similar between groups. If withdrawal or loss to follow-up was 
MNAR, for instance patients with poor health due to treatment were more likely to withdraw than those in good 
health; any effect would be in favor of OC and reducing the measured effect of CGC. We therefore conclude that it is 
unlikely that the observed difference in favor of CGC is flawed by attrition bias.  
Our overall evaluation of internal validity is that there are no obvious biases in selection, and that any bias in 
performance detection and attrition are most likely to be small even if we have not completely ruled out possibilities 
for these. 
6.2.2 External validity 
External validity may be described as “To whom does the results of this trial apply?”(332) Several aspects affect 
external validity and the generalizability of the result from an RCT: 
- The setting of a trial. 
- The selection of patients 
- Characteristics of randomized patients. 
- Differences between trial protocol and routine practice 
- Outcome measures and follow-up 
- Adverse effects 
6.2.2.1 Setting 
This was a single-site trial in a large university hospital. The practice in the hospital is fairly similar to other Norwegian 
hospitals. It is a public hospital, and due to training a large part of surgery is performed by junior surgeons. This 
setting is fairly typical for hip-fracture surgery in Scandinavia and probably even Western  Europe.  
Our study population is a mix of rural and urban participants, but with most patients from the City of Trondheim 
which is a large city in Norway (169 000 inhabitants in the city, 182 000 in the entire municipality). Most of the other 
patients are from mainly agricultural municipalities. Patients from small towns are represented to a limited degree. 
Our population is representative for a Norwegian hip fracture population. Most other orthogeriatric trials recruit their 
populations from large cities surrounding the hospital. (48, 96, 190) Therefore, participants from rural areas increase 
the external validity of the study. 
6.2.2.2 Selection and characteristics of patients 
Patient selection and characteristics are important for external validity.  An unselected population with no or few 
exclusion criteria has a high external validity, but the risk of not identifying effects due to confounders or feasibility 
issues increases. We wanted to study effect of mobility and place of residence, and our patients had to have pre-
fracture ability to walk and could not have a permanent institutional position due to this. We choose 70 years as our 
lower age limit. We believed that younger patients to some degree would object to treatment in a geriatric ward, 
even if there is some evidence that younger hip fracture patients share many characteristics with older patients, and 
also have an excess mortality and morbidity as compared with age matched patients without fracture.(2) We wanted 
to study short and long time effects, and the primary end point at 4 months was chosen as a compromise between 
clinical stability (some patients are still improving)  and power (more patients alive than after a year). As a 
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consequence of this we also excluded patients with an expected survival of less than 3 months. High-energy trauma 
patients were excluded as they are a different entity as compared to fragility fractures. 
A total of 680 patients were excluded from the study, 250 due to nursing home status and 154 were younger than 70 
years and only 143 due to other exclusion criteria. Only 54 refused to participate. As many as 79 patients did not 
participate without known reason. As they do not contribute to any arm in the RCT, this should not represent a 
selection bias, but could possibly affect the composition of our population and affect external validity, for instance if 
they shared any characteristics as gender or function. As we have no data on these patients, we can not exclude this 
possibility. Most of these patients were not randomized due to lack of available space in CGC, and this would make 
lack of inclusion a random event that would not affect validity. If patients were not included due to an active choice in 
the ER, for instance due to opinions that functionally fit patients do not belong in CGC, the threat to external validity 
would be of more concern, but we have no obvious indications that this was the case. Our vigorous follow-up of 
admissions and late randomizations of patients passing ER without randomization should also make this problem 
limited. The average age of patients in our study was 83 years. This is similar to most recent hip fracture studies, even 
if our limit of 70 years of age is higher than most studies. Most orthogeriatric trials have participants with a mean age 
in the early eighties. One exception is the Taiwanese trials where patients were in their seventies, (333) while 
populations that  include nursing home patients are somewhat older.(48)  
Previous publications suggest that one third or more of hip fracture patients are permanently institutionalized.(48, 
211) Exclusion of nursing home patients affects external validity of the study, but we still think it was necessary and 
have made it possible to identify important effects in the home-dwelling population. However, only 23% of patients 
screened in our material were actually residents in nursing homes. This may suggest a healthier than normal 
population in our catchment area or more likely, a higher threshold to be admitted into a nursing home for instance 
due to improvement of home-based care in recent years or lack of available rooms in institutions. This would increase 
the external validity of the study, and may explain why our “low-function” group benefitted less than anticipated of 
CGC. The Oslo Orthogeriatric Trial did include nursing home patients, but failed to show an effect of their primary 
outcome at least in part due to the case-mix of their population.(48)  
6.2.2.3 Differences between protocol and routine practice 
In this study, differences in treatment (“performance”) and its effect of outcomes are the subject actually studied. 
The clinical treatment during CGC is described under the methods section. I will discuss a limited numbers of 
elements in the clinical treatment.  
Comprehensive Geriatric Assessment (CGA) is widely used and found effective in a meta-analysis investigating 
geriatric care.(165) The data on CGA in orthogeriatric treatment is more limited, but in a fairly recent meta-analysis 
the conclusion is that a multidisciplinary intervention is likely to be beneficial.(334) We have used the acronym CGC 
instead CGA to emphasize our focus on both assessment and treatment. The content in our model as described 
earlier is still similar to orthogeriatric guidelines for multidisciplinary treatment.(103) Geriatric patients often present 
symptoms and not a disease. Fracture patients, however, are an exception as the diagnosis is clear-cut. We had to 
compromise between comprehensive assessment and efficacy in our unit. Symptoms possibly relating to serious 
underlying disease as cancer were investigated, while less alarming findings were referred to the patient’s primary 
physician at discharge. There is very little information in literature on how this is practiced in other orthogeriatric 
units or programs. 
The plan for further treatment was mainly based on pre-fracture functional status, and the adjusted according to 
progress, complications or other elements through daily meetings. One important element for success (return to own 
home functionally independent directly from hospital) was not to suggest need of institutionalization before decided 
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within the team. In our experience it was almost impossible to suggest differently once any member have made this 
suggestion. Another effect of these interdisciplinary meetings was to schedule when different specialists were to see 
the patient to improve work planning and reduce patient strain. 
We followed a liberal transfusion strategy to prevent delirium with blood transfusion if hemoglobin values dropped 
below 10 g/dL as recommended by Scandinavian studies.(335) A large American study found no effect on ability to 
walk or mortality after 60 days by a liberal transfusion strategy, (153) but even if patients had a higher HgB in the 
liberal group at time of transfusion only 40% of patients in both groups got transfused. The question of liberal versus 
conservative strategy of anemia in hip fracture patients is unanswered, and it is still possible to defend the strategy 
we choose in this study. 
 A systematic treatment of osteoporosis was intended in our method, but many patients were referred to the hospital 
out-patient clinic for investigation and start of treatment after discharge .Despite this element of uncertainty, 
evaluation of drug use at discharge indicate that more patients received treatment for osteoporosis after CGC.(324) 
We intended for a vigorous follow-up on nutrition with measurement of Body Mass Index (BMI) and caloric intake 
assessment during the index stay in line with other orthogeriatric interventions.(232) We have not published any data 
on this, and unfortunately it is likely that this part of our treatment program was not as good as intended. A 
nutritionist was not part of the staff in the CGC ward. We did not include a systematic follow-up after discharge, 
which is recommended by some authors.(323)  
To conclude, we believe that the content of our intervention is up to date, even if there is room for improvement. All 
elements of this intervention can be implemented with limited extra resources in a western society. It is likely that 
our results reflect a beneficial effect of CGC per se. 
6.2.2.4 Outcomes and follow-up 
Outcomes in a clinical trial should be relevant for the disease studied, and they should possibly be affected by the 
intervention given, and the tools used to investigate the outcome should be feasible and validated in the population 
studied.(290)  
In our original protocol, we used TUG at four months as our primary end point, while this was changed to SPPB at 4 
months in the final version. We discovered that TUG had a clear floor effect in our run-in period before study start, as 
many patients were unable to perform the test, and changed the protocol as SPPB was possible to score in all 
patients. SPPB may also be more sensitive to change as compared to gait speed alone, (257, 336) but we have not 
identified any study comparing TUG and SPPB. SPPB is a performance based tool, and possibly more reliable than a 
questionnaire based tool in an elderly population where many may suffer from cognitive decline.(337) Some authors 
argue that performance based tools and questionnaires investigate different properties, and that both are 
appropriate, but in different settings.(338) Performance based tools are probably better when examining changes in 
physical function. (338) It may be argued that SPPB is a surrogate end point as it delivers a “score” as compared to 
gait speed, ability to ambulate independently or having the ability to walk. While for instance gait speed can only be 
assessed in patients able to perform the test, the SPPB, which also includes gait speed, gives a score to all patients, 
even those unable to walk, thus making it possible to include all patients in the analysis. SPPB also includes activities 
of relevance for daily life: walking 4 meters, ability to rise from chair and standing balance, and is suitable for use in 
different settings and for patients at different functional levels.  
We have a wide range of secondary outcomes. All instruments are presented in the Methods section, and I will only 
discuss a few aspects of some of the instruments below. 
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P- and i-ADL are measured to investigate disability and not only functional limitations.(337)NEAS is found to be 
reasonably reliable and feasible in elderly patients.(267, 270, 339) It is validated for hip replacement patients, but not 
for fracture patients. We believe that the similarity between fracture and replacement patients is acceptable for 
using NEAS as a measure of i-ADL. The problem with a ceiling effect described in replacement patients,(267) was not 
present in our material as very few patients reached maximum score . 
CDR was used to measure pre-fracture cognition and also repeated two more times during the trial. It is 
recommended by the inventors of CDR that all assessors take an online training and certification in testing before 
using the test in clinical and research practice to ensure a consistent scoring between individual assessors. We have 
used a Norwegian translation of CDR by Engedal, where this recommendation was omitted. Even if all assessors 
received instructions how to score CDR, none received systematic training as recommended. This is a methodological 
weakness, but any deviations from ideal scoring should be equally divided between groups and should not affect the 
overall result. 
We did use the generic EQ-3d measurement for quality of life and not a disease specific scale like Harris Hip scale. 
(340) Generic instruments are less sensitive to small but important changes in quality of life, but this was  done to be 
able to perform cost utility analyses in a later stage.(290) It can be argued that we could have performed a disease 
specific measure as well, but we chose not to limit patient attrition.(302) 
A complete registry of use of services would include in-formal resources as help of next of kin and private delivery of 
services.(341) In our population we believed that attempts to register such data would be difficult in this old 
population with increased risk of cognitive decline, and result in missing data and possibly patient attrition. The 
registration of use of resources and services are therefore from a health care perspective only. 
6.2.2.5 Evaluation of external validity 
We find our results valid for a home-dwelling population 70 years or older. These results are produced in a public 
Western European setting, and we can not conclude whether similar results would be produced for instance in USA. 
We believe however, that the methodology used in the trial is relevant and may also be used in such a setting. The 
main weakness is the absence of nursing-home patients, and further trials are needed in such populations to prove 
efficacy of CGC even in older and frailer populations. 
 
6.2.3 Statistics 
Validity can be compromised by statistical methods.(342) We have done our best to comply to standards and deliver 
quality also in this area.(343) This is described in the Papers II and III, and also comprehensively in our Statistics 
Analysis plan. We have tried to use state-of-the-art methods regarding limitations of the chosen methods, and all 
analyses are performed under the guidance of experienced statisticians. 
Mixed models is valid even when there is missing data.(303) It is not reliable if missing data is mainly NMAR. It is likely 
that our missing data is affected by age, comorbidity and functions making missing data MAR and not CMAR, but we 
have no reason to suspect any unknown confounder that would affect the groups and creating any bias. 
There is a controversy in regard of testing for imbalance in the material by performing significance testing on 
background variables and covariates,  and we have chosen not to do so as any difference should be due to 
randomization.(344) Covariates were chosen due to their clinical relevance to reduce the error margin as suggested 
by Senn.(344)  
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All data in our study is collected after the fracture occurred except for CDR, BI and NEAS which collects baseline data 
retrospectively. We have used a mixed model including a possible effect of the intervention also at the time of the 
first measurement. Hence, the fact that the first data collection was after initiation of the intervention does not 
introduce bias in the estimates. 
 
6.3 Areas for further research 
Our model is now the best documented treatment option for this patient group, and new models and also existing 
models should if possible be tested in RCTs against our or a similar model. Other existing models as so-called co-
managed care or clinical pathways are probably easily adapted as treatment still takes place within an orthopedic 
ward, and there will be no relocation of resources from an orthopedic unit to a “competing” geriatric unit, but in my 
opinion lack documentation. 
Even if our results are promising, patients in both arms suffered from a decline in function as compared to pre-
fracture status.  Future studies should aim to reduce this loss further. There are good reasons to believe that more 
physical training between discharge and during the first year after the fracture could improve physical function. 
Future research should identify better rehabilitation methods, for instance methods of home based training that 
would give additional benefits. Our group is currently investigating this in a large RCT.(321) 
Our data indicate that patients with the best prognosis still benefitted most from CGC, even if some effect was 
observed in all sub-groups. The analyses in Paper III are post hoc, and the results should be tested in future studies. 
Improving treatment even for nursing home patients and frail home-dwelling patients should also be an area of 
future research, and it is likely that other outcomes as control of pain or fear of falling might be more important in 
these populations. 
 
6.4 Summary of discussion and conclusion of thesis 
We have developed an acute orthogeriatric intervention which is clinically effective and available with a reasonable 
degree of use of resources and cost-effectiveness. Description of our method and results are published in peer-
reviewed journals and analyzed with modern statistical methods of high standard. 
The Trondheim Hip Fracture Trial has shown a statistical significant and clinically meaningful effect of CGC on the 
main outcome of mobility at 4 months. The effect was maintained after a year. A similar effect was found for p- and i-
ADL, fear of falling and quality of life. For cognition we found a statistically significant and probably also clinical 
meaningful effect after 12 months. 
Subgroup analyses indicate that the results were better in the patients with the best prospects at admission, and not 
to the same degree in patient with a poorer prognosis that we would hypothesize to benefit more from the 
intervention. Even if some patients may benefit less than others, the methodology presented in this thesis represent 
the State of the Art of hip fracture treatment of today. 
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Development and delivery of patient treatment in
the Trondheim Hip Fracture Trial. A new geriatric
in-hospital pathway for elderly patients with hip
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Abstract
Background: Hip fractures are common among frail elderly persons and often have serious consequences on
function, mobility and mortality. Traditional treatment of these patients is performed in orthopedic departments
without additional geriatric assessment. However, studies have shown that interdisciplinary geriatric treatment may
be beneficial compared to traditional treatment. The aim of the present study is to investigate whether treatment
of these patients in a Department of Geriatrics (DG) during the entire hospital stay gives additional benefits as
compared to conventional treatment in a Department of Orthopaedic Surgery (DOS).
Findings: A new clinical pathway for in-hospital treatment of hip fracture patients was developed. In this pathway
patients were treated pre-and postoperatively in DG. Comprehensive geriatric assessment was performed as an
interdisciplinary, multidimensional, systematic assessment of all patients focusing on each patient’s capabilities and
limitations as recommended in guidelines and systematic reviews. Identification and treatment of co-morbidities,
pain relief, hydration, oxygenation, nutrition, elimination, prevention and management of delirium, assessment of
falls and osteoporosis were emphasized. Discharge planning started as early as possible. Initiation of rehabilitation
with focus on early mobilisation and development of individual plans was initiated in hospital and continued after
discharge from hospital. Fracture specific treatment was based upon standard treatment for the hospital, expert
opinions and a review of the literature.
Conclusion: A new treatment program for old hip fracture patients was developed, introduced and run in the DG,
the potential benefits of which being compared with traditional care of hip fracture patients in the DOS in a
randomised clinical trial.
Keywords: Hip fractures, Geriatric assessment, Oldest old, Randomized controlled trial, Interdisciplinary health team
Findings
Background
Hip fractures are common in elderly people [1]. Patients
with hip fractures are heterogeneous with respect to age,
pre-fracture function and morbidity [2,3]. Many are frail,
have chronic comorbid disorders, cognitive impairment,
low body weight and are functionally impaired before
the fracture [3]. On admission to hospital they fre-
quently suffer from concurrent minor or major medical
conditions that may impact on prognosis [4,5].
After hip fractures a high proportion of the patients
experiences reduced performance of basic and instru-
mental activities of daily living, reduced mobility with
need of walking aids, decreased ability to move outside
their own home, and they often report deterioration of
health status [6-8]. A considerable proportion needs
* Correspondence: ingvild.saltvedt@ntnu.no
1Department of Geriatrics, St. Olav Hospital, University Hospital of Trondheim,
Trondheim, Norway
2Departments of Neuroscience, Norwegian University of Science and
Technology (NTNU), Trondheim, Norway
Full list of author information is available at the end of the article
© 2012 Saltvedt et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Saltvedt et al. BMC Research Notes 2012, 5:355
http://www.biomedcentral.com/1756-0500/5/355
nursing home placement [7,8] and one-year mortality is
high [1].
The Research Group on Geriatrics, St Olav Hospital,
University Hospital of Trondheim, Norway, has previ-
ously performed a randomised clinical trial showing that
by treating acutely sick, frail elderly patients in a geriat-
ric evaluation and management unit, mortality was sig-
nificantly reduced and the chance of living at home was
improved [9-11]. Over years the group has also been fo-
cusing on research on assessment and treatment of older
persons at risk of falling [12].
In 2007 the research group decided to perform a pro-
spective randomised trial on treatment of hip fracture
patients in order to investigate if treatment in the De-
partment of Geriatrics (DG) can improve outcomes as
compared to standard treatment in the Department of
Orthopaedic Surgery (DOS). Primary outcome is mobil-
ity measured by the Short Physical Performance Battery
(SPPB) [13] 4 months after surgery. Secondary outcomes
measured at 1, 4 and 12 months postoperatively are
place of residence, activities of daily living, balance and
gait, falls and fear of falling, quality of life and depressive
symptoms, as well as use of health care resources and
survival. The complete study protocol has been
described previously [14].
During the last years several studies have been per-
formed on treatment of hip-fracture patients by geriatric
interdisciplinary teams. The study design including
intervention and outcomes have varied and the studies
have been performed within different health care sys-
tems. To be able to compare studies and evaluate factors
of importance for success it is important to describe the
interventions in detail. The aim of the present paper is
to report the basis for the treatment model in the
Trondheim Hip Fracture Trial and to describe treatment
options offered to the patients in the DG (experimental
group) and the DOS (control group), respectively.
Basis for the experimental treatment
Model
During the last years new models in treatment of elderly
hip fracture patients including interdisciplinary care and
some kind of geriatric intervention have been intro-
duced. The results have been summarized as systematic
reviews, guidelines and meta-analyses [15-21].
The models studied have been treatment in ortho-
paedic wards with geriatric consultant services on re-
quest, orthopaedic wards with daily consultative services
by geriatricians, initial treatment in an orthopaedic ward
with transfer to geriatric wards postoperatively, and
treatment in orthopaedic wards where orthopaedic sur-
geons and geriatricians treat patients together [17,20].
The literature is still inconclusive as to which of these
models are most beneficial. However, models with an
integrated approach with early involvement of a geriatric
interdisciplinary team seem to be superior as compared
to models using consultative services or where there is a
late involvement of the geriatric interdisciplinary team
[17,20].
In the present study the choice of model was based on
a review of the literature and also partly being a conse-
quence of a reorganisation in our hospital in 2007. The
number of beds was cut down in the DOS reducing the
total capacity of the department, therefore temporary
solutions were sought to be able to care for the high
number of patients admitted with fractures. Therefore,
an orthogeriatric bed-unit was established in an acute
geriatric ward giving us the opportunity to investigate
the potential benefits of performing comprehensive geri-
atric assessment (CGA) on hip fracture patients in a de-
partment previously having shown its efficacy on
treating frail geriatric patients in general [9]. The in-
novative element in this model is a DG being responsible
for the medical treatment from admission to discharge,
including CGA and initiation of rehabilitation, although
most of the rehabilitation program was completed after
discharge either at home or in a suitable institution.
To our knowledge this is the first randomised clinical
trial of a model treating hip fracture patients pre- and
postoperatively performing CGA in a DG with main
focus on the intervention during the acute phase.
Comprehensive geriatric assessment (CGA)
CGA applied on acutely sick, elderly patients treated in
specialised geriatric units has been shown to increase
the chance of living at home, reduce functional decline
and also the risk of nursing home placement
[9,10,22,23].
Based upon the evidence from systematic reviews and
meta-analyses [22-25] CGA should be performed by an
interdisciplinary team of professionals specialised in
treatment of elderly patients. Usually the team is com-
prised of a geriatrician collaborating with nursing staff
trained in geriatrics, physiotherapists, and occupational
therapists, and in many cases a nutritionist and a social
worker. The interdisciplinary team should collaborate
both informally and in regular interdisciplinary meetings
to discuss the patients, developing individual care plans
and defining short- and long term goals for each patient
[25].
The assessment should be systematic and multidi-
mensional to identify all relevant problems and initi-
ate adequate assessments. Protocols and assessment
tools for common conditions are recommended. Use
of care plans is beneficial in order to comply with as-
sessment and treatment. Communication with
patients and caregivers throughout the hospital stay is
important.
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Treatment should be performed in a dedicated unit
with sufficient space for patients to move around, offer-
ing available aids for mobility and self care, and calen-
dars and clocks as cues for orientation. Discharge
planning should start as early as possible. Collaboration
across sectors as well as with the patient and her care-
givers is necessary to achieve continued rehabilitation
and a successful discharge.
In general, CGA should therefore be an optimal tool
when treating frail elderly hip fracture patients.
Developing a treatment program for hip fracture patients
in a new clinical pathway
While the DG had extensive experience in performing
CGA on acutely admitted geriatric patients, it was not
so for the treatment of hip fracture patients within the
same context. We therefore had to develop a new pro-
gram taking into consideration standard routines already
established at the hospital on perioperative treatment in-
cluding anaesthesiological and surgical techniques, and
time to surgery. Based on a literature review [16,17,26],
the present guidelines of the DOS and a visit to Dia-
konhjemmet Hospital in Oslo [3] a new program on op-
timal pre-and postoperative treatment was developed.
We focused at identification and treatment of co-
morbidities, pain relief, hydration, oxygenation, nutri-
tion, elimination, prevention and management of delir-
ium, assessment of falls and osteoporosis. Programs for
prevention of acute delirium, new fractures, constipa-
tion, decubital ulcers, and falls were developed [3,27,28].
A program for early mobilisation and rehabilitation was
developed aiming at individualised in-hospital rehabilita-
tion [29,30].
Clinical pathways
Patient flow
After an orthopaedic resident had diagnosed a hip frac-
ture in the Emergency Room, patients were screened for
eligibility in the study. Randomization was performed
after the patients had given their informed consent [14].
For patient flow, see Figure 1.
Patients randomized to experimental treatment were
transferred to the DG located in the Clinics of Internal
Medicine. In Norway geriatric medicine is a branch spe-
ciality within internal medicine, and geriatricians and
internists were responsible for the treatment in DG.
Patients randomized to the control group were trans-
ferred to the Trauma Unit located in the DOS, and
orthopaedic surgeons were responsible for the
treatment.
In both groups patients were transferred to the Oper-
ation Theatre for surgery and postoperatively to a recov-
ery unit for observation during the first hours after
surgery. Afterwards patients were transferred back to
the DOS or DG according to the randomisation.
Patients were discharged from the hospital as soon as
they were medically stable after surgery and a suitable
place of discharge was available. The DG and DOS dealt
with the same municipalities and had the same options
for care, treatment and rehabilitation after the hospital
stay. After discharge general practitioners and/or doctors
at nursing and rehabilitation facilities were responsible
for treatment.
Follow-up consultations in the orthopaedic outpatient
clinic were decided by the orthopaedic surgeons during
the hospital stay and performed in selected patients.
There was no follow-up program at the geriatric out-
patient clinic. If study patients were referred by general
practitioners for assessment in the geriatric outpatient
clinic, this was performed “as usual” in both groups.
Study-related follow-ups at 1, 4 and 12 months were
performed by separate study investigators. A few
patients meeting for study related assessments were in
need of immediate medical evaluation. These consulta-
tions were performed by consultants in the DG.
The major part of the health care system in Norway is
organised and financed by the public sector. The govern-
ment owns and run the hospitals through regional
health authorities. General practitioners, physiothera-
pists and rehabilitation institutions get reimbursement
from the government and the regional health authorities.
In-hospital treatment and assistance from home care
nurses is free of charge. Patients have to cover costs for
drugs, physiotherapy and medical treatment up to a total
limit of about 200 Euros, above which all is free. Prac-
tical help in the patients’ homes are charged according
to income. Due to relative low costs for out-patient
medical treatment and care the patients’ individual fi-
nancial situation is normally not determinative for
choice of treatment after hospital stay.
Organization of wards and staffing
The DG consisted of a 10 bed-ward of acute geriatrics
services linked to an out-patient facility. During the trial
an orthogeriatric 5 bed-unit was established as an add-
itional, but still integrated part of the acute geriatric
ward. The DG was located in a new-built part of the
hospital. All patients had single-bed rooms. There were
no corridor-beds. The department had a separate dining
room and the corridors were suitable for moving
around. As far as possible an “enriched” environment
was created to enlighten the patients’ orientation [28].
This included use of visible calendars and clocks in all
rooms, naming plates and signs on the doors, sufficient
lightening, and access to necessary aids (including hear-
ing aids) and to news (television, newspapers, and
magazines).
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In the DOS patients were bedded in the Trauma Unit.
During the first part of the study the DOS was located
in an old part of the hospital with 19 beds in single-,
double- and four-bed rooms with commonly use of add-
itional corridor-beds. The DOS moved into a new hos-
pital building in September 2009 having similar facilities
as the DG. At the time of this transfer 219 of 398 study
patients had been recruited.
The staff in both departments consisted of doctors,
nurses, assistant nurses and physiotherapists. The DG
also had occupational therapists. The number of posi-
tions per bed for the different professions is shown in
Table 1 demonstrating that the DG was generally better
staffed than the DOS.
The head of the DOS was involved in planning of the
study. Both orthopaedic surgeons and other personnel
categories of the DOS participated in training of doctors,
nursing staff and physiotherapists in the DG both during
the four month run-in period and also the initial part of
the study. The educational program involved lectures
and bed side practical training. Later the staff in the DG
had regular teaching on issues relevant for treatment of
elderly hip-fracture patients.
Orthopaedic surgeons assessed patients in DG on re-
quest; vice versa geriatricians assessed patients in the
DOS on request.
Standard treatment
In the Emergency Room all patients underwent a stand-
ard general clinical examination by an orthopaedic resi-
dent, with additional blood samples, measurement of
blood pressure, temperature, pulse, oxygenation and an
electrocardiogram. Femoral neck fractures were classi-
fied according to the Garden classification system [31].
The resident notified the anaesthesiologists and the Op-
eration Theatre.
Figure 1 Patient flow in the Trondheim Hip Fracture Trial.
Table 1 Organization of treatment in Department of Geriatrics (DG) as compared with the Department of Orthopaedic
Surgery (DOS)
Experimental group Control group
Department Clinic of Internal Medicine, Clinic of Orthopaedics and Rheumatology
Department of Geriatrics (DG) Department of Orthopaedic Surgery (DOS)
Facilities* Single bed rooms Before relocation: single, double or four –bed rooms
After relocation: single bed rooms
Number of beds in the ward 15 19 before / 24 after relocation
Organization of ward 5 beds dedicated for hip fracture patients
allocated to one single cluster
Hip fracture patients spread among other patients
Staff working bed-side (number per bed) Nurses/assistant nurses: 1.67 Nurses/assistant nurses: 1.48
Doctors : 0.13 Doctors: 0.11 (0.08 after relocation)
Physiotherapists: 0.13 Physiotherapists: 0.09 (0.07 after relocation)
Occupational therapists: 0.13 Occupational therapists: 0
Patients were recruited from April 18th 2008 to December 30th 2010.
*DG was located in a new hospital building during the entire study period while DOS was relocated from an old to a new hospital building in September 2009 (as
219 of 398 patients were recruited).
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All patients received intravenous saline or Ringer’s
acetate at admission. Low molecular heparin (enoksa-
parin) was given as thromboembolic prophylaxis from
admission to hospital to 14 days after surgery, 20 mg
twice daily preoperatively and 40 mg once daily post-
operatively . Elastic stockings were used postopera-
tively if patients had peripheral oedema.
All patients had urinary catheters preoperatively, being
removed within 24 hours postoperatively. Pressure re-
lieving mattresses were standard equipment in the new
part of the hospital and the nursing staff focused on pre-
vention of decubitus in both groups.
For pre-operative analgesia most patients received
femoral nerve blockade. In addition, patients were rou-
tinely given paracetamol 1 g every 6 hours during the
entire hospital stay, while opioids were given on de-
mand preoperatively and regularly postoperatively.
Preoperatively all patients were assessed by an anaes-
thesiologist using the American Society of Anaesthe-
siologists (ASA) score [32]. Minor or moderate
medical disturbances did normally not cause delay of
surgery, while in cases with medical disorders such as
unstable cardiac problems, a severe infection or pul-
monary embolism surgery was delayed until stabilisa-
tion was achieved. The operability was decided by the
anaesthesiologist in collaboration with the orthopaedic
surgeon, and in the experimental group also with the
geriatrician. Sometimes other specialists were involved
such as cardiologists if unstable cardiac disorders or
murmurs were found. To avoid complications during
anesthesiological and surgical procedures patients
using therapeutic doses of heparin, clopidogrel or war-
farin were postponed until the risk of bleeding was
normalised. Patients using clopidogrel had to wait five
days before spinal anaesthesia was considered safe,
while patients on warfarin got vitamin K and were
ready for surgery when INR was 1.8 or less [33]. Logis-
tic problems within the hospital were the most com-
mon cause of delay.
Most patients received spinal anesthesia. For Garden type
1 or 2 fractures most patients were treated with a two-
screw fixation but in some few cases hemiprosthesis were
used. Garden type 3 or 4 fractures were treated with hemi-
prosthesis. Pertrochanteric fractures were treated with a
sliding hip screw system (Dynamic Hip Compression
Screw, DHS, or Compression Hip Screw, CHS). Subtro-
chanteric fractures were treated either with DHS/CHS
(most cases) or antegrade intramedullary nailing. Most
patients irrespective of fracture type were allowed full
weight bearing postoperatively. Prophylactic antibiotics
(cephalotin) were given to all patients, except those getting
a two-screw fixation.
Postoperatively the patients were observed in a recov-
ery ward until they were able of moving both legs and
their medical condition were stabilised, normally about
six hours after surgery.
Table 2 Comprehensive geriatric assessment at the Department of Geriatrics
Dimensions assessed Somatic health – concurrent injuries or medical conditions, drug regimen, pain, falls, osteoporosis
Mental health - cognition, depression, anxiety
Function - ADL, IADL, mobility, sensory loss, elimination
Social situation - place of residence, network, caregiver burden
Interdisciplinary team work Dedicated responsibilities
Interdisciplinary team meetings 1st day postoperatively: plan for individual treatment, goal setting, discharge planning,
4th day postoperatively: evaluation, discharge planning
Systematic approach Checklists
Treatment protocols
Assessment scales (Barthel Index, Cumulated Ambulation
Score: Confusion Assessment Method, Verbal Rating Scale)
Mobilization/Rehabilitation Mobilization out of bed 1st day postoperatively
Individualised plan for mobilization and participation in ADL being integrated
in care plans and ward activities
Discharge planning Collaboration with patient, caregivers and municipality
Mapping of pre-fracture function, place of residence and social situation
Discuss discharge destination 1st day postoperatively
Set realistic short- and long-term goals
Organize institutional care, aids, assistance, physiotherapy when appropriate
ADL – Activities of Daily Living. IADL- Instrumental Activities of Daily Living.
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Treatment in the experimental group
Comprehensive Geriatric Assessment (CGA)
CGA was essential in treatment of all patients in the DG
(Table 2, Table 3). The aim was to offer as good treat-
ment as possible within available resources, to prevent
complications, start rehabilitation as early as possible,
and plan for discharge from hospital and further re-
habilitation. The work-up focused on assessment and
improvement of the patients’ somatic and mental health,
functional status and socio-/environmental situation.
The patients’ status before the hip-fracture was
mapped by the nurses and the occupational therapists by
interview with the patients, and with permission from
the patients, also with the care-givers and the Home
Services. Information on pre-fracture cognition, activities
of daily living (ADL), and instrumental ADL (IADL), mo-
bility, nutrition, living situation, caregiver distress, par-
ticipation in social activities and assistance needed from
the Home services was retrieved. This information was
important to make an individual plan for each patient.
The team members in the DG had separate responsibil-
ities. A close formal and informal collaboration between
team members was emphasised. Brief interdisciplinary
team meetings were held the first postoperative day to
discuss the process of early rehabilitation, need of further
investigations during the hospital stay, and to set realistic
short- and long-term goals and plan for discharge. After
three working days a brief follow-up meeting evaluated if
progress was as expected aiming at decisions on site of
destination and day of discharge.
The in-hospital rehabilitation focused on early
mobilization and weight bearing exercise programs, if no
restrictions had been made from the orthopaedic sur-
geon. In addition participation in ADL was emphasized.
An individual rehabilitation plan with short term goals
was based upon previous function, cognition, type of
surgery and motivation. This was integrated with care
plans and executed by physiotherapists and nursing staff.
Progression was evaluated by the physiotherapists regu-
larly and performance of ADL was evaluated by the oc-
cupational therapists on 3rd postoperative day. The long-
term goal was to achieve pre-fracture function.
A systematic approach was achieved using check-lists
both for each professional category and for the interdis-
ciplinary team work and applying treatment protocols
developed for the most common conditions. The follow-
ing standardised assessment tools were used: Cumulated
Ambulation Score (CAS) [34] during the first three days
postoperatively. Barthel Index (BI) [35] was scored pre-
fracture, and 1st and 3rd postoperative day and at dis-
charge. Verbal Rating Scale (VRS) for assessment of pain
[36], Confusion Assessment Method (CAM) was used as
screening for delirium [37], Geriatric Depression Scale
was used for assessment of depression [38].
Length of stay, discharge destination and necessary
arrangements for discharge were discussed within the
team and with the patients and their caregivers at sev-
eral occasions during the stay. Destination for discharge
was based upon the patients’ functional and medical sta-
tus, place of living, and the patients’ and caregivers’ mo-
tivation. For patients living in the city of Trondheim
(n = 315) a resolution on necessary actions after dis-
charge was made in a discharge planning meeting. Both
the patient, his caregivers, representatives for the muni-
cipality and nurse and doctor from the DG participated
in these meetings. For the other municipalities arrange-
ments were discussed and agreed upon through phone
calls with primary health care representatives.
Table 3 Medical treatment in the two groups
DOS DG
Hydration
Intravenous fluid preoperatively V V
Monitoring fluid intake postoperatively V
Perioperative antibiotic prophylaxis V V
Thromboembolic prophylaxis V V
Nutrition
Assessment of nutritional status* V
Nutritional drinks V
Decubitus prophylaxis by pressure relieving mattresses V V
Oxygenation
Transfusion if Hb< 10 V
Oxygen if saturation< 95% V
Avoiding hypotension (including orthostatic hypotension) V
Analgesia
Femoral nerve block V V
Paracetamol 1 g every 6 h, opioids on demand V V
Pain assessment during rest and activity by VRS V
Urine
Removal of catheter within 24 h postoperatively V V
Screening for infection pre- and postoperatively V
Screening for urinary retention V
Constipation
Prophylaxis and monitoring (in cognitively impaired patients) V
Delirium
Regular assessment V
Focus on prevention V
Osteoporosis assessment V
Falls assessment V
DOS – Department of Orthopaedic Surgery. DG- Department of Geriatrics
VRS- Verbal Rating Scale.
*Nutritional status – history of recent weight loss, low body mass index, low
caloric intake.
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If possible the patients were discharged to their own home
with assistance from the Home Services. For these patients
physiotherapy was offered to take place either at home, in a
physiotherapy clinic or at a day-time rehabilitation centre.
Many patients needed institutional rehabilitation and were
discharged to private or public inpatient facilities such as re-
habilitation wards in hospitals or nursing homes. Some
needed continued medical treatment in a community hos-
pital, while some were too sick to be rehabilitated and were
discharged to ordinary nursing home wards.
Communication with general practitioners, rehabilita-
tion facilities and nursing homes about individual
patients was based mainly upon written discharge
reports covering medical treatment, drug regimens, car-
ing needs, physiotherapy and recommended follow-up.
At discharge the patients received written reports on
their medical situation and drug regimens.
Medical assessment and treatment
At admission to the DG all patients were clinically
examined by a geriatrician or the resident on call and
were screened preoperatively by an extensive battery of
blood tests, tests of urine and repeated measurements of
pulse, temperature, blood pressure and oxygenation.
Chest imaging was performed routinely. Medical assess-
ment to reveal concurrent somatic disorders and opti-
misation of somatic status was emphasised through
treatment of medical disorders, electrolyte disturbances,
hypoxemia, anaemia and elevated glucose levels.
Hydration and electrolytes were evaluated regularly
during the stay. Fluid intake was measured the first days
postoperatively, and intravenous fluid was given until
patients were able to drink enough.
Oxygenation was measured regularly; oxygen was sup-
plied if saturation was less than 95%. Blood transfusions
were given if Hb< 10 g/dl. Monitoring of supine and
orthostatic blood pressure was performed. Medication
with cardiovascular drugs was adjusted according to
these measurements.
To optimise analgesic treatment the nursing staff and
physiotherapists assessed pain by using a Verbal Rating
Scale (VRS) ranging pain in a scale from one to five dur-
ing rest and activity [36]. There is no consensus on
which opioid should be preferred in frail elderly patients.
In DG slow release morphine was the drug of choice; in
case of side-effects oxycodone was given instead.
After the urinary catheter was removed on the first
postoperative day all patients were scanned with respect
to residual urine and checked for infections.
Constipation is very common among hip fracture
patients postoperatively. Therefore, preventive treatment
with laxatives started the first postoperative day accord-
ing to a standard procedure. The staff had routines to
register defecation of individual patients in order to
intensify treatment, especially in patients with cognitive
impairment.
Nutrition was in focus both pre-and postoperatively and
a specific attention was given to those having a low body
mass index, history of recent weight loss or poor appetite.
Food intake was monitored if patients were undernourished
or had poor appetite. Several patients underwent investiga-
tions for pre-fracture weight loss. Many patients were
offered specified nutritional drinks until two hours before
surgery and protein enriched nutritional drinks and vitamin
supplement postoperatively. Meals could be adjusted to
each patient’s preferences and needs.
The drug regimen was evaluated in all patients. Preopera-
tively the following drugs were considered to be withdrawn:
antihypertensives, diuretics, all drugs with moderate or
strong anticholinergic side-effect [39], and drugs with im-
pact on coagulation. Oral antidiabetic drugs were with-
drawn and blood glucose was monitored frequently, insulin
was given in reduced doses and on demand. Drugs for heart
failure, beta-blockers and antiepileptic drugs were contin-
ued, while corticosteroids were given in increased doses if
adrenal suppression could be suspected. Postoperatively the
entire drug regimen was evaluated with respect to indica-
tion, dose, side-effects and interactions.
Confusion Assessment Method (CAM) [37] was used for
assessment of delirium. The treatment given to the patients
in the DG group has been shown to prevent and/or shorten
duration of delirium [28]. Use of aids for impaired hearing
and/or vision was used regularly. Repeated information to
the patients about their medical situation and encourage-
ment of visits by caregivers was considered important. Oxa-
zepam and/or haloperidol (low doses and short duration)
were sometimes used for agitation when pharmacotherapy
was considered necessary. If an underlying dementia was
suspected the general practitioner was recommended to as-
sess the patient on a later occasion.
Many patients had anxiety and were depressed during
the hospital stay. This was mainly treated by caring
attempts and occasionally by using oxazepam on de-
mand. If anxiety and depression had been a significant
problem before the fracture, medical treatment with
SSRI or SNRI was sometimes started.
The falls assessment performed during the hospital stay
was based upon the case history from patient and care-
givers on previous falls and mobility problems, the cause(s)
of the present fall and a clinical assessment with focus on
comorbid disorders, drugs, muscle strength and balance
according to guidelines developed for the DG.
Many patients already received treatment for osteopor-
osis. If not, a bone mineral density (BMD) measurement
was performed in patients with previous fractures or if the
hip fracture was a consequence of a low energy trauma. In
case of osteoporosis treatment with calcium and vitamin D
was given. Treatment with bisphosphonates (orally or
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intravenously) was initiated if there were no contraindica-
tions and the patient was expected to live long enough to
benefit from such treatment.
Ethics
Participation in the trial was voluntary and according to
the Helsinki Declaration. Both oral and written informa-
tion was given at admission to hospital, later during the
hospital stay and at follow up assessments. Written
informed consent was achieved from all patients prefer-
ably before randomization at admission to hospital, but
in a few cases 3 to 5 days afterwards. In patients not
being able to write, an oral consent was accepted. Prox-
ies were informed about the study if available, this was
especially important if the patient was cognitively
impaired. The study has been approved by the Regional
Committee of Ethics in Medical Research (Mid- Nor-
way) (REK 4.2008.335). Further details have been
described in the protocol article [14].
Discussion
The present paper describes the rationale behind, and the
development and delivery of a new clinical pathway for
treatment of elderly hip fracture patients. As far as we know
this is the first randomised clinical trial evaluating a treat-
ment model where elderly hip fracture patients are treated
in a DG from admission to discharge. The experimental
model focused at CGA, fracture specific treatment and ini-
tiation of rehabilitation that was continued after discharge
from hospital. Statistical analyses on effect of the interven-
tion will be performed later this year.
In our DG we have long-term experience in perform-
ing CGA, the efficacy being shown in a study performed
10 years ago [9]. Since then the CGA process in our DG
has continuously improved according to recommenda-
tions in the Cochrane review by Ellis et al. [25]. The
length of stay has been shortened substantially, as well.
In theory, the use of CGA should therefore represent an
excellent and effective evaluation and treatment option
for frail hip fracture patients.
Benefits in favour of DG can only be shown if patient
treatment is better than in the DOS. However, treatment
of hip fracture patients was introduced into the DG only
four months before study start. The competence on
medical treatment of hip fracture patients improved rap-
idly during this piloting and also during the study
period. Orthopaedic surgeons were not routinely
engaged in the in-hospital follow-up of patients treated
in DG which is a potential weak point. Vice versa there
has been a quality improvement in treatment of geriatric
patients at our hospital during the last 10 years due to
extensive involvement of the DG in teaching at hospital
level. This is of course of benefit for geriatric patients in
general, but brings uncertainties as to the question on
whether the new clinical pathway is sufficiently different
from “improved” traditional care.
The intention of the present study was to evaluate if
the new model would represent a better in-hospital
treatment program. Therefore, to avoid a mix of in-
hospital and post-discharge interventions the trial fo-
cused on CGA and rehabilitation during the hospital
stay with no specific follow-up after discharge. Potential
effects of the in-hospital CGA on the primary endpoint
of mobility may therefore be lost when measuring for
potential benefits 1, 4 and 12 months after discharge.
The Cochrane review by Ellis and co-workers did not
show targeting to be essential for outcomes of CGA
[25]. Our study population is a case-mix of both healthy
and frail participants, although nursing home patients
and patients being unable to walk 10 m were excluded
due to choice of mobility and place of residence as end-
points. Intuitively we still think that frail hip fracture
patients would potentially benefit more from CGA than
the non-frail, and that CGA would potentially be benefi-
cial also for patients excluded from the study.
Both the DG and the DOS are treating acutely sick
patients and therefore considerably better staffed than
for example the ward in Stenvall’s study [27]. In our hos-
pital the nursing staff also has to take responsibility for
kitchen work and household (except cleaning of floors),
thus requiring more nursing staff. The present paper
shows that the DG is somewhat better staffed than the
DOS. This may of course be explained by an ambitious
CGA program. However, other aspects may also have
impact i.e. the case-mix in the DG is in general more
frail and complex, with almost all patients needing help
in ADL, and most of them are cognitively impaired. The
DG staff is also extensively involved in supervision and
teaching obligations outside the ward and the hospital.
The last follow up sessions in the study are recently
finished and the results will reveal if the experimental
clinical pathway will be beneficial for both hip fracture
patients and society.
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Comprehensive geriatric care for patients with hip fractures: 
a prospective, randomised, controlled trial
Anders Prestmo*, Gunhild Hagen*, Olav Sletvold, Jorunn L Helbostad, Pernille Thingstad, Kristin Taraldsen, Stian Lydersen, Vidar Halsteinli, 
Turi Saltnes, Sarah E Lamb, Lars G Johnsen, Ingvild Saltvedt
Summary
Background Most patients with hip fractures are characterised by older age (>70 years), frailty, and functional 
deterioration, and their long-term outcomes are poor with increased costs. We compared the eﬀ ectiveness and cost-
eﬀ ectiveness of giving these patients comprehensive geriatric care in a dedicated geriatric ward versus the usual 
orthopaedic care.
Methods We did a prospective, single-centre, randomised, parallel-group, controlled trial. Between April 18, 2008, and 
Dec 30, 2010, we randomly assigned home-dwelling patients with hip-fractures aged 70 years or older who were able 
to walk 10 m before their fracture, to either comprehensive geriatric care or orthopaedic care in the emergency 
department, to achieve the required sample of 400 patients. Randomisation was achieved via a web-based, computer-
generated, block method with unknown block sizes. The primary outcome, analysed by intention to treat, was mobility 
measured with the Short Physical Performance Battery (SPPB) 4 months after surgery for the fracture. The type of 
treatment was not concealed from the patients or staﬀ  delivering the care, and assessors were only partly masked to 
the treatment during follow-up. This trial is registered with ClinicalTrials.gov, number NCT00667914.
Findings We assessed 1077 patients for eligibility, and excluded 680, mainly for not meeting the inclusion criteria such 
as living in a nursing home or being aged less than 70 years. Of the remaining patients, we randomly assigned 198 to 
comprehensive geriatric care and 199 to orthopaedic care. At 4 months, 174 patients remained in the comprehensive 
geriatric care group and 170 in the orthopaedic care group; the main reason for dropout was death. Mean SPPB scores 
at 4 months were 5·12 (SE 0·20) for comprehensive geriatric care and 4·38 (SE 0·20) for orthopaedic care (between-
group diﬀ erence 0·74, 95% CI 0·18–1·30, p=0·010).
Interpretation Immediate admission of patients aged 70 years or more with a hip fracture to comprehensive geriatric 
care in a dedicated ward improved mobility at 4 months, compared with the usual orthopaedic care. The results 
suggest that the treatment of older patients with hip fractures should be organised as orthogeriatric care.
Funding Norwegian Research Council, Central Norway Regional Health Authority, St Olav Hospital Trust and Fund 
for Research and Innovation, Liaison Committee between Central Norway Regional Health Authority and the 
Norwegian University of Science and Technology, the Department of Neuroscience at the Norwegian University of 
Science and Technology, Foundation for Scientiﬁ c and Industrial Research at the Norwegian Institute of Technology 
(SINTEF), and the Municipality of Trondheim.
Introduction
Hip fractures are frequent in older people (>70 years) 
and represent a worldwide challenge.1 Because of 
population ageing, fragility fractures are an increasing 
burden on health-care systems and societies.2 Most 
older people who fracture a hip are frail, have 
comorbidities, and show a functional deterioration that 
is typical of geriatric patients.3 After a fracture, both 
short-term and long-term outlooks for patients are 
generally poor, with increased 1 year mortality (18–33%),4 
and negative eﬀ ects on activities of daily living and 
mobility. A review of long-term disability in patients 
with hip-fractures that summarised a weighted average 
of relevant studies estimates that 42% of survivors do 
not return to their prefracture mobility, 35% are 
incapable of walking independently, 20% are unable to 
shop independently,5 and about 20% enter a long-term 
care facility during the ﬁ rst year after a fracture.6 Hip 
fractures have substantial socioeconomic eﬀ ects and 
large, attributable costs, with acute and post-acute 
institutional care as the primary driver.6
Although surgical care is crucial for improving 
outcomes after a hip fracture, the proposal that a hip 
fracture in an older person represents a geriatric rather 
than an orthopaedic disorder calls for new clinical 
approaches.7 Comprehensive geriatric care is an alternative 
form of care; when practised in dedicated geriatric wards, 
it improves outcomes for frail older patients who are 
acutely admitted to hospital, and might be equally relevant 
for geriatric patients with hip fractures.8
Guidelines and recommendations have addressed the 
importance of combined geriatric and orthopaedic 
(orthogeriatric) care as an alternative to traditional 
treatment,9 although the optimum treatment model is 
unknown. As summarised in reviews,10,11 several in-
hospital models of orthogeriatric care have been 
Lancet 2015; 385: 1623–33
Published Online
February 5, 2015
http://dx.doi.org/10.1016/
S0140-6736(14)62409-0
See Comment page 1594
*Joint ﬁ rst authors
Department of Neuroscience 
(A Prestmo MD, O Sletvold PhD, 
Prof J L Helbostad PhD, 
P Thingstad MSc, 
K Taraldsen PhD, 
L G Johnsen PhD, I Saltvedt PhD), 
Department of Public Health 
and General Practice 
(G Hagen MPhil, 
V Halsteinli PhD), and Regional 
Centre for Child and Youth 
Mental Health and Child 
Welfare (Prof S Lydersen PhD), 
Norwegian University of 
Science and Technology, 
Trondheim, Norway; 
Department of Geriatrics 
(A Prestmo, O Sletvold, 
I Saltvedt), Department of 
Clinical Services 
(Prof J L Helbostad), and 
Department of Orthopaedics 
(L G Johnsen), St Olav Hospital, 
University Hospital of 
Trondheim, Trondheim, 
Norway; The Central Norway 
Regional Health Authority, 
Stjørdal, Norway (V Halsteinli); 
The Norwegian Directorate of 
Health, Trondheim, Norway 
(T Saltnes MSc); and Oxford 
Clinical Trials Research Unit, 
University of Oxford, Oxford, 
UK (Prof S E Lamb PhD)
Correspondence to:
Dr Ingvild Saltvedt, Department 
of Neuroscience, Norwegian 
University of Science and 
Technology, Medical Faculty, 
Post box 8905, 
N-7491Trondheim, Norway
ingvild.saltvedt@ntnu.no
Articles
1624 www.thelancet.com   Vol 385   April 25, 2015
developed, including geriatric consultation teams, 
comanaged care between geriatricians and orthopaedic 
surgeons, and a range of interdisciplinary orthogeriatric 
care pathways. These models have had beneﬁ cial eﬀ ects 
on delirium, comp lication rates, and mortality.
Most models of orthogeriatric care reported in the 
scientiﬁ c literature are initiated after surgery and 
undertaken in orthopaedic contexts, and are linked to 
speciﬁ c in-hospital and post-discharge rehabilitation 
programmes10 A few, non-randomised studies have 
investigated acute orthogeriatric care pathways for which 
all assessments and treatments except surgery were done 
within a geriatric ward by an interdisciplinary team. One 
of these studies7 showed important beneﬁ ts for 
complication rates, walking ability, and mortality. 
Investigators from the Oslo Orthogeriatric Trial12 reported 
a clinical pathway for patients with a hip fracture, for 
which the entire assessment and treatment programme, 
except surgery, took place in an acute geriatric setting; 
however, no eﬀ ect was shown on cognition as the primary 
outcome. 
The aim of our trial was to assess the eﬀ ectiveness of 
comprehensive geriatric care versus usual orthopaedic 
care provided throughout an entire hospital stay, with 
only the fracture assessment and surgical treatment 
done by orthopaedic surgeons. We investigated both 
short-term and long-term outcomes in randomly 
assigned patients, with assessments done at 1, 4, and 
12 months after surgery. Because immobility is an 
immediate result of a fracture and also later contributes 
to long-term functional deterioration,5 we chose mobility 
at 4 months as the primary outcome.
Methods
Study design and participants
We did a prospective, single-centre, randomised, controlled 
trial at St Olav University Hospital in Trondheim, Norway. 
St Olav is a central hospital for 300 000 inhabitants of Sør-
Trøndelag County, with 25 municipalities and a total area 
of 18 848 km², and a regional centre for 696 000 inhabitants 
in mid-Norway. The health-care system in Norway is 
organised and ﬁ nanced by the public sector, and based on 
equal access to services irrespective of social or economic 
status. In Norway, most patients with hip fractures stay in 
hospital for at least 2 days after surgery. A few patients are 
discharged directly home, but most are transferred to 
dedicated rehabilitation facilities or nursing homes for 
short-term or long-term stays. Services after discharge are, 
in principle, provided according to needs.
The protocol and intervention programmes for the 
study have been published previously.13,14
All patients admitted to the hospital with hip fractures 
were screened (brieﬂ y, a nurse approached all potentially 
eligible patients with a conﬁ rmed hip fracture in the 
emergency room, or their next-of-kin). Home-dwelling 
people aged 70 years or older who had been able to walk 
10 m before the fracture were eligible. (Patients living in 
their homes or sheltered housing, or who were staying 
temporarily in any kind of institution were deﬁ ned as 
home-dwelling.) We excluded patients with pathological 
fractures, multiple traumas, or a short life expectancy, or 
who were living permanently in nursing homes or 
already participating in the investigation. The study was 
approved by the Regional Committee of Ethics in Medical 
Research (REK4.2008.335), the Norwegian Social Science 
Data Services (NSD19109), and the Norwegian Directorate 
of Health (08/5814). Patients or their next-of-kin gave 
informed written consent to be included in the study 
before participation.
Randomisation and masking
Provided eligibility criteria were conﬁ rmed, patients were 
enrolled and randomly assigned in a 1:1 ratio by a nurse to 
either the orthopaedic ward for orthopaedic care or the 
geriatric ward for comprehensive geriatric care. Patients 
were transferred to the allocated wards directly from the 
emergency department after treatment allocation.
The randomisation sequence was computer-generated 
in blocks of a size unknown to the investigators. We used 
a web-based, computer-generated service prepared by the 
Unit of Applied Clinical Research, Norwegian University 
of Science and Technology (NTNU).
Masking of the patients and staﬀ  delivering the 
treatment was not possible, and we were only partly able 
to accomplish masking of assessors during follow-up.
Procedures
The initial diagnosis of a hip fracture was made by an 
orthopaedic surgeon, who also established the type of 
operation that was needed. Preoperative and postoperative 
care was undertaken in the two wards by separate teams. 
Patients in both groups of the trial received care and 
physiotherapy in accordance with national and inter-
national guidelines.14 Geriatricians or other doctors with 
skills in the management of older people did not routinely 
visit the orthopaedic ward, and orthopaedic specialists did 
not routinely visit the geriatric ward. By request, for only a 
few patients, geriatricians brieﬂ y assessed patients 
receiving orthopaedic care; vice versa, the orthopaedic 
surgeon assessed a few patients receiving comprehensive 
geriatric care.
The clinical pathway for comprehensive geriatric care 
(table 1) was organised both before and after the operation 
as a systematic and interdisciplinary process, with an 
emphasis on comprehensive medical assessment and 
treatment, initiation of rehabilitation through mobilisation, 
and planning of discharge started early. Individualised 
rehabilita tion plans were developed for patients who were 
discharged directly home. The number of staﬀ  members 
per bed was higher in the comprehensive geriatric care 
unit than in the orthopaedic care unit (nurses 1·67 vs 1·48, 
doctors 0·13 vs 0·11, physiotherapist 0·13 vs 0·09, and 
occupational therapist 0·13 vs 0·00). The orthopaedic ward 
was relocated to a new hospital building on 1 Sept, 2009.
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After discharge from hospital the primary health-care 
services were responsible for follow-up in both groups, 
but neither group was routinely oﬀ ered hospital-based 
follow-up after discharge. When needed, the orthopaedic 
surgeon arranged follow-up at the orthopaedic outpatient 
clinic for patients in both groups. For baseline 
registration of prefracture comorbidity we used the 
Charlson comorbidity index. The scores range from 0 to 
30, with a high score suggesting high comorbidity.15 For 
the preoperative risk classiﬁ cation we used the Acute 
Physiology And Chronic Health Evaluation II severity of 
disease classiﬁ cation system (APACHE II), with scores 
ranging from 5 to 89, high scores suggesting a high 
risk.16 The minimum score with APACHE II is 5 points 
because all patients were aged 70 years or older.
Follow-up assessments were done on day 5 after the 
operation, and 1, 4, and 12 months after surgery. 
Assessments were done by assessors who were not 
associated with patient care. 4 month and 12 month 
assessments were undertaken at the hospital if possible. 
These assessments were not linked to medical 
assessments except for ﬁ ve emergency cases from both 
groups that were managed by a geriatrician. All 1 month 
assessments, and 4 month and 12 month assessments in 
very sick patients, were done wherever the patient 
resided. Whenever possible during data collection, 
patients were the primary informant. The exception was 
for Clinical Dementia Rating scores, which were collected 
from proxies by telephone for all patients, and scores for 
the Barthel index and the Nottingham Extended ADL 
scale, which were collected from proxies by telephone for 
10–20% of patients in both groups who were unable to 
provide the data.
Medical information, including complications, 
admissions to hospital, and visits to outpatient clinics 
was obtained from hospital records. Information about 
admissions to institutional rehabilitation centres was 
obtained from the Norwegian Patient Registry, visits to 
family doctors and physiotherapists from the 
Norwegian Health Economics Administration, and 
nursing home stays and other primary care services 
from the municipalities’ records (appendix).
Outcomes
The primary outcome was mobility at 4 months after 
surgery measured by the Short Physical Performance 
Battery (SPPB),17 assessing standing balance, walking 
speed, and ability to rise from a chair, assessed in the 
intention-to-treat population. The total score ranges from 
0–12; high scores suggest better mobility.
Secondary outcomes were mobility assessed by Timed 
Up and Go (TUG) measured as time in seconds to 
complete speciﬁ c actions—a short time suggests better 
mobility,18 personal activities of daily living (ADLs) 
measured by the Barthel Index with a score range of 
0–20 (a high score suggests increased independence),19 
instrumental ADLs (i-ADL), measured by the 
Nottingham Extended ADL scale with a score of 0–66 (a 
For the Norwegian Patient 
Registry see www.npr.no
Comprehensive geriatric care Orthopaedic care
Department Department of Geriatrics,
Clinic of Internal Medicine
Department of Orthopaedic Surgery,
Clinic of Orthopaedics and Rheumatology
Facilities* Geriatric ward:
Five one-bed rooms organised in a group together
reserved for patients with hip fractures within a 15-bed 
ward
Orthopaedic trauma ward:
One, two, or four-bed rooms in a 19-bed ward 
before, or single rooms in a 24-bed ward after 
relocation
Mixed orthopaedic trauma patient population
Team members,†number per bed
Geriatricians 0·13 ··
Registered nurses, licensed practical nurses 1·67 1·48
Physiotherapists 0·13 0·09 (0·07 after relocation)
Occupational therapists 0·13 None
Orthopaedic surgeons ·· 0·11 (0·08 after relocation)
Treatment Structured, systematic interdisciplinary comprehensive 
geriatric assessment and care focusing on: somatic health 
(comorbidity management, review of drug regimens, 
pain, nutrition, elimination, hydration, osteoporosis, and 
prevention of falls); mental health (depression, delirium); 
function (mobility, p-ADL and i-ADL) and social situation
Early discharge planning
Early mobilisation and initiation of rehabilitation
Following of routines of Department of 
Orthopaedic Surgery
For both groups, management of standard treatment and surgery is the same: standard treatment consists of preoperative intravenous ﬂ uid, analgesia (preoperative femoral 
nerve block, regular paracetamol, opioids on demand), thromboembolic prophylaxis, perioperative antibiotic prophylaxis, use of pressure relieving mattresses to avoid 
decubitus ulcers, and preoperative assessments by an anaesthetist; surgery consists of spinal anaesthesia, two-screw ﬁ xation for non-dislocated femoral neck fractures, 
hemiarthroplasty for dislocated femoral neck fractures, and a sliding hip screw system for trochanteric and subtrochanteric fractures (some subtrochanteric fractures are ﬁ xed 
with antegrade intramedullary nailing). p-ADL=personal Activities of Daily Living. i-ADL=instrumental Activities of Daily living. *Orthopaedic care was relocated to a new 
hospital building after 219 of 397 patients were recruited. †Separate teams with no collaboration.
Table 1: Management in the comprehensive geriatric assessment and care and the orthopaedic care groups
See Online for appendix
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high score suggests better ability to undertake 
instrumental i-ADL),20 cognition assessed with the 
Clinical Dementia Rating scale scored with a sum of 
boxes with a range of 0–18 (a low score suggests better 
cognitive function)21 and the Mini Mental Status 
Examination (MMSE) with a score range of 0–30 (a high 
score suggests better cognition)22 and quality of life 
assessed by the EuroQoL-5 dimension-3L (EQ-5D-3L) 
questionnaire with a score range of –0·594 to 1 (a low 
score suggests a worse quality of life).23 Fear of falling 
was assessed by the Falls Eﬃ  cacy Scale 
International-short form (FES-I-s) with a score range of 
7–28 points, for which a low score suggests decreased 
fear,24 and mood by the Geriatric Depression Scale, 
ranging from 0 to 15 points, for which a low score 
suggests a better mood.25
Additional outcomes described in the protocol 
manuscript13 such as gait control and daily physical 
activity from the whole set of participants will be 
published in separate reports. Our choice of this wide 
range of outcome variables is, to a large extent, in line 
with published recommendations for studies assessing 
orthogeriatric comanagement of hip fractures.26
Statistical analysis
Sample size was calculated from an estimated eﬀ ect size 
of 1·0 point in mean SPPB score at 4 months after surgery. 
(1·0 point is regarded as a substantial meaningful change, 
and 0·5 points is a small meaningful change).27 We 
expected a reduction of 10% in participants resulting from 
death and a 10% dropout because of withdrawals during 
Figure 1: Trial proﬁ le
*One participant registered as deceased in the comprehensive geriatric care group and one in the orthopaedic care 
group ﬁ nished their ﬁ nal tests before death. Data for health-care services and economics were available for all 
patients except one in the orthopaedic care group who withdrew consent to collect data from registries; therefore 
n=198 in both groups.
1077 assessed for eligibility
397 randomly assigned 
680 excluded
 547 did not meet inclusion criteria
 250 in a nursing home
 154 aged <70 years
 30 with a terminal illness or unable
  to walk
 49 located outside the catchment area
 64 for other reasons 
 54 declined to participate
 79 for other reasons
198 allocated to comprehensive geriatric care 
 (ITT population)
 197 received allocated care 
 183 tested during hospital stay
 15 had incomplete data obtained by
  telephone or from patient records
199 allocated to orthopaedic care 
 (ITT population)
 198 received allocated care
 161 tested during hospital stay
 38 had incomplete data obtained by
  telephone or from patient records
187 participants remaining at 1 month 
 168 tested at place of residence
 11 had incomplete data obtained by 
  telephone or from patient records 
 8 lost to follow up
9 deceased
2 withdrawn consent 
183 participants remaining at 1 month
 152 tested at place of residence
 19 had incomplete data obtained by
  telephone or from patient records
 12 lost to follow up
12 deceased
  4 withdrawn consent
174 participants remaining at 4 months
 165 assessed at hospital
 3 had incomplete data obtained by
  telephone or from patient records
 6 lost to follow-up
19 deceased
   5 withdrawn consent
170 participants remaining at 4 months
 156 assessed at hospital
 9 had incomplete datasets obtained by
  telephone or from patient records 
 5 lost to follow-up 
21 deceased
  8 withdrawn consent
162 participants remaining at 12 months
 152* assessed at hospital
 5 had incomplete data obtained by 
  telephone or from patient records 
 6 lost to follow-up
30 deceased*
  6 withdrawn consent
149 participants remaining at 12 months
 132* assessed at hospital
 10 had incomplete data obtained by
  telephone or from patient records
 8 lost to follow-up
37 deceased* 
13 withdrawn consent
Comprehensive 
geriatric care 
(N=198)
Orthopaedic 
care (N=199)
Age (years) 83·4 (5·4) 83·2 (6·4)
Female 145 (73%) 148 (74%)
Sheltered housing 26 (13%) 20 (10%)
Living alone 115 (58%) 124 (62%)
Barthel Index (0–20) 18·3 (2·3) 18·1 (2·8)
Nottingham Extended ADL scale 
(0–66)
42·5 (17·7) 41·9 (17·5)
Clinical Dementia Rating Scale 
(0–18)
2·7 (4·0) 2·7 (3·9)
APACHE II (5–89) 9·3 (3·3) 9·1 (2·9)
Charlson comorbidity index (0–30) 2·3 (2·3) 2·3 (2·0)
Previous diagnoses
Heart disease 97 (49%) 89 (45%)
Stroke 49 (25%) 57 (29%)
Diabetes 23 (12%) 28 (14%)
Dementia 27 (14%) 26 (13%)
Cancer 53 (27%) 43 (22%)
Kidney disease 18 (9%) 9 (5%)
Fracture type
Femoral neck 119 (60%) 127 (64%)
Trochanteric 66 (33%) 58 (29%)
Subtrochanteric 13 (7%) 14 (7%)
Surgical treatment
Hemiarthroplasty 76 (38%) 88 (44%)
Screws 38 (19%) 32 (16%)
Bone plates and screws 69 (35%) 63 (32%)
Other 13 (7%) 14 (7%)
Died before surgery 2 (1%) 2 (1%)
Data are mean (SD) or n (%). ADL=activities of daily living. APACHE II=Acute 
Physiology And Chronic Health Evaluation disease severity classiﬁ cation II.
Table 2: Baseline characteristics
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the ﬁ rst 4 months. With an α value of 0·05, 304 patients 
were needed for 80% power, but 380 patients were needed 
to allow for an estimated 20% dropout rate. We planned to 
stop recruiting participants by the end of 2010.
A statistical analysis plan was completed before doing 
any data analyses. Group allocation was masked during 
analysis of the primary outcome. All randomly assigned 
patients who met the inclusion criteria were included in 
the intention-to-treat population.
An independent clinical trials unit (Warwick Clinical 
Trials Unit, University of Warwick, Warwick, UK) 
reviewed emerging safety data (mortality and serious 
adverse events), and the assumptions underlying the 
sample-size calculation when 200 patients had been 
recruited. No planned or unplanned formal interim 
analyses were undertaken.
We used single imputation with the expectation 
maximation algorithm for individual missing items on 
questionnaires and performance tests, with scores from 
the same timepoint as predictors.
We checked the normality of residuals by visual 
inspection of Q-Q plots. Results are reported as means, 
SE, and SD. Linear mixed models for repeated 
measurements were done with all outcome assessment 
scales as dependent variables, controlling for age, sex, 
and femoral neck fractures.28 We analysed diﬀ erences in 
the length of stay in the hospital between groups with 
linear regression. Diﬀ erences between groups in the 
number of patients discharged directly home, admitted 
to hospital, or staying in nursing homes were analysed 
with Pearson’s χ² test.
We assessed the eﬀ ect of the move of the orthopaedic 
care unit to new facilities on SPPB, the Barthel index, 
and the Nottingham Extended ADL scale by use of a 
linear mixed model with an interaction product of group, 
before and after the move.
We regarded two-sided p values of less than 0·05 to be 
deemed statistically signiﬁ cant, and report 95% CIs 
when relevant.
We assessed cost-eﬀ ectiveness from a broad health-care 
perspective. We calculated QALYs with the area-under-the-
curve approach, with an assumption of a linear change in 
EQ-5D-3L values over time.29 If a patient died, they were 
classiﬁ ed as having no previous decrease in quality of life. 
All patients were given an equal EQ-5D-3L baseline score 
based on a systematic review of osteoporosis-related utility 
values.30 The diﬀ erent health states generated from the EQ-
5D-3L were assigned values from the UK time-trade-oﬀ  
tariﬀ 23 (ie, each health state was assigned a number 
between –0·594 and 1·000).
We imputed missing data for the EQ-5D-3L by multiple 
imputation using age, sex, fracture type, Charlson 
comorbidity index, APACHE II, the Barthel index, and 
MMSE as predictors. Imputations were done 100 times.
The sum of surgical treatment costs and length of stay 
multiplied by the cost per day constituted the cost per 
index stay, with costs per day for comprehensive geriatric 
Comprehensive 
geriatric care
Orthopaedic care Diﬀ erence
N Mean (SE) N Mean (SE) Estimate 
(95% CI)
p value
Hospital 198 199
Mobility
Short Performance 
Physical Battery
183 1·61 (0·19) 161 1·04 (0·20) 0·56
(0·20 to 1·10)
0·042
1 month 187 183
Mobility
Short Performance 
Physical Battery
173 3·59 (0·19) 160 3·09 (0·20) 0·50
(–0·05 to 1·05)
0·08
Timed Up and Go 140 31·32 (1·53) 120 32·80 (1·66) –1·48
(–5·92 to 2·95)
0·51
Cognition
Mini Mental Status 
Examination
168 23·43 (0·44) 152 22·40 (0·46) 1·03
(–0·22 to 2·27)
0·11
Activities of daily living
Barthel Index 179 14·53 (0·28) 169 14·21 (0·29) 0·32
(–0·47 to 1·11)
0·43
Nottingham Extended 
ADL Scale
179 17·05 (1·25) 169 14·87 (1·29) 2·19
(–1·33 to 5·71)
0·22
Depressive symptoms
Geriatric Depression Scale 169 4·81 (0·25) 154 4·84 (0·26) 0·03
(–0·74 to 0·68)
0·94
Fear of falling
Falls Eﬃ  cacy Scale 
International-short form
158 12·73 (0·35) 139 13·97 (0·37) –1·24
(–2·24 to –0·24)
0·015
Quality of life
EQ–5D–3L 176 0·46 (0·26) 165 0·40 (0·26) 0·05
(–0·02 to 0·12)
0·16
4 months 174 170
Mobility
Short Physical 
Performance Battery
165 5·12 (0·20) 160 4·38 (0·20) 0·74
(0·18 to 1·30)
0·010
Timed Up and Go 153 24·05 (1·47) 136 25·94 (1·56) –1·90
(–6·09 to 2·31)
0·38
Cognition
Clinical Dementia Rating 
scale
159 3·59 (0·35) 145 4·38 (0·36) –0·79
(–1·70 to 0·20)
0·12
Mini Mental Status 
Examination
165 23·92 (0·44) 156 22·83 (0·46) 1·10
(–0·15 to 2·34)
0·08
Activities of daily living
Barthel index 168 16·31 (0·29) 165  15·30 (0·29) 1·01
(0·21 to 1·81)
0·013
Nottingham Extended 
ADL Scale
168 33·59 (1·29) 164 27·42 (1·31) 6·17
(2·57 to 9·78)
0·001
Depressive symptoms
Geriatric Depression Scale 165 4·32 (0·25) 155 4·75 (0·26) –0·42
(–1·14 to 2·90)
0·24
Fear of falling
Falls Eﬃ  cacy Scale 
International—short form
154 11·31 (0·35) 144 12·57 (0·37) –1·27
(–2·27 to –0·27)
0·013
Quality of life
EQ–5D–3L 177 0·54 (0·26) 170 0·46 (0·26) 0·08
(0·01 to 0·15)
0·033
(Table 3 continues on next page)
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care and orthopaedic care calculated on the basis of 
diﬀ erences in staﬀ  numbers. Patient use of services after 
discharge was combined with unit costs to calculate the 
cost per patient (appendix).
We evaluated cost-eﬀ ectiveness by calculating the 
diﬀ erence in mean costs and dividing by the diﬀ erence 
in mean QALYs, assuming a theoretical threshold of 
€62 500 per QALY gained. We estimated any uncertainty 
about the incremental cost-eﬀ ectiveness ratio (ICER) by 
bootstrapping the costs and eﬀ ects 1000 times.31
Any patient who died during the course of the trial was 
allotted zero costs and zero health from the date of death 
and was not classiﬁ ed as censored.32 We did all analyses 
with the IBM SPSS statistics 20.0 program.
This trial is registered with ClinicalTrials.gov, number 
NCT00667914.
Role of the funding source
The funders of the study had no role in the study 
design, data collection, data analyses, or data 
interpretation, or writing of the report. The corre-
sponding author had full access to all the data in the 
study and had ﬁ nal responsibility for the decision to 
submit for publication.
Results
Patients were recruited from April 18, 2008, to 
December 30, 2010 (the prespeciﬁ ed ﬁ nishing 
timepoint). 1077 patients were screened for eligibility, of 
whom 397 were randomly assigned to receive either 
comprehensive geriatric care (n=198) or orthopaedic 
care (n=199) (ﬁ gure 1). Most patients were randomly 
assigned in the emergency room before they were 
transferred to their assigned ward. 22 were randomly 
assigned in the orthopaedic ward within 24 h of 
Comprehensive 
geriatric care
Orthopaedic care Diﬀ erence
N Mean (SE) N Mean (SE) Estimate 
(95% CI)
p value
(Continued from previous page)
12 months 162 149
Mobility
Short Physical 
Performance Battery
151 5·30 (0·21) 133 4·61 (0·22) 0·69
(0·10 to 1·28)
0·023
Timed Up and Go 139 21·93 (1·54) 117 23·25 (1·68) –1·32
(–5·79 to 3·15)
0·56
Cognition
Clinical Dementia Rating 
scale
152 4·00 (0·36) 138 4·59 (0·37) –0·59
(–1·59 to 0·41)
0·25
Mini Mental Status 
Examination
152 24·13 (0·46) 132 22·69 (0·49) 1·44
(0·12 to 2·77)
0·033
Activities of daily living
Barthel Index 158 16·46 (0·29) 142 15·33 (0·30) 1·13
(0·31 to 1·96)
0·007
Nottingham Extended 
ADL Scale
158 35·20 (1·33) 142 28·81 (1·41) 6·39
(2·59 to 10·19)
0·001
Depressive symptoms
Geriatric Depression Scale 151 4·10 (0·26) 131 4·82 (0·27) –0·72
(–1·46 to 0·02)
0·06
Fear of falling
Falls Eﬃ  cacy Scale 
International–short
form
149 10·81 (0·36) 119 12·03 (0·39) –1·21
(–2·24 to –0·18)
0·021
Quality of life
EuroQol–5d–3L 176 0·52 (0·22) 161 0·45 (0·23) 0·09
(0·02 to 0·16)
0·015
QALY 0–12 months 198 0·49 (0·02) 199 0·42 (0·02) 0·07
(0·01 to 0·13)
0·019
ADL=activities of daily living. QALY=quality-adjusted life-years.
Table 3: Clinical assessments
Figure 2: Mobility, activities of daily living, and instrumental activities of daily living
Data are mean, 95% CI. ADL=activities of daily living.
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admission; ten of these were randomly assigned to 
comprehensive geriatric care and moved to the geriatric 
ward after surgery. The most common reason for 
ineligibility was that the patient resided permanently in 
a nursing home (250 [46%] of 547) or was too young 
(aged <70 years; 154 [28%] of 547). At 12 months, only 
33 patients (8%) had withdrawn or were registered with 
missing data (lost to follow-up) and we noted no 
signiﬁ cant diﬀ erences between the groups for 
withdrawn patients or missing data (p=0·14, 95% CI 
–8·70 to 3·70).
Baseline characteristics did not diﬀ er between the 
groups (table 2). For the 397 randomly assigned patients, 
the mean age was 83 years (SD 6·1), 293 (73%) were 
women, and 239 (60%) lived alone before the fracture. 
The proportion of patients with femoral neck fractures 
did not diﬀ er between groups (table 2). Mortality in the 
comprehensive geriatric care and orthopaedic groups at 
12 months was 30 (15%) of 198 and 37 (18%) of 
199 patients, respectively (p=0·36). We noted no 
diﬀ erences in fracture-related or other complications 
during the index stay (data not shown). Mean prefracture 
personal-ADL Barthel index scores were 18·3 (SD 2·3) 
and 18·1 (2·8), and mean prefracture Nottingham 
Extended ADL scale scores were 42·5 (17·7) and 41·9 
(17·5).
For the primary outcome of mobility at 4 months, the 
comprehensive geriatric care group had better mean 
SPPB scores than the orthopaedic care group, with a 
between-group diﬀ erence of 0·74 points (95% CI 
0·18–1·30, p=0·010; table 3, ﬁ gure 2). The between-group 
diﬀ erence at 12 months was 0·69 (0·10–1·28; p=0·023). 
165 patients in the comprehensive geriatric care group 
and 160 in the orthopaedic care group were assessed for 
the primary outcome. Between-group diﬀ erences in 
mean SPPB scores were in favour of comprehensive 
geriatric care on day 5 after the operation but were not 
signiﬁ cant at 1 month (table 3, ﬁ gure 2). We noted no 
signiﬁ cant between-group diﬀ erences for mobility TUG 
during follow-up (table 3).
The mean instrumental ADL score during the study 
was signiﬁ cantly better in the comprehensive geriatric 
care group than in the orthopaedic care group at 4 months 
and at 12 months (table 3). Mean p-ADL score at 4 and 
12 months after surgery also favoured comprehensive 
geriatric care. Quality-of-life measures were higher in 
the comprehensive geriatric care group than in the 
orthopaedic care group; however, the diﬀ erence at 
1 month was not signiﬁ cant (table 3, appendix).
Cognitive function assessed by the MMSE at 4 months 
and the Clinical Dementia Rating Scale at any timepoint 
did not diﬀ er signiﬁ cantly between the groups (table 3). 
However, MMSE scores were better for comprehensive 
geriatric care at 12 months than for orthopaedic care 
(table 3).
Fear of falling was reduced in the comprehensive 
geriatric care group compared with the orthopaedic care 
group at 1 month, 4 months, and 12 months. We noted 
no signiﬁ cant between-group diﬀ erences in symptoms of 
depression as measured by the Geriatric Depression 
Scale (table 3).
The mean preoperative waiting times were similar 
between groups; however, mean length of hospital stay 
was signiﬁ cantly longer in the comprehensive geriatric 
care group than in the orthopaedic care group (table 4). A 
signiﬁ cantly higher proportion of patients in the 
comprehensive geriatric care group was discharged 
directly home than in the orthopaedic care group 
Comprehensive 
geriatric care
Orthopaedic 
care
Diﬀ erence
 Estimate (95% CI) p value
Preoperative waiting-time (h) 28·7 (26·1) 29·3 (20·6) –0·6 (–5·3 to 4·1) 0·80
Length of stay (days) 12·6 (0·43) 11·0 (0·54) 1·7 (0·20 to2·93) 0·025
Discharged directly home 47 (25%) 20 (11%) 13·9 (6·3 to 21·4) 0·001
Number of patients living at home
1 month after treatment 171 (91%) 161 (87%) 3·9 (–2·5 to 10·4) 0·23
4 months after treatment 154 (86%) 141 (80%) 6·4 (–1·5 to 14·2) 0·14
12 months after treatment 140 (83%) 122 (76%) 7·6 (–1·2 to 16·2) 0·09
Patients admitted to hospital
0–4 months after treatment 55 (29%) 58 (31%) –2·2 (–11·4 to 7·0) 0·64
4–12 months after treatment 54 (30%) 66 (37%) –7·1 (–16·7 to 2·7) 0·16
Rehabilitation
0–4 months after treatment 121 (63%) 135 (72%) –8·8 (–18·0 to 0·6) 0·07
4–12 months after treatment 13 (7%) 19 (11%) –3·5 (–9·7 to 2·5) 0·25
Short-term stay in a nursing home
0–4 months after treatment 44 (23%) 51 (27%) –4·2 (–12·9 to 4·5) 0·34
4–12 months after treatment 17 (10%) 30 (17%) –7·5 (–14·6 to –0·4) 0·038
Permanent stay in a nursing home
0–4 months after treatment 28 (15%) 32 (17%) –2·5 (–9·9 to 5·0) 0·51
4–12 months after treatment 36 (20%) 45 (25%) –5·3 (–14·0 to 3·4) 0·22
Number included in the analyses for comprehensive geriatric care versus orthopaedic care: index stay 198 versus 198; 
discharge home 191 versus 187; place of residence at 1 month 188 versus 185, at 4 months 179 versus 177, at 
12 months 168 versus 161; use of care after the index stay: 0–4 months 191 versus 187, 4–12 months 179 versus 177.
Table 4: Health-care use
Comprehensive 
geriatric care 
(n=198)
Orthopaedic 
care (n=198)
Diﬀ erence
Mean (SD) Mean (SD) Estimate (95% CI) p value
Index stay 11 868 (4185) 9537 (4 393) 2331 (1483 to 3178) <0·0001
Hospital costs after 
discharge
7 745 (15 006) 11 022 (20 119) –3277 (–6784 to 230) 0·07
Rehabilitation stay 8 105 (9076) 9633 (11 125) –1529 (–3535 to 477) 0·14
Nursing home stay 14 874 (30 153) 18 798 (32 959) –3923 (–10 164 to 2318) 0·22
Other primary health 
and care services
11 741 (15 128) 10 496 (14 498) 1246 (–1683 to 4173) 0·40
Total cost 54 332 (38 048) 59 486 (44 301) –5154 (–13 311 to 3007) 0·22
Costs are in euros for 2010.
 Table 5: Cost per patient
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(table 4). Fewer patients receiving comprehensive 
geriatric care were admitted to short-term nursing home 
stays between 4 and 12 months after surgery than patients 
receiving orthopaedic care. Diﬀ erences between groups 
in the proportions of patients living at home, or admitted 
to hospital or long-term nursing homes during follow-up 
were not signiﬁ cant (table 4).
The comprehensive geriatric care index stay was more 
costly than the orthopaedic care stay, with a mean 
diﬀ erence of €2331 (95% CI 1483–3178), p<0·0001. 
Diﬀ erences between the groups for total costs per patient 
were non-signiﬁ cant (mean €–5154 [–13 311 to 3007], 
p=0·22). Table 5 and appendix show further details about 
costs for other health services.
The number of QALYs was higher in the comprehensive 
geriatric care group than in the orthopaedic care group at 
4 and 12 months (table 3).
The ICER was calculated to €–71 751 per QALY gained. 
Bootstrap results suggest that comprehensive geriatric 
care has a 99% probability of being cost eﬀ ective 
compared with orthopaedic care, with the assumption 
of a threshold of €62 500 per QALY gained. 
Comprehensive geriatric care has an 88% probability of 
being both less costly and more eﬀ ective than 
orthopaedic care—ie, of being a dominant alternative 
(ﬁ gure 3).
At the time that the orthopaedic care group relocated to 
a new hospital, 219 (55%) of 397 patients had been 
recruited. The interaction analyses of the eﬀ ect of the 
orthopaedic care group moving to new facilities during 
the study period did not show signiﬁ cance at the 0·05 
level for mobility (SPPB scores, p=0·078), personal ADLs 
(Barthel index scores, p=0·13), or instrumental-ADLs 
(Nottingham Extended ADL scale scores, p=0·19).
Discussion
We investigated if any beneﬁ t was gained when patients 
with a hip fracture receive all assessments and treatments 
except surgery in an acute geriatric ward from an 
interdisciplinary team, rather than the usual orthopaedic 
care ward. For the primary outcome of mobility as 
measured by SPPB 4 months after surgery, the results 
were better with comprehensive geriatric care than with 
traditional orthopaedic care (see appendix for details). 
Most secondary outcomes were also better with 
comprehensive geriatric care than with orthopaedic care, 
including mobility and cognition at 12 months, activities 
of daily living, fear of falling, and quality of life at 4 and 
12 months. The length of stay was signiﬁ cantly longer in 
the comprehensive geriatric care group, and signiﬁ cantly 
more patients in this group were discharged directly 
home, than were patients in the orthopaedic care group. 
Diﬀ erences in the place of residence, and the number of 
patients admitted to hospital, rehabilitation, or long-term 
nursing-home care during 1 year of follow-up did not 
diﬀ er between groups, except for fewer patients in the 
comprehensive geriatric care group admitted for short-
term stays in a nursing home 4–12 months after surgery 
than those in the comprehensive geriatric group. The 
analyses suggest a high probability of comprehensive 
geriatric care being both less costly and more eﬀ ective 
than orthopaedic care for patients aged 70 years or older.
Mobility was chosen as the primary outcome because 
immobility is an immediate result of a fracture, and older 
patients with hip fractures often have a marked and 
permanent deterioration in their walking ability.5 SPPB is 
regarded as an objective outcome of physical 
performance, and also captures the health status of 
the participant.33 Therefore the signiﬁ cant SPPB 
Figure 3: Cost per QALY analysis
The ﬁ gure shows the cost-eﬀ ectiveness plane and acceptability curve. CGC=comprehensive geriatric care. QALY=quality-adjusted life-years.
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between-group diﬀ erence of 0·74 at 4 months, regarded 
as a clinically meaningful change,27 and long-term 
improvement of mobility with comprehensive geriatric 
care, represent important ﬁ ndings. This result is 
consistent with the orthogeriatric study of Shyu and 
colleagues34 done in an acute orthopaedic context (panel). 
Results from subgroup analyses in the Oslo 
Orthogeriatric trial12 done in a geriatric context also 
indicated improved mobility with comprehensive 
geriatric care for home-dwelling patients. We noted, 
however, no between-group diﬀ erences for the secondary 
mobility outcome of TUG. It seems that the TUG is less 
sensitive to change than the SPPB, possibly because 
patients who are unable to undertake this test are not 
given a score.
The signiﬁ cant and clinically meaningful beneﬁ ts35 of 
comprehensive geriatric care for instrumental-ADLs at 
4 and 12 months have not been shown in previous studies 
of patients with hip fractures. The ability to complete 
instrumental-ADLs is an important need for independent 
living. In line with previous rehabilitation studies10 and 
results from the trial by Shyu and colleagues,34 we showed 
a slight eﬀ ect on ability to undertake personal-ADLs in 
favour of the comprehensive geriatric care group. The 
magnitude of the diﬀ erences in quality of life at 4 and 
12 months is roughly the mean of reported minimally 
important diﬀ erences, which further supports the results 
of ADL beneﬁ ts for the comprehensive geriatric care 
group.36 The 1·44 point diﬀ erence in mean MMSE scores 
at 12 months can be regarded as clinically signiﬁ cant at a 
group level in these frail, older patients, although a 
diﬀ erence of 3 points is needed to be of clinical importance 
for individual patients with dementia.37 We noted a 
signiﬁ cant and probably clinically important 1·2 point 
diﬀ erence in FES-I-s scores at 1, 4, and 12 months in 
favour of the comprehensive geriatric care group.38
The proportion of patients discharged directly home 
was signiﬁ cantly higher in the group receiving 
comprehensive geriatric care than in the group assigned 
to orthopaedic care. This ﬁ nding could be attributed to a 
better in-hospital programme for discharge planning and 
mobilisation. On one hand, the notion of a better mobility 
programme in the comprehensive geriatric care group 
during the hospital stay is supported by patients spending 
more time in a standing position and walking in the 
comprehensive geriatric care group than the orthopaedic 
care group, as measured by use of body-worn sensors on 
day 4 after surgery.39 On the other hand, length of stay in 
the hospital was signiﬁ cantly increased in the group 
receiving comprehensive geriatric care, compared with 
the group receiving orthopaedic care. These ﬁ ndings 
contrast with previous studies of orthogeriatric care, as 
summarised in a review.10 In our study context, periods of 
heightened need for trauma-ward beds in the orthopaedic 
care department might have increased the rate of 
discharge for this group. Another explanation for the 
discharge policy could be that comprehensive geriatric 
care and discharge planning are time-consuming. Also, 
some extra days in hospital might have been suﬃ  cient 
for some patients to have been discharged directly home.
Costs separated by service categories show that the 
index stay was more costly in the comprehensive 
geriatric care group than in the orthopaedic care group; 
between-group diﬀ erences of costs for later hospital 
stays, stays in rehabilitation facilities and nursing 
Panel: Research in context
Systematic review
We searched the PubMed database, with no date restrictions, for English-language 
studies of orthogeriatric treatment models of hip fractures, especially new models 
focusing on long-term results of acute comprehensive geriatric assessment and care 
practised in geriatric wards. The search included studies with or without randomisation, 
reviews, and meta-analyses.
We started the search on Feb 17, 2007, during the planning of the study and repeated it 
several times until Dec 15, 2013. The search terms were “hip fracture” combined with 
either “orthogeriatric” or “comprehensive geriatric assessment”. The last search identiﬁ ed 
69 and 42 reports, respectively, of which we manually searched reference lists to identify 
relevant publications not found by the primary search. We excluded studies of long-term, 
in-hospital rehabilitation, events within an orthogeriatric environment that were not 
related to the treatment itself, consultation services after discharge, and rehabilitation 
were excluded.
We found two reviews10,11 describing an update of the scientiﬁ c literature on orthogeriatric 
treatment of hip-fracture patients in various service contexts. We identiﬁ ed only one 
randomised trial focusing on both an acute care setting and a short-term comprehensive 
geriatric care programme investigating long-term eﬀ ects on mobility and function.34 
However, this model was run in an orthopaedic context including speciﬁ c elements of 
rehabilitation both in-hospital and after discharge.
Other publications presented protocols without results and some reported results from 
non-randomised trials. One such large study from Israel compared acute treatment of 
hip-fracture patients in a geriatric ward as compared with treatment in an orthopaedic 
ward and reported impressive short-term and long-term results in favour of the geriatric 
pathway. This study was the origin of our model.7 However, several limitations make the 
reliability of results from this kind of study questionable, the most important being 
related to the non-randomised design. A model similar to ours has been studied in the 
Oslo Orthogeriatric trial.12 Although no eﬀ ect on cognition was shown, subgroup analyses 
from this trial suggested improved mobility in the comprehensive geriatric care group.
Interpretation
Our trial showed that patients aged 70 years or more with hip fractures have signiﬁ cant 
and clinically important improvements in mobility, activities of daily living, and quality of 
life when they receive comprehensive geriatric assessment and care in a specialised 
orthogeriatric unit, compared with usual care on an orthopaedic trauma ward. 
Comprehensive geriatric care is also more cost eﬀ ective than orthopaedic care. The 
strengths of the study were the size, the controlled design, and the care of the 
participants, and the main limitations are the absence of masking and the single-centre 
location.
To our knowledge this is the ﬁ rst time such an eﬀ ect has been shown in a large, 
prospective, randomised, controlled trial. Our results are in accordance with ﬁ ndings from 
previous non-randomised studies of hip fractures and studies of acutely sick, frail, older 
patients without hip fractures, for which comprehensive geriatric assessment and care 
were implemented in dedicated geriatric wards.
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homes, and costs for health-care services at home were 
not signiﬁ cant. The combined eﬀ ect of diﬀ erences in 
costs, mortality, and quality of life as captured by the 
ICER, shows that comprehensive geriatric care is a cost-
eﬀ ective alternative to orthopaedic care. To our 
knowledge, the cost-eﬀ ectiveness of comprehensive 
geriatric care has not been reported in previous trials of 
orthogeriatric comanaged care in patients with hip 
fractures, although it has been shown in a non-
randomised investigation.40
The major strengths of our study are the randomised 
controlled design with the control group receiving usual 
orthopaedic care, the large sample size, the high retention 
rate, the focus on long-term functional outcomes and 
cost-eﬀ ectiveness, and that our primary outcome measure 
was a detailed, performance-based test17,27 rather than the 
self-reported measures often used in previous studies.5 
Analyses were done according to a prespeciﬁ ed statistical 
analysis plan and treatment allocation was masked during 
the ﬁ rst data analysis.
The main study limitation is related to masking and 
concealment of the treatment allocation. Masking of the 
patients and staﬀ  delivering the treatment was not 
possible, and we were only partly able to accomplish 
masking of assessors during follow-up. The absence of 
masking might potentially have aﬀ ected results from 
performance-based tests and questionnaires. However, 
data collection for discharge destination, place of 
residence, and use of health-care services was 
undertaken with the group allocation concealed. The 
results on these outcomes and also the activity 
monitoring data assessed on day 4 after the surgery39 
support our results for the primary outcome. Therefore, 
despite the absence of masking, we argue that our 
results are robust.
Important limitations for the analysis of cost-eﬀ ective-
ness include the absence of baseline EQ-5D-3L 
measurements, making it impossible to control for any 
potential imbalances in baseline values.41 Data for costs 
were obtained from registries, which avoids any 
diﬃ  culties with recall and selection bias, but might be 
aﬀ ected by incorrect coding or absence of registration. 
The economic evaluation is based on secondary outcomes; 
however, this trial was not powered adequately enough to 
show diﬀ erences in costs.
Our study was a single-centre trial, which also raises 
the important question of generalisability and feasibility. 
Comprehensive geriatric care is a multifaceted, 
integrated assessment and treatment involving several 
people from diﬀ erent professions and backgrounds. 
Treatment eﬀ ects are therefore not likely to result from 
the competence and skills of one person. The work was 
undertaken in a large hospital, with national and 
international guidelines applied by the Department of 
Orthopaedic Surgery. Thus, the treatment in the 
orthopaedic care group should be similar to such 
treatment in many other hospitals in northern Europe. 
Furthermore, our study sample was large, and 
representative of home-dwelling, older patients with a 
hip-fracture and preserved walking ability, and 
constituted 397 (75%) of all 530 screened patients with 
hip fractures that were eligible. Patients were mainly 
excluded because they were too young and not regarded 
as in need of comprehensive geriatric care, or they were 
staying permanently in nursing homes and excluded 
because of the choice of primary and secondary 
outcomes. Furthermore, our results are supported by 
results from previous studies of orthogeriatric hip-
fracture treatment,10,11 and also by results from studies of 
comprehensive geriatric care in frail, older patients in 
general.8 Accordingly, we think that our results are valid 
and that comprehensive geriatric care is feasible in other 
settings, although only multicentre studies can support 
this hypothesis.
This is the ﬁ rst trial to show beneﬁ t and cost-
eﬀ ectiveness when patients aged 70 years or older with 
hip fractures are admitted directly to a geriatric ward for 
comprehensive geriatric care. Existing guidelines suggest 
that treatment of older patients with fragility fractures 
should be organised as orthogeriatric care.9 The present 
study supports these recommendations for older patients 
with hip fractures, and shows that preoperative and 
postoperative orthogeriatric manage ment of these 
patients improves outcomes for 4 months, and for at 
least 1 year after surgery, compared with treatment in 
traditional orthopaedic trauma wards.
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Perspective and time horizon 
The economic evaluation was conducted from a broad health care perspective. In keeping with the outcome 
analyses from the main paper, a twelve months perspective was applied in the cost utility analysis. 
Health services and cost parameters 
Health and social care services, for which patient utilisation data have been collected, are listed in Table A1, 
together with the corresponding unit costs. Patient service utilisation data was combined with unit costs to 
calculate cost per patient. Services received after the index stay (post discharge), were aggregated into four main 
categories: hospital care, institutional rehabilitation, nursing home, and other primary health and social care 
services.  
Published unit costs were used if available; otherwise we used information from local experts and municipal 
web-sites to establish unit cost. References are listed in Table A1. All cost values are presented in 2010 Euro 
(EUR). The average exchange rate in 2010 was eight Norwegian kroner (NOK) to one EUR.1 
The unit cost of the index stay was calculated as the sum of surgical treatment cost and length of stay (LOS) 
multiplied by per diem cost. Surgical treatment cost was assumed equal across groups and calculated based on 
published data.2 The cost per diem of care in the orthogeriatric and the orthopaedic ward was calculated 
separately on the basis of staff level differences3 and wage cost information from the hospital accounting system 
multiplied by an over-head. The staff category specific wage costs per full time equivalent were equal across 
Comprehensive Geriatric Care (CGC) and Orthopaedic Care (OC), with staff category levels as the only 
difference. Staff level per patient in CGC and OC groups respectively were: nurses 1·67/1·48, medical doctors 
0·13/0·11, physiotherapists 0·13/0·09 and occupational therapists 0·13/0·00.3 
The unit cost for institutional rehabilitation was gathered from the municipality and private care providers. The 
costs of nursing home services are calculated by using average per diem costs for these services, as they are 
reported to Statistics Norway. Other primary health and social care services include home nursing care, hour-
based rehabilitation, home care services, safety alarm, meals-on-wheels, visits to daycentre and GP services, for 
which published unit costs were applied, except for safety alarm and meals-on-wheels.  
Service utilisation data  
Use of resources is shown in Table A2. All information concerning the index stay was collected from St Olav 
Hospital’s patient administrative system. Post discharge hospital service utilisation data was collected from St 
Olav Hospital’s patient administrative system and institutional rehabilitation data from the Norwegian Patient 
Register, with supplementary information from the municipal patient records. Nursing home utilisation data and 
information on resource consumption of primary health and social care services were collected from municipal 
patient records, with two exceptions: visits to general practitioners (GPs) and visits to physiotherapist were 
collected from the Norwegian Health Economics Administration. There was no missing data on the use of 
resources except for one patient who withdrew consent for further collection of data during hospital treatment. 
Health outcomes and missing data 
Patients completed the EQ-5D-3L at one, four and 12 months, but no baseline measurements were collected 
because the patients were admitted as emergencies and with severely deteriorated health state. Instead all 
patients were given an equal base line score, 0·268, gathered from a systematic review of osteoporosis related 
utility values.4 Number of missing units, i.e. whole EQ-5D-3L questionnaires of remaining participants, were 
50/391 (12·8%), 37/384 (9·6%) and 41/378 (10·8%) at the one, four and 12 months respectively. Missing data 
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on the EQ-5D-3L (whole questionnaires) were imputed by multiple imputations in 100 imputed data sets. The 
imputation model included EQ-5D-3L index values at the three time points, age, gender, fracture type, treatment 
group, Charlson Comorbidity Index, APACHE 2 measured at baseline, and the clinical outcome variables 
Barthel Index and the Mini Mental Status Examination. The imputation model was restricted to predict values 
inside the possible range, i.e. values between -0·594 and 1 for the EQ-5D-3L. The results are described in Figure 
A1.  
When scoring the EQ-5D-3L we used the UK TTO tariff.5 Quality adjusted life years (QALYs) were calculated 
using the area under the curve approach,6 assuming a linear change in EQ-5D-3L values between time points. 
Patients who died were assumed to have the last measured EQ-5D-3L value until death. 
Evaluation of cost effectiveness 
Cost effectiveness was evaluated by calculating the difference in mean costs divided by the difference in mean 
QALYs; the incremental cost effectiveness ratios (ICER). A theoretical threshold of EUR 62500 per QALY 
formed the basis for cost-effectiveness evaluation. This threshold is currently under debate in Norway. 
Uncertainty in the ICER was estimated by means of bootstrapping, due to the skewed costs and effects data, and 
the challenges related to calculating a confidence interval around a ratio. 7 
1000 samples were drawn randomly from the sample of costs and effects, with replacement, to build an 
empirical non-parametric estimate of the uncertainty in the ICER. The 1000 recalculated ICERs were plotted on 
the cost-effectiveness plane and the percentage of simulated ICERs falling below the assumed limit was 
calculated.7, 8 
Patients’ deceases during the course of the trial were allotted zero costs and zero health from the date of dying, 
but were not considered censored.9, 10 
One way sensitivity analyses 
We assessed the robustness of the findings by sensitivity analyses. Unit costs for post discharge hospital stay 
(cost per diem) were set equal to CGC index stay unit costs, while unit costs for nursing home stay and unit cost 
of rehabilitation stay were decreased by 25%. Both separate and simultaneous analyses were performed. All 
analyses showed only minor changes in mean total cost difference between CGC and OC and did not alter 
conclusions, c.f. Table A3. 
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Abstract 
Background: In The Trondheim Hip Fracture Trial patients treated with comprehensive geriatric care (CGC) in a 
geriatric ward had better mobility, and personal and instrumental ADL (p-and i-ADL) than patients receiving 
traditional orthopaedic care (OC). In this study we investigate whether the effect of CGC depended on age 
(over/under 80 years), gender, fracture type (intra-capsular (ICF)/extra-capsular (ECF)), or pre-fracture i-ADL.  
Methods: Home-dwelling hip fracture patients >70 years were randomised to receive CGC (n=198) or OC 
(n=199). Mobility was measured by Short Physical Performance Battery (SPPB), p-ADL by Barthel Index (BI), 
i-ADL by Nottingham Extended ADL scale (NEAS), cognition by Mini-Mental Status Examination (MMSE). 
Data were analysed by linear mixed models with interactions (treatment, time, and subgroup). 
Results:  
Within-group differences: At four and/or 12 months CGC patients with ICF, pre-fracture NEAS ≥45, females, 
independent of age had better scores for SPPB and NEAS. CGC was superior to OC for men with better MMSE 
scores at 12 months, for ECF patients with better NEAS scores at 12 months, and  for patients with pre-fracture 
NEAS <45 on NEAS at four months.  
Between-group differences: CGC was significantly better for patients <80 years on NEAS at four months,  for 
ICF on BI at four and 12 and SPPB at 12 months, and with pre-fracture NEAS >45 on NEAS at 12 months.   
Conclusions: The benefits of CGC were more pronounced in patients with ICF and high pre-fracture i-ADL. The 
results should be used to tailor CGC treatment for hip fracture patients. 
ClinicalTrials.gov registration number: NCT00667914. 
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Background/Introduction 
Hip fractures are common with more than 1.3 million fractures annually world wide [1]. A hip fracture 
represents a major burden both for the individual patient and the society [2], and results in reduced survival, 
impaired function and problems with independent living. Older age is associated with not regaining basic 
mobility following a hip fracture. After a hip fracture mortality is higher among men. However, there are 
conflicting results on gender differences in the regaining of function [3, 4], while several studies have reported 
that risk of reduced mobility after a fracture is higher in patients with low pre-fracture mobility and in those with 
extra-capsular fractures (ECF) [5, 6]. 
 
Geriatric patients and hip fracture patients share features such as high age, comorbidities, functional limitations, 
and frailty [7]. Therefore, orthogeriatric treatment models where geriatricians and orthopaedic surgeons 
collaborate have been developed. As summarised in literature reviews, orthogeriatric treatment models have 
shown reduction of delirium, post-surgery complication rates and mortality [8, 9], and improved mobility [10]. A 
recent paper from The Trondheim Hip Fracture Trial reported that treatment of home-dwelling hip-fracture 
patients with comprehensive geriatric care (CGC) throughout the entire hospital stay gave statistically significant 
and clinically meaningful better mobility, personal activities of daily living (p-ADL),  instrumental ADL (i-
ADL), and cognition, and was also cost-effective as compared to traditional care [11]. 
 
Previous studies indicate beneficial effects of comprehensive geriatric care (CGC) for hip-fracture patients in 
general [11, 12], but less is known about benefits of CGC in targeted subgroups.  Although a number of 
prognostic factors for functional outcomes are relatively well known, we have not found any randomised 
controlled trial (RCT) evaluating treatment effects of CGC versus traditional orthopaedic care (OC) related to 
subgroup characteristics.  
 
When planning for The Trondheim Hip-Fracture Trial, we hypothesised that benefits of a comprehensive and 
individualised orthogeriatric treatment programme were independent of age, gender and fracture type, and that 
focusing functional recovery in the CGC group would especially benefit those with more severe pre-fracture 
impairments. 
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The aim of the present study is to explore post hoc if treatment effects of CGC as compared to OC depend on 
subgroups defined by age, gender, type of fracture or pre-fracture function. This will be studied separately for 
the outcome measures of mobility, p-ADL, i-ADL, and cognition.  
 
Methods 
Trial design and patients 
The Trondheim Hip-fracture Trial is a prospective RCT performed at St. Olav University Hospital in Trondheim, 
Norway between April 2008 and January 2012. The protocol, the intervention and clinical outcomes from the 
study have been published previously [11, 13-15]. Patients were randomised in the emergency room to receive 
CGC or OC and were transferred to the allocated wards directly after randomisation. Home-dwelling patients 70 
years or older who had been able to walk 10 meters prior to the hip-fracture were eligible. Patients with 
pathological fractures, multiple trauma, short life expectancy, living permanently in a nursing home, or already 
participating in the study were excluded. 
 
Treatment 
As described previously [14] patients in both groups received the same perioperative treatment. In most patients 
surgery was performed in spinal anaesthesia. Arthroplasty was used for dislocated ICFs (Garden type 3 or 4) 
while Garden type 1 or 2 fractures were mainly treated with a two-screw fixation. A sliding hip screw system 
was used for ECF except for some sub trochanteric fractures that were treated with intramedullary nailing. Most 
patients were allowed full weight bearing postoperatively. In the orthopaedic trauma ward OC patients received 
treatment according to national and international guidelines. In the geriatric ward patients were treated pre- and 
postoperatively using CGC performed as a multidimensional interdisciplinary diagnostic process focusing on the 
patients’ medical, mental, social and functional situation. We developed an integrated plan for treatment and 
follow-up for each patient [14]. The CGC used a broad geriatric scope focusing on medical assessment including 
review of drug regimen, pain relief, hydration, nutrition, elimination, and assessment of fall risk and 
osteoporosis. In addition the interdisciplinary team focused on early mobilisation and rehabilitation and early 
individualised discharge planning.  
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The primary health care services were responsible for follow-up after discharge from hospital in both groups. 
Neither group was routinely offered hospital-based follow-up, except for selected patients who were offered 
follow-up in the orthopaedic outpatient clinic as decided by the orthopaedic surgeons.  
 
Measurements 
P-ADL and i-ADL before the fracture and at four and 12 months were assessed by the Barthel Index (BI; 0 to 20 
points; 20 best score) and the Nottingham Extended ADL Scale (NEAS; 0 to 66 points; 66 best score) [16, 17]. 
The median pre-fracture NEAS score was 45, and patients with NEAS scores ≥45 before the fracture were 
regarded “well-functioning”, while those with scores < 45 were regarded “functionally impaired”. Data were 
obtained by interviewing the patient or, if he/she was not able to respond, their next of kin. Mobility at four and 
12 months was assessed by the Short Physical Performance Battery (SPPB; 0 to 12 points; 12 best score) [18].  
Cognition was assessed by the Mini Mental Status Examination (MMSE; 0 to 30 points; 30 best score) [19]. The 
American Society of Anaesthesiologists (ASA) score [20] was used as preoperative risk score for mortality. 
Medical information was collected from hospital records.  
 
Statistical analysis 
Differences between subgroups were analysed by linear mixed models with interactions between treatment, time, 
and subgroup, using SPPB, BI, NEAS, and MMSE as dependent variables. Independent variables were time, 
group allocation (CGC vs OC), and age (70 to 79 vs ≥80 years), gender, fracture type (ICF vs ECF) and pre-
fracture function (median NEAS< 45 vs ≥45). An interaction between the subgroup and the treatment effect 
implies a three-way interaction (between time, treatment and subgroup). The magnitude of the three-way 
interaction is not of practical interest, but the interest lies in the effect of treatment group at four and 12 months. 
Hence, at each time point, we report the treatment effect within subgroups, and the difference in treatment effect 
between subgroups.  
 
The results within and between subgroups are presented as mean scores for differences with 95% Confidence 
Intervals (CI). Differences in treatment effect between subgroups are reported with CIs and p-values for the 
relevant two-way interactions. Two-sided p-values <0.05 were considered statistically significant. For evaluation 
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of whether test score differences are clinically meaningful previously reported reference values were used: SPPB 
> 0.5 points [21], BI > 1.49 points [22], NEAS > 2.4 points) [23], and MMSE > 2 points [24]. Analyses were 
performed using SPSS 21.  
 
Ethics 
The study was approved by the Regional Committee of Ethics in Medical Research (REK4.2008.335), the 
Norwegian Social Science Data Services (NSD19109) and the Norwegian Directorate of Health (08/5814).  
ClinicalTrials.Gov registry number was NCT00667914. 
 
Results 
Baseline characteristics 
The CGC and the OC  were comparable regarding baseline characteristics (Table 1). Mean age was 83 years, 
three of four patients were female, and 60% were living alone. More than 50% in both groups had an ASA score 
of 3 or higher. About 60 % had ICF, of whom 76 (63.9%) in the CGC and 89 (69.3%) in the OC were operated 
with arthroplasty (Table 1). 
 
Clinically meaningful treatment effects of CGC versus OC within subgroups 
Table 2 and Figure 1 show that at four months patients aged 70-79 years treated with CGC had better 
performance on SPPB, BI and NEAS than patients treated with OC, and at 12 months better performance on 
NEAS and MMSE. CGC patients’ ≥80 years of age had better SPPB scores at four and 12 months, and better 
NEAS score at 12 months than the OC patients.    
 
In females there were clinically meaningful treatment effects in favour of CGC for SPPB and NEAS at four and 
12 months. For men the MMSE scores for the CGC group was better at 12 months, but there were no other 
statistically significant differences at four or 12 months. 
 
At four and 12 months patients with ICF treated with CGC had better scores on SPPB, BI and NEAS. Patients 
with ECF had a better treatment effect of CGC than OC only for NEAS at 12 months.  
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CGC patients with pre-fracture NEAS ≥45 had better scores on SPPB and NEAS at four and 12 months and 
better MMSE scores at 12 months.  Among patients with pre-fracture NEAS <45 there was no statistically 
significant differences between the CGC and OC group in functional outcomes at four and 12 months.   
 
Clinically meaningful treatment effects of CGC versus OC between subgroups 
The analysis showed that CGC was better than  OC for patients 70-79 years of age as compared to patients >80 
years for NEAS at four months, while there were no differences at 12 months. In patients with ICF as compared 
to ECF, CGC was better for BI at four and 12 months and for SPPB at 12 months. In patients with pre-fracture 
NEAS ≥45 as compared to NEAS < 45, CGC was better for NEAS at 12 months.  
 
Discussion 
We have previously reported that treating home-dwelling hip-fracture patients in an orthogeriatric ward 
improves mobility, p-ADL, i-ADL and cognition more than treating patients in an orthopaedic ward. Our overall 
aim of the present study was to explore treatment effects on functional measures between subgroups of the hip-
fracture population. This post hoc study have shown that home-dwelling hip-fracture patients irrespective of age, 
gender, type of fracture or pre-fracture function have better effect of CGC than OC in one or more functional 
outcomes, and that these group differences are of clinical importance. Nevertheless, the results demonstrated 
only minor differences in functional outcomes between the CGC and OC group among men, patients with ECF, 
and those with impaired i-ADL before the fracture.  Interaction analyses showed that at four months CGC was 
statistically significantly better for patients < 80 years of age regarding impact on i-ADL, and for ICF patients on 
p-ADL. At 12 months, CGC was superior in patients with ICF for mobility and p-ADL, and for well-functioning 
patients regarding i-ADL.   
 
We have not found other publications studying if effects of orthogeriatric care differ in subgroups of patients. 
However, our overall results indicating somewhat better effects of CGC than OC irrespective of subgroup are in 
line with a Cochrane review on comparison of comprehensive geriatric assessment with general medical care in 
hospitalised acutely sick elderly patients, that showed that the benefits were related to treatment in a geriatric 
ward per se and not a consequence of admission criteria like age and other factors [25].   
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Previous studies have shown that older patients have poorer functional recovery than younger patients after hip-
fractures [26]. In the present study there were statistically and/or clinically meaningful differences between the 
CGC and OC groups independent of age group. For patients ≥ 80 years the effect of CGC was more pronounced 
at 12 months. The between-subgroup analysis showed a significant effect of CGC on NEAS at four months in 
patients 70-79 years as compared to patients’ ≥80. This difference between age groups disappears after one year 
where the superior effect of CGC is fairly similar regardless of age. The change is mainly due to improved 
NEAS in the older group by CGC but not in OC. Our interpretation is that patients ≥80 need more time to 
improve, and that the effect of CGC may persist beyond discharge due to a better definition of treatment goals, 
better discharge planning or a better individual plan for rehabilitation. 
 
Arinzon & al [27] have previously found that both men and women improve mobility during hip-fracture 
rehabilitation, while other studies have found better prognosis for female hip-fracture patients [28]. In our study 
we found that while female CGC patients had statistically and clinically significant better mobility and i-ADL at 
four and 12 months, the only effect for male CGC patients was on cognition at 12 months. Still, there was no 
significant effect of gender in the between-group analyses, possibly due to lack of statistical power. Further 
research particularly designed to assess gender effects of rehabilitation is warranted in order to improve 
treatment outcomes particularly in male hip-fracture patients. 
 
Better effect in favour of CGC on the ICF group was found at both four and 12 months, while for the ECF group 
there was only a rather small effect on i-ADL at four and 12 months. The interaction analyses confirmed these 
findings by revealing increased benefit of CGC versus OC on several outcomes for ICF as compared to ECF 
patients. Our findings also support previous studies showing that in general ECF patients have poorer prognosis 
than ICF patients [29]. One explanation may be that these patients are older, have a larger trauma with more soft 
tissue damage and needing more extensive surgery. Further research is needed in order to improve the outcome 
for this patient group. 
 
At four months patients with pre-fracture NEAS score ≥45 showed superior effect of CGC only on p-ADL (BI), 
while CGC was favourable for i-ADL (NEAS) at 12 months.  When planning the study we hypothesised that 
Patients benefitting from orthogeriatric treatment 
 
9 
 
patients being “well functioning” before the fracture would benefit least from CGC, while we actually found 
greatest benefits for this group. However, the median NEAS score was only 45 at baseline, indicating that most 
participants actually had a functional decline before the fracture. Thus, our findings support previous studies 
reporting that impaired pre-fracture function appears to be a consistent predictor of unfavourable outcomes and 
not regaining mobility in older persons with hip-fractures. [5, 6, 26, 29, 30] Since NEAS may be less sensitive to 
changes among patients with functional decline, the results should be interpreted cautiously.  
 
The strengths of the study are the randomised controlled design and large sample size, and that we had a plan for 
analysis of subgroup effects based on pre-fracture function before the study started. The main weakness is the 
post-hoc design with choice of remaining subgroups based upon literature review (defined after the main 
outcomes of the study were known). We have found no consensus on how to categorise patients with impaired 
function before the fracture, and we therefore dichotomised variables by the median of the baseline i-ADL 
(NEAS) scores in order to give most power for the analysis. Other weaknesses are lack of power for some 
subgroups, and that a large number of analyses have been performed increasing the chance of Type I error. The 
outcome measures in this study were chosen to represent aspects of function, while subjective reported outcomes 
as for example quality of life were not studied. Thus, conclusions should not be generalised to other domains.  
The study was exploratory, and further studies primarily designed to study effect of treatment on subgroups have 
to be undertaken to confirm findings. 
Our main results were that in home-dwelling hip-fracture patients all subgroups of patients benefit of CGC on 
one or more functions (mobility, i- and p-ADL, and cognition), irrespective of age, gender, type of fracture and 
pre-fracture function. These findings support the implementation of CGC for different subgroups of home-
dwelling hip-fracture patients. Our results also show that there is  need of further research, especially on ECF, of 
males,  and patients with  functional decline before the fracture, where our results indicate a limited value of 
CGC.  
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Table 1: Baseline characteristics  
   Geriatric 
n= 198 
Orthopaedic 
n= 199 
Age (years) - mean (SD) 83.4 (5.4) 83.2 (6.4) 
Sex (female) - n (%) 145 (73.2) 148 (74.4) 
Sheltered housing - n (%) 26 (13.5) 20 (10.3) 
Living alone - n (%) 115 (58.1) 124 (62.3) 
Barthel Index  (0-20) -  mean (SD) 18.3 (2.3) 18.1 (2.8) 
Nottingham Extended ADL Scale (0-66)  - mean (SD) 42.5 (17.7) 41.9 (17.5) 
ASA (1-5) mean(SD) 2.5 (0.7) 2.6 (0.7) 
ASA (1-5) – n (%)     
   1 or 2 – healthy or mild systemic disease  89 (45.0) 82 (41.2) 
   3- severe systemic disease 103 (52.0) 106 (53.3) 
   4 or 5 - severe systemic disease or moribund 6 (3.0) 11 (5.5) 
Previous diagnoses n(%)† 
    Heart disease -  
    Stroke -  
    Diabetes – 
    Dementia -  
    Cancer -  
    Kidney disease - 
 
97 
49 
23 
27 
53 
18 
 
(49.0) 
(24.7) 
(11.6) 
(13.6) 
(26.8) 
(9.1) 
 
89 
57 
28 
26 
43 
9 
 
(44.7) 
(28.6) 
(14.1) 
(13.1) 
(21.6) 
(4.5) 
Fracture type n(%) 
    Femoral neck -  
    Extra capsular fracture-  
 
119 
79 
 
(60.1) 
(39.9) 
  
127 
72 
 
(63.8) 
(36.1) 
Surgery n(%) 
    Hemi  prosthesis - 
    Bone plates and -screws - 
    Screws –  
    Other††-  
 
76 
69 
38 
15 
 
(38.4) 
(34.8) 
(19.2) 
(7.6) 
 
88† 
63 
32 
16 
 
(44.2) 
(31.7) 
(16.1) 
(8.0) 
† from the hospital records. 
 †† Including patients treated with combinations of surgery or no surgery at all due to death. 
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Effect of in-hospital comprehensive geriatric
assessment (CGA) in older people with hip
fracture. The protocol of the Trondheim Hip
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Abstract
Background: Hip fractures in older people are associated with high morbidity, mortality, disability and reduction in
quality of life. Traditionally people with hip fracture are cared for in orthopaedic departments without additional
geriatric assessment. However, studies of postoperative rehabilitation indicate improved efficiency of
multidisciplinary geriatric rehabilitation as compared to traditional care. This randomized controlled trial (RCT) aims
to investigate whether an additional comprehensive geriatric assessment of hip fracture patients in a special
orthogeriatric unit during the acute in-hospital phase may improve outcomes as compared to treatment as usual
in an orthopaedic unit.
Methods/design: The intervention of interest, a comprehensive geriatric assessment is compared with traditional
care in an orthopaedic ward. The study includes 401 home-dwelling older persons >70 years of age, previously
able to walk 10 meters and now treated for hip fracture at St. Olav Hospital, Trondheim, Norway. The participants
are enrolled and randomised during the stay in the Emergency Department. Primary outcome measure is mobility
measured by the Short Physical Performance Battery (SPPB) at 4 months after surgery. Secondary outcomes
measured at 1, 4 and 12 months postoperatively are place of residence, activities of daily living, balance and gait,
falls and fear of falling, quality of life and depressive symptoms, as well as use of health care resources and survival.
Discussion: We believe that the design of the study, the randomisation procedure and outcome measurements
will be of sufficient strength and quality to evaluate the impact of comprehensive geriatric assessment on mobility
and other relevant outcomes in hip fracture patients.
Trials registration: ClinicalTrials.gov, NCT00667914
Background
Every year about 9000 persons undergo hip fracture sur-
gery in Norway [1]. Hip fractures among older people
are associated with high morbidity, mortality, disability
and subsequent hospital and societal costs as well as
reduction in quality of life [2-6]. A Study from Oslo,
Norway showed that the proportion of patients living in
nursing homes increased from 15% before to 30% after
the hip fracture; the proportion walking without any aid
decreased from 76 to 36%; and 43% of the patients lost
their pre-fracture ability to mobilise outside their own
home [7].
Older people with hip fracture often have extensive
co-morbidity which is associated with functional impair-
ments and frailty. The frailty phenotype is defined by
deterioration of multiple organ systems including the
neurological, musculoskeletal, cardiovascular, metabolic
or immunological systems [8]. Frailty has been shown to
be associated with falls resulting in injuries [9].* Correspondence: olav.sletvold@ntnu.no1Department of Geriatrics, St. Olav Hospital, University Hospital of Trondheim,
Norway
Full list of author information is available at the end of the article
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Previous studies show improved outcomes when older
people with hip fracture are cared for by a specialist
multidisciplinary team [10-12]. Reports indicate
improved efficiency of multidisciplinary geriatric rehabi-
litation especially regarding delirium, recurrent falls and
fractures, and use of institutional care [13-15]. There is
now a growing body of evidence supporting this
approach [16,17] and recently evidence-based guidelines
as for treating hip fracture patients have been devel-
oped,[18] although context and organisation of so-called
hip-units differs widely [19].
However, the findings in these studies are not conclu-
sive and we still do not know which specific input, if
any, is crucial to beneficial effects. Is it the management
of medical complications; is it a goal-oriented interven-
tion by one single professional staff-member, i.e. the
physiotherapist, nurse or physician; or is it related to a
multi-component mix of some or all these?
In a previous study we have shown that treating
acutely sick and frail older patients in a care pathway
based on a geriatric evaluation and management service
significantly reduced mortality and also improved
patients’ chances of living at home [20,21]. Therefore, it
would seem reasonable that frail old hip fracture
patients would benefit from comprehensive geriatric
assessment (CGA) in the acute setting. Evaluation of
efficiency of care pathways for hip fracture patients
should emphasise both survival, general function; espe-
cially mobility and physical activity, but also quality of
life (QoL) and caregiver burden, as well as costs. There
is a strong focus in health care management today on
the efficient use of limited resources, especially on
shortening of length of stay (LOS) and lowering of
costs. Furthermore, over the years LOS for patients with
hip fracture has declined irrespective of settings and the
organizing of health care, indicating that new models of
care are less costly than traditional clinical pathways.
However, shortening of LOS and reduced emphasis on
acute and in-hospital rehabilitation may increase admis-
sion rates to nursing homes and reduce the quantity
and quality of rehabilitation, and consequently reduce
recovery of walking ability and function [22,23] and also
shift costs between sectors.
In the present study we aim to investigate whether
an alternative clinical pathway for hip fracture patients
during the in-hospital acute phase applying CGA in an
orthogeriatric ward may improve outcomes in the
short (1 and 4 months postoperatively) and long (12
months postoperatively) term without introducing
additional specific follow-up programs. Hopefully we
will increase the knowledge of whether in-hospital
treatment of hip fracture patients in a geriatric acute-
unit primarily will improve mobility, and secondly
increase the chance of being discharged to and live in
their own homes, and improve function and self-rated
health, while maintaining the new care pathway cost-
neutral in comparison to treatment in a traditional
orthopaedic unit.
In accordance with general guidelines for the develop-
ment, evaluation and reporting of randomized con-
trolled trials (RCT) for complex interventions [24] the
purpose of the this paper is to present context and
study design, a short description of intervention, out-
come measures and power calculations and also proce-
dures for the Trondheim Hip Fracture Trial. An
extensive report on the intervention program will be
published later.
Aims
Primary aim
• To estimate the effect on mobility 4 months after
surgery of treating hip fracture patients in an ortho-
geriatric ward as compared to treatment in an ortho-
paedic ward.
Secondary aims
• To estimate the effect of the intervention on place
of residence, gait, activities of daily living, mood and
health related quality of life 1, 4 and 12 months
postoperatively.
• To investigate change in gait control and daily
physical activity through one year after surgery.
• To estimate the effect of the intervention on the
use of health care resources and survival.
• To estimate the effect of the intervention on fear
of falling and falls 4 and 12 months postoperatively.
Methods/design
Project context
The present study is conducted at St. Olav Hospital, the
University Hospital of Trondheim, Mid-Norway. St.
Olav Hospital also serves as a local hospital for 280.000
inhabitants of Soer-Troendelag County, admitting all
hip fracture patients from this catchment area.
During the study period the Department of Orthopae-
dics will run a Trauma Unit consisting of 19 beds for
inpatient orthopaedic care. While in the Emergency
Department hip fracture patients are examined by the
orthopaedic resident on call who in collaboration with
the orthopaedic surgeon in charge establishes diagnoses
and indication for surgery.
The Department of Geriatrics is organised as a formal
unit of the Clinic of Internal Medicine consisting of a
10 bed-ward of acute geriatrics services linked to an
out-patient facility. During a recent hospital reorganisa-
tion with cutting down of beds in the Department of
Orthopaedics an orthogeriatric 5 bed-unit was estab-
lished as an additional but still integrated part of the
acute geriatric ward.
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Being a new service for hip fracture patients routinely
offered in parallel with the traditional orthopaedic care
pathway, it was decided to evaluate potential benefits of
this unit, now investigated through the present study.
Enrolment of study patients was planned to start after a
4 months clinical run-in period for the new unit.
Study design
The study is designed as a RCT with parallel groups
where the intervention of interest, a CGA and manage-
ment of hip fracture patients taking place in this ortho-
geriatric unit is compared with traditional care in an
orthopaedic ward.
Study population
All people over 70 years of age, with an acute hip frac-
ture, previously being able to walk 10 meters, and living
in their own homes or staying temporarily in an institu-
tion, suffering an intracapsular, trochanteric or subtro-
chanteric fracture, and able to give an informed consent,
are invited.
Excluded are patients with pathological fractures or
multi trauma injuries or with terminal illness not
expected to live longer than 3 months or patients who
have already been enrolled in this study. At study start
the catchment area consisted of the City of Trondheim
and the nearest municipalities. In case of slow recruit-
ment we will use the option of expanding the catchment
area to comprise all municipalities of Soer-Troendelag.
Intervention
Patients randomised to the intervention group are trans-
ferred directly from the Emergency Department to the
orthogeriatric ward while control patients are trans-
ferred to the trauma unit at Department of Orthopaedic
Surgery. Orthopaedic surgeons are responsible for the
initial assessment, diagnosing of the fracture and deci-
sions on type of surgery for both groups. Anaesthesiolo-
gists make preoperative assessments regarding analgesia,
operability and perioperative anaesthesiological proce-
dures. After surgery and for a limited time period all
patients are observed in the recovery unit.
On request orthopaedic surgeons examine study
patients in the orthogeriatric ward and supervise the
staff. Geriatricians serve the orthopaedic ward
equivalently.
The experimental intervention program is offered only
during the acute hospital stay. The orthopaedic surgeons
decide on traditional follow-up consultations after dis-
charge irrespective of group allocation.
Experimental group
Physicians at the Department of Geriatrics or residents
on call have the 24-hour medical responsibility pre- and
postoperatively.
The treatment strategy is based upon CGA which is a
systematic and multidimensional diagnostic process
focusing on evaluation of frail elderly persons’ medical,
psychosocial and functional capabilities and limitations
in order to develop a coordinated and integrated plan
for treatment and long-term follow-up by the primary
health care system [25]. An interdisciplinary team con-
sisting of geriatricians and residents, nurses, phy-
siotherapists and occupational therapists with special
competence in geriatrics is responsible for the CGA pro-
gram. The team emphasizes adequate nutrition, early
mobilization and functioning in activities of daily living,
initial in-hospital rehabilitation and early discharge plan-
ning. Discharge planning starts as early as possible
involving all team members. Whenever possible, patients
are recommended to receive post discharge rehabilita-
tion in their own home. In addition to treatment of cur-
rent medical conditions, the management program also
focuses on factors related to the fall incident causing the
fracture.
Control group
Control patients receive traditional treatment at the
Trauma Unit and follow-up at the Orthopaedic Out-
patient Clinic. All patients are referred for in-hospital
physiotherapy. Staff nurses are responsible for the dis-
charge planning.
Measures
Mobility as primary outcome is assessed using the com-
posite measure of the Short Physical Performance Bat-
tery (SPPB) [26,27]. SPPB consists of three tasks: 10
second of standing balance in three different positions
(side-by-side, semi-tandem and tandem); 4 meter timed
walking at preferred speed; and time to rise from a chair
five times [26]. Each task is scored on a 0-4 scale. A
score of 0 is given if the participant is unable to com-
plete the task. Scoring from 1-4 for each task is assigned
based on quartiles of performance derived from the
Established Populations for the Epidemiologic Study of
the Elderly (EPESE) [27]. A summary score ranging
from 0-12, with 12 as the best score is created by sum-
mation of scores from the three tasks. The test is suita-
ble for scoring persons with a large range of functional
levels. It has been shown to have acceptable internal
consistency (Chronbach alpha = 0.76) and test-retest
reliability [28], ability to predict functional decline,
rehospitalisation and death in older patients after hospi-
talization [29] and also to measure change in mobility in
hip fracture patients.
Mobility as secondary outcome is measured by the
Timed Up & Go (TUG). According to the procedure
time needed to rise from a chair, walk 3 meters, turn
and walk back and sit down is measured [30]. The test
is performed twice and the mean time (seconds) of the
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two trials is used as outcome. In the original paper by
Podsiadlo the second of two trials is used, while in an
earlier intervention study we have described high relia-
bility of using the mean of two [31]. For participants not
able to complete two trials, only one trial is used. Parti-
cipants are instructed to use walking aids support if
used regularly. Repeated tests aim to obtain fast speed
while preserving safety, irrespective of using walking
aids or not. TUG is well validated [30] and has been
used in several studies on hip-fracture patients to pre-
dict falls [32], to assess functional mobility [33-35] and
to assess effect of home-based therapy [36]. A limitation
of using TUG is that scoring presupposes that the per-
son is able to perform all sub-components of the task.
Mobility and mobilisation during the index stay will be
measures by use of Cumulated Ambulation Score (CAS)
[37].
Place of residence is used as a secondary outcome.
Registrations of place of residence and change in place
of residence are based on Gerica - the Electronic Health
Record (EHR) of municipality of Trondheim by a proce-
dure similar to one we have reported previously [20].
The typology differentiates between patients living in
their own home, sheltered housing, nursing home, reha-
bilitation facility or hospital, respectively.
Activities of daily living (ADL) is measured using the
Barthel Index [38] and Nottingham extended I-ADL
scale [39] based on reports, if possible from the patient,
from next of kin or from nursing staff. Supplementing
Gerica ADL-scores are filled in by community nursing
staff. The Barthel Index evaluates a patient’s self-care
abilities in 10 areas, including bowel and bladder con-
trol. The scoring depends on the person’s need for help
such as in feeding, bathing, dressing, and walking. The
Barthel index was constructed for stroke patients but
has also been extensively used in hip fracture patients.
I-ADL scales measure a series of life functions necessary
for maintaining a person’s immediate environment-eg,
obtaining food, cooking, laundering, house cleaning and
phone use. The Nottingham extended I-ADL scale has
been shown to be reliable and valid in patients under-
going surgery for osteoarthritis but may underestimate
the sizes of the health gain, at least after arthoplasty
[40].
Health Related Quality of Life
The EuroQol is a widely-used standardised measure of
self reported health [41] using questions in five domains
(EQ-5D) that is applicable to a wide range of health
conditions and treatments providing a simple descriptive
profile and a single index value for health. Pain is mea-
sured by a numeric rating scale (NRS) (0-10) [42]. The
Charnley’s Hip Score as used in the SAHFE protocol
(Standardized Audit of Hip Fractures in Europe) is used
as a supplement [43].
Gait
Gait assessments are recorded for a subset of partici-
pants being able to walk without assistance from
another person and attending the 4- and/or 12-month
evaluations at the outpatient clinic. These measurements
are performed using an electronic gait mat GaitRite®
which is regarded a reliable measure of spatio-temporal
gait parameters also in elderly and frail people [44-46].
Participants should preferably walk the gait mat without
walking aids. Physical activity is monitored in all
patients when sensors are available for use. For these
measurements we are using the small body worn accel-
erometer-based sensor ActivPal®[47], which is under-
going extensive evaluation in our research group [48].
Falls and fear of falling
Number of falls and fall related injuries are registered
retrospectively in three ways at each follow-up; through
medical records, and asking the patient and the next of
kin. Fear of falling is assessed by a) asking a simple
question: “Are you afraid of falling"-yes/no scored on a
simple four-point Likert scale [49] and b) by applying
the 7-item Falls Efficacy Scale International (FES-I) [50].
Cognitive function is measured by use of the Clinical
Dementia Rating scale (CDR)[51] based on registrations
from next of kin and the performance based screening
tool of patients, the Mini Mental State Examinations
(MMSE)[52].
Depression
To assess the effect of the intervention on depressive
symptoms we use the Geriatric Depression Scale 15
(GDS-15) [53-55]. GDS-15 can be interpreted as an
indication of presence/absence of depressive mood
[56,57].
Health economics
We will compare direct costs related to treatment in the
orthogeriatric ward vs orthopedic ward, readmissions,
rehabilitation, care in institutions, and home care ser-
vices by calculating the incremental cost effectiveness
ratio (ICER) and use a non-parametric bootstrapping
approach. We will assign a value to the EuroQol states
using previously developed tariffs of values. Robustness
of results to choice of value set will be discussed. Where
there are incomplete (censored) benefits or cost data
due to loss to follow-up we will use non-parametric
methods to infer cumulative costs and benefits [58,59].
Information on time of death will be collected from the
National Registry.
Hospital related information
Data on cause and duration of any hospital admissions
during the trial period is extracted from participants’
hospital records. Hospital records will also be the most
important information source for medication, previous
and present co-morbidity and data related to pre-, peri-
and postoperative monitoring.
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Consent and enrolment
Nurses on call in the Emergency Department will
undertake eligibility screening of all hip fracture
patients. If there is a free bed in the orthogeriatric unit
patients fulfilling the inclusion criteria are informed
about the study and asked to participate. Depending on
general health, pain, anxiety and fatigue study informa-
tion is given as a short version. Proxies are informed
about the study when appropriate and/or available, espe-
cially in relation to patients whose consenting compe-
tence could be questioned. Written consent is collected
primarily at admittance in the Emergency Department
or occasionally on day 3 or 5 at the clinical ward where
research assistants routinely give a second orally, and
also a written version of the study information to be
kept by the patient or proxy. Furthermore, participating
patients consent to participation for all four data collec-
tion points, otherwise being excluded. Explicit oral con-
sent is accepted for patients unable of writing. At each
data collection point participants receive repeated infor-
mation on the study.
Randomisation and allocation concealment
After giving their informed consent participants are
enrolled and randomized to immediate transfer for med-
ical treatment in the orthogeriatric unit followed by sur-
gical treatment by orthopaedics and further geriatric
work-up and management in the orthogeriatric unit, or
to receive traditional care in the Department of Ortho-
paedics. Randomisation is performed by using a web-
based computerised randomisation service at the Unit of
Applied Clinical Research, NTNU. Randomisation is
blocked, with a random block length being integrated
into the programming.
Research assistants are monitoring all hip fracture
patients admitted to the hospital. Occasionally eligible
patients may mistakenly be transferred to the Orthopae-
dic Department without being evaluated for eligibility. If
not already being transferred for immediate surgical
treatment and within 24 hours since admittance,
patients are informed about the study and asked to par-
ticipate. If patients consent, they are enrolled and rando-
mised according to the protocol. After surgical
treatment these patients are transferred to the orthoger-
iatric unit or returning to the orthopaedic unit accord-
ing to results of the randomisation.
Data collection
For practical reasons it is not possible to implement sys-
tematic blinding of testing during the hospital stay. For
the 1-, 4-, and 12-month assessments testers will not
have access to information about the patients’ group
assignment.
Background information on living conditions, physical
and cognitive function before the fracture is collected
for all participants starting already during the stay in the
Emergency Department. On day 3 or 5 research assis-
tants collect details from patients’ on falls history, use of
mobility aids, pre-fracture scoring of Barthel ADL-Index
and Nottingham extended I-ADL Scale when the clinical
condition makes it appropriate, or from proxies when
they are available. These registrations will be used as
explanatory variables in the statistical analyses.
Mobilisation is monitored using CAS during the 3 first
days after the operation. On day 3 a research assistant
attaches an ActivPal sensor anteriorly on the non-
affected thigh for at least a 24-hour activity monitoring.
The sensor is removed on day 5. On day 5 or the near-
est working day a SPPB mobility score is completed by
a research assistant.
Research assistants will continually scrutinise study
forms on missing data. Missing data from proxies are
collected through telephone calls, as is also information
needed to fill in the CDR form. Electronic hospital
records will give further information on clinical exami-
nations, medication, blood tests and other investigations
performed during the index stay.
The 1-month registration is performed by research
assistants at the site where the patient is living, irrespec-
tive of location. This might be the patient’s own home,
a nursing facility or a rehabilitation institution. The time
window is 4 weeks ± 5 days. For details on data collec-
tion and questionnaires, see Table 1. Information on
Barthel ADL Index or Nottingham extended I-ADL
Scale items are collected primarily from the patients
depending of cognitive function, or alternatively from
the proxy. Whenever possible, information on partici-
pants living at remote locations from St. Olav Hospital
is collected by trained local physiotherapists hired as
research assistants.
The 4-month registration is performed by a research
assistant at the hospital out-patient facility applying the
present infrastructure for testing aspects of mobility and
gait using the electronic gait mat. To secure maximal
study compliance and low attrition rate, transportation
both to and fro is taken care of by the same experienced
taxi driver. An ActivPal sensor is worn for at least a 96-
hour period of activity monitoring. Participants are
urged to be tested at the hospital. In case of extensively
impaired physical or mental capacity a pragmatic and
reduced test protocol is applied in their own home or
where they are staying for the time being. The time win-
dow is 4 months ± 2 weeks. For details on data collec-
tion and questionnaires, see Table 1.
The 12-month registration is performed similar to the
4-month registration. The time window is 12 months ±
4 weeks. For details on data collection and question-
naires, see Table 1.
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Adverse event management
Mortality rate is closely monitored. If the mortality rate
becomes 50% higher for the intervention group the trial
steering committee will be asked to evaluate individual
case notes, reports and general aspects. The trial will be
closed if the difference holds a significance level p <
0.10.
Power and statistical analyses
Sample size estimates are based on mobility assessed by
SPPB at 4 months following the fracture. A change in
the SPPB score of 0.5 points is considered a small but
meaningful change, while 1 point is considered a more
substantial change. In order to detect an effect size of
1.0 when power is 80% and alpha = 0.05, a sample size
of 304 participants would be needed. Based on data
from a previous prospective observational study in a
similar study population (work in progress), we expect a
drop out rate of 10% due to death and 10% due to with-
drawals during the first 4 months following the fracture.
To allow for 304 patients to remain in the project at
four months after the fracture 380 persons need to be
included. Thus, the plan is to include a total sample of
400 participants. The assumptions underlying the
sample size (i.e. the standard deviation at baseline) has
been checked by an independent clinical trials unit after
the first 200 patients enrolled, and found to be
acceptable.
All data will be analysed and presented according to
the updated CONSORT guidelines for reporting parallel
group trials[60]. Patterns of missing data will be
explored prior to analysis, and accounted for in the ana-
lysis by imputation methods [61]. To study differences
in change between groups we will use multivariate ana-
lyses by use of mixed models for longitudinal data by
general linear modelling (GLM) for continuous out-
comes and by logistic regression for binary outcomes
[62]. To study associations between the new clinical
pathway and time to events, we will use Kaplan Meyer
plots and the Cox proportional hazards regression
model. In all analyses we will control for confounding
factors and interactions and present both unadjusted
and adjusted effects with 95% confidence intervals.
Time plan of the study
Since study start on April 18th 2008 until December 30th
2010 altogether 1077 hip fracture patients have been
admitted to the Emergency Department at St. Olav Hos-
pital, Trondheim University Hospital and screened for
eligibility, of whom 401 have consented to participation,
see Figure 1.
The final 12-month registrations will take place in
December 2011. The formal analyses are estimated to
start when the data base on the 4-month primary end-
point measures of mobility is finalised by May 2011.
With exception of the study statistician, the study team
will be masked from the trial results until the final fol-
low up is completed.
Ethics and approvals
The study is approved by the Regional Committee of
Ethics in Medical Research (Mid-Norway)
(REK4.2008.335), the Norwegian Social Science Data
Services (NSD19109), and the Norwegian Directorate of
Health (08/5814).
Discussion
Presenting this paper of the study protocol covering
design, outcome measures, power calculations and pro-
cedures of the Trondheim Hip Fracture Trial is in
accordance with general guidelines for reporting of RCT
protocols for complex interventions [24], although it is
published after the conclusion of the recruitment phase
but still before the onset of data analysis and while the
data collection is going on.
The objective of the study is to evaluate the impact of
CGA on older hip fracture patients still having potential
of functional improvement and preservation of health
related quality of life aiming at prolonging their ability
Table 1 Measures, scales, questionnaires and time-points
of data collection
Index stay 1 month
postoperatively
4 and 12 months
postoperatively
CAS (3 days)
SPPB SPPB SPPB
TUG TUG TUG
Place of residence Place of residence
MMSE MMSE
GDS-15 GDS-15
FES-I FES-I
EQ-5D EQ-5D
NRS-pain NRS-pain
ActivPal (24
hours)
ActivPal (4 days)
GaitRite
Hand grip
strength
Hand grip strength Hand grip strength
Quadriceps strength
Before fracture:
Barthel Index Barthel Index Barthel Index
NEIADL NEIADL NEIADL
Falls Falls Falls
Walking aids Walking aids Walking aids
CDR CDR CDR
Abbreviations: CAS = Cumulative Ambulation score, CDR = Clinical Dementia
Rating, EQ-5D = EuroQual-5 Domains, FES-I = Falls Efficacy Scale-International,
GDS-15 = Geriatric Depression Scale, MMSE = Mini Mental State Examination,
NEIADL = Nottingham extended Instrumental Activities of Daily Living, NRS =
Numeric Rating Scale, SPPB = Short Physical Performance Battery, TUG =
Timed Up & Go.
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to live in their own home. Excluded are young hip frac-
ture patients, patients with terminal illness, permanent
nursing home residents and patients unable to walk.
Patients with cognitive impairment and also temporary
nursing home residents are included, representing
patients known to be at especially high risk of further
deterioration. Therefore, the study sample should com-
prise the most relevant segments of hip fracture patients
regarding measurable benefits of CGA, being neither too
healthy nor too ill.
We have chosen mobility as the primary endpoint,
mainly because impaired mobility is one of the most
feared consequences of a hip fracture in addition to
death and nursing home placement, hopefully being
accessible for intervention [16]. Still, potential benefits
of CGA on mobility at 4 months will be more or less an
Assessed for eligibility (n=1077) Excluded (n=676) 
   Not meeting inclusion criteria (n=539) 
   Decline participation (n=60) 
   Excluded for other reasons (n=77) 
Estimated attrition rate  
 Dead during index  stay (<3% ) 
 Decline participation (<2%) 
 Excluded for other reasons (<5%) 
Analyses comparing 
treatment effect of 
Orthogeriatric unit vs 
Orthopaedic unit 
1-month Follow-Up 
Enrollment 
Allocated (n=401) 
Estimated attrition rate  
 Dead  since index stay (<5% ) 
 Decline participation (<2%) 
 Excluded for other reasons (<5%) 
Estimated attrition rate 
 Dead since last follow-up (<3% ) 
 Decline participation (<2%) 
 Excluded for other reasons (<2%) 
Estimated attrition rate 
 Dead since last follow-up (<15% ) 
 Decline participation (<8%) 
 Excluded for other reasons (<8%) 
4-month Follow-Up 
12-month Follow-Up 
Allocation 
Index stay 
Figure 1 Flowchart. Overview of patients and attrition rates at enrollment, index stay and follow-up 1, 4 and 12 months after the hip fracture.
Attrition rates at all assessment time points are presented as estimated percentages of participants allocated into the study (%). The estimates
are based on preliminary data from an observational study in our department.
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indirect consequence of the intervention. Although
mobility has been defined as the most important out-
come, several secondary study outcomes i.e. ADL and I-
ADL, health related quality of life, the extent of being
discharged to own home, and costs may be equally rele-
vant. This study is not sampled for mortality and nur-
sing home placement as endpoint, and thus this
information will only be used for hypothesis generation
for future studies.
The context and organisation of care pathways for hip
fracture patients differ extensively even in a small coun-
try like Norway. Nevertheless, there are consistent
efforts by hospital managements towards shortening of
hospital LOS based on fast-track orthopaedic services.
Important consequences are less time for stabilisation of
clinical conditions, assessment and treatment of relevant
co-morbidity, as well as shifting of rehabilitation services
out of hospitals, contrasting important constitutive ele-
ments of CGA-based specialist services.
Since the present intervention program will not imple-
ment any kind of medically follow-up by geriatric spe-
cialist services, and recommendations are to be dealt
with by general practitioners and nursing homes or
rehabilitation facilities outside hospital, important
aspects of CGA may be lost. However, the competence
and compliance of primary health care system vary
extensively. Limitations of the study might thus be
related both to study sample, non-blinding of assessors
and choice of endpoints, as well as content and perfor-
mance of the experimental intervention program.
The most important challenge is still the black box of
inter-linked elements of CGA, of which we still do not
know what is actually working. Therefore, evaluating the
benefit of CGA within the present context without
including an extended and optimal geriatric rehabilita-
tion service or a relevant follow-up program after dis-
charge from hospital may in fact increase the knowledge
base as to the most important elements of CGA. The
present study will hopefully be able to designate poten-
tial predictors of a successful or non-successful care
pathway.
To our knowledge the present study is the largest and
most comprehensive RCT investigating CGA on elderly
persons having suffered a hip fracture. There is however
need of more research on alternative care pathways [16].
As a second step our research group is now implement-
ing two studies. The first one will focus on potential
benefits of a more extensive involvement of and follow-
up by the community care system including physiother-
apy in the patient’s own home to start immediately after
discharge from hospital or after returning home from an
out-of-hospital rehabilitation facility. This is a case-con-
trol study with historic controls from the present study.
The second study is a RCT investigating the potential
effect of a boost of a 10 weeks intensive physiotherapy
program 4 months after the hip fracture.
In conclusion we believe that study design, randomisa-
tion procedure and outcome measurements will be of
sufficient strength and quality to evaluate important
impacts of CGA during the index stay on mobility and
other relevant outcomes in hip fracture patients.
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1. Background 
 
1.1 Aims of the study  
The aim of this RCT is to investigate effectiveness of treating elderly patients with a hip fracture 
in a specialized orthogeriatric unit, as compared to standard care in a traditional orthopedic 
unit. 
 
Primary end point is mobility after 4 months as evaluated by the Short Physical Performance 
Battery (SPPB). Secondary end points are specified physical, emotional and cognitive functions, 
and place of residence at 1, 4 and 12 months and costs of the new versus the old treatment.   
 
1.2 Eligibility criteria 
All patients diagnosed at St Olav’s University Hospital with a proximal femur fracture (ICD 10 
code S72.0, .1 and .2) from mid April 2008 until finishing recruitment on December 30th 2010 
were eligible for inclusion. 
 
Inclusion criteria        Exclusion criteria 
Age > 70 
 
Pathological fracture or multi-trauma 
Registered home address in Sør-Trøndelag Terminal illness, not expected to live 
longer than 3 month 
Hip-fracture, including collum fractures, trochanteric 
fractures and sub-trochanteric fractures. 
Already included in the study because of 
a recent hip-fracture 
Able to walk 10 m without assistance from a person before 
the fracture 
 
Living at home or temporar stay in an institution  
 
Participation is voluntarily and according to the Helsinki declaration. The patient or next of kin 
give a written informed consent before enrollment. 
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 1.3 Timeline: 
 2008 2009 2010 2011 2012 
 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
Protocol                     
Recruitment /education of 
assessors 
                    
Pilot                     
Inclusion                     
Follow up, 1month                     
Follow up, 4month                     
Follow up, 12 month                     
Data analysis                     
Publications                     
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1.4 CONSORT flowchart 
 
                                          Flowchart
Assessed for eligibility (n=1077) Excluded (n=676)
i   Not meeting inclusion criteria (n=539)
i   Decline participation (n=60)
i   Other reasons (n=77)
Estimated attrition rate
i Dead during index  stay (<3% ) 
i Decline participation (<2%)
i Excluded for other reasons (<5%)
Analyses comparing
treatment effect of 
Orthogeriatric unit vs
Orthopaedic unit 
1-month Follow-Up
Enrollment
Allocated (n=401)
Estimated attrition rate
i Dead since index stay (<5% ) 
i Decline participation (<2%)
i Excluded for other reasons (<5%) 
Estimated attrition rate
i Dead since last follow-up (<3% ) 
i Decline participation (<2%)
i Excluded for other reasons (<2%)
Estimated attrition rate
i Dead since last follow-up (<15% ) 
i Decline participation (<8%)
i Excluded for other reasons (<8%)
4-month Follow-Up
12-month Follow-Up 
Allocation
Index stay
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1.5 Design 
The study is a block randomized controlled study. 
Assessment schedule: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index stay: 
Registration of background variables includes pre-fracture personal and instrumental ADL 
and cognitive function as soon as possible after operation. 
3rd-5th postoperative day: registration of daily activity by activPAL 
After discharge patient and/or next of kin 
receive a form on patient satisfaction 
Enrollment: 
While in the Emergency Room (ER), patients are screened by a nurse for eligibility and asked to 
participate, then block randomized to treatment in the orthogeriatric unit OR to standard care 
in the orthopedic unit, using a web-based system. 
Eligible patients not being asked to participate in the ER can be randomized before operation 
Follow up at 1 month: assessment of mobility, ADL, fear of falling, health related quality 
of life, mood and cognitive function at patients’ place of residence.  
Follow up at 4 months: assessment of mobility, ADL, fear of falling, health related quality 
of life, mood and cognitive function registered at the hospital out patient clinic. 
Evaluation of cognitive function by next of kin  
Follow up at 12 months: Same assessment as for the 4-month-assessment 
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1.6 Power and statistical analyses 
 
Sample size estimates are based on mobility assessed by SPPB at 4 months following the 
fracture. A change in the SPPB score of 0.5 points is considered a small but meaningful change, 
while 1 point is considered a more substantial change[1]. In order to detect an effect size of 1.0 
when power is 80% and alpha = 0.05, a sample size of 304 participants would be needed. Based 
on data from a previous prospective observational study in a similar study population (work in 
progress), we expect a drop out rate of 10% due to death and 10% due to withdrawals during 
the first 4 months following the fracture. 
 
To allow for 304 patients to remain in the project at four months after the fracture 380 persons 
need to be included. Thus, the plan is to include a total sample of 400 participants. The 
assumptions underlying the sample size estimation (i.e. the standard deviation at baseline) has 
been checked by an independent clinical trials unit after the first 200 patients enrolled, and 
found to be acceptable.  
 
1.7 Harm 
We have performed an interim analysis on early mortality including the first 200 patients. Our 
predefined end point was 50% excess mortality in the intervention group with a P-value of 0.1. 
Mortality was not increased in the intervention group and the study inclusion therefore 
continued as planned. 
 
2. Populations 
 
2.1Total study population  
A total of 1077 patients entering St Olav’s Hospital with a proximal femur fracture from April 
17th 2008 to December 30th 2010 have been registered. The inclusion period was terminated 
when 401 patients fulfilling the inclusion criteria had been correctly randomized.  
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2.2 Intention to treat population  
Of the 436 patients being randomized 35 did not meet the inclusion criteria (error during 
inclusion). The 401 fulfilling the inclusion criteria and being correctly randomized will be 
included in the intention to treat analyses regardless of actual received treatment. Patients not 
fulfilling the inclusion criteria but still being randomized by mistake will be described  with 
respect to diagnose, gender and age and group allocation. 
 
2.3 Efficacy/treated population  
 Efficacy analyzes will be performed on patients who have been randomized correctly and 
having received the intended interventions. Two cases did not receive allocated treatment (one 
in each group). Patient data exclusive protocol violators will be analyzed separately after initial 
analysis according to intention to treat. 
 
 
2.4 Pre planned sub group analysis  
Prespesified subgroup analysis will be performed on the following subgroups: 
 
-Old versus new orthopedic ward: During the study period the orthopedic ward moved from an 
old to a new building. We will evaluate whether change in the physical environment have an 
impact of the results in the study for primary end point of SPPB, place of residence and 
patient/proxy satisfaction.  
  
- Subgroups of frailty: Subgroups identified by combining Barthel, Nottingham and CDR scores 
and frailty measures will evaluated as for potential differing effects on the SPPB and place of 
residence and fear of falling at 1, 4 and 12 months. We will also perform a separate cost utility 
analysis for the frail patient group. 
 
3. Datasets 
 
3.1 Registered datasets 
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Data being collected during the index stay (including data of premorbid function) and at 1, 4 and 
12 months after the fracture and information from questionnaires being sent to patient/next of 
kin after discharge. 
  
3.2 Imputation of data 
 
Patterns of missing data will be described and analyzed, and appropriate methods of imputation 
will be chosen accordingly for separate groups of missing data based on the chosen statistic that 
will be used to assess group differences of change [2]. We will examine the baseline 
characteristics of those participants with missing data, by randomization group to determine 
whether there are systematic differences between groups.  
 
We will use imputation on missing data due to 3 mechanisms: 
i) Missing at random- eg not participating at a single control due to i.e. bad weather. 
ii) Missing completely at random- eg: data missing due to loss of single forms during follow up. 
iii) Not missing at random- eg: patients who refuse to perform a test because of pain. 
 
No separate imputation will be performed if analyzing with mixed models (auto imputation is 
part of model). 
 
4. Protocol violators 
 
4.1 Ineligible patients   
Thirty five patients were enrolled by mistake without fulfilling the inclusion criteria. For these 
patients only data on diagnoses, gender and age are registered. These patients will not be 
included in the intention to treat neither the efficacy analyzes.  
Reasons/mistakes: 
-Age below 70 years 
-Not suffering fracture 
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-Permanent resident in nursing home 
-Not able to walk before fracture 
-Misunderstandings on refusing of participation 
 
We will report group belonging for violators and if they are unevenly distributed between 
groups. 
 
4.2 Non –adherence 
Patients withdrawing from the study before discharge from the index stay and patients treated 
in wrong department according to randomization will be included in the intention to treat 
analyses and analyzed according to the randomization result.  
 
4.3 Withdrawals 
All withdrawals and reasons for withdrawals from the study will be described for each treatment 
arm:  
i) Withdrawal from  
ii) Withdrawal from follow up. Some patients refuse to participate at scheduled assessments, 
but have accepted data from journal and registries to be used.  
iii) Withdrawal of consent. Data up till time of withdrawal will be included in the analyses.   
 
4.4 Missing follow up 
Some patients have not met for single scheduled assessments or have no data on single tests in 
scheduled assessment. These will be included in the intention to treat analysis. 
A complete list of violators and ineligible patients will be made up before any analyses of data 
are performed. 
 
5. Derived variables 
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Most variables are scored by assessor except patient satisfaction which is scored by patient/next 
of kin. Gaitrite and ActivPal are registered electronically. Forms are then scanned and checked 
by assessor or are plotted manually (SPPB, TUG and CDR). 
 
Assessment and measurements 
 
5.1 Gait/balance /strength 
i) SPPB- Short physical Performance battery 
We will use the test as described by Guralnik [3]with a total score 0-12 points in 3 different 
modalities- standing balance, 8 foot walk and sit to stand from a chair- and a maximum score of 
4 points in each modality with the highest score for the best performance. 1 points difference in 
total score is found to be substantial , while 0.5 points is found to have a small but meaningful 
effect[4]. 
 
ii) TUG –Timed up and go 
Time is measured as the patient raises from chair, walks 3 meters, turns and walk back before 
she sits down[5]. In a old home dwelling  population 16 seconds [6] is a cut-off that signals risk 
of falling, while 24 seconds is found to be a cut-off after a recent hip fracture[7]. 
 
 
iii) Gaitrite 
Patients walk over an electronic carpet while their pattern of walking is registered [8].  
A separate protocol will be developed for analysis of these data.  
 
iv) ActivPal 
Measurement of in –hospital activity by a small body worn accelerometer-based sensor 
ActivPal®  [9] is found to be a good measurement of daily activity, and the method is evaluated 
by our group for our patient group [10]. A separate protocol will be developed for analysis of 
these data.  
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 v) Muscle strength 
Grip strength measured with a dynamometer is shown to be fairly representative for total body 
strength and health condition. Low grip strength is associated with increased risk of low mineral 
bone density [11], falling and suffering a hip fracture [12]. We have also measured bilateral 
isometric quadriceps strength at 4 and 12 months with a digital dynamometer, where force is 
measured as Nm. 
 
5.2 ADL  
i) Barthel Index 
The Barthel Index is used to evaluate activities of daily living [13]. This scale has been used in a 
large number of studies, and is established and validated in hip fracture patients. 
 
5.3 Instrumental ADL 
i) Nottingham Extended IADL scale 
The Nottingham scale of I-ADL is a tool that is well established and validated in hip fracture 
patients. It was primary designed as a tool for measuring iADL function for patients suffering 
from stroke[14], but is later also used in hip fracture patients[15] and patients with hip 
replacement[16]. 
 
5.4 Cognitive function/psychiatric symptoms 
i) CDR 
We have used a Norwegian version of the CDR scale by Hughes[17] which is a 6 items scale with 
scores of 0 to 3 points on each item. It can be used in two ways: 
i) Memory is primary item; the other items (orientation, judgment/problem solving, community, 
home/hobbies and personal care) are secondary items. The memory score gives the score of the 
test. If three or more secondary scores are 1 point higher or lower than the primary score, the 
result is adjusted according to the difference. 
ii) It can also be used as a continuous scale with an average score on all items as main score, as 
shown by Engedal. 
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ii) MMSE 
The Mini-Mental Status Examination MMSE) is well established as a screening tool for cognitive 
impairment in older persons [18]. MMSE is not measured during the index stay. 
 
 
iii) Geriatric Depression Scale 
GDS-15 is a well established tool to assess depressive symptoms in older people. It consists of a 
15 items questionnaire where 0-5 is normal, 5-9 indicating mild and >10 moderate to severe 
depression. The GDS-15 score is shown to affect results of rehabilitation in hip fracture 
patients[19]. 
 
 
5.5 Quality of Life 
i) EuroQol 
EuroQol [20] is established to evaluate quality of life. Each participant scores his mobility, ability 
of self-care, activities, pain/discomfort, and anxiety/depression. The result is presented as a 5-
digit number. In addition we use the EuroQol thermometer were each patient grades his quality 
of life on a 0-100 point scale. 
 
5.6 Patient/proxy satisfaction 
i) PasOp 
Patient/proxy satisfaction with in-hospital stay is measured with the PasOp which is sent to 
patient/next of kin at discharge after the index stay. This questionnaire is used by the Central 
Norway Regional Health Authority and produced by Heltef (Foundation for Health Services 
Research). The questionnaire  consists of 36 items regarding experiences and 8 items regarding 
courtesy and respect by the staff. In addition it contains a 9 item form asking for suggestions 
regarding needs of improvement of staff (nurses, physicians), organization, equipment, 
treatment of next of kin, information (drugs, investigations, discharge procedures) and 
communication. 
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The questionnaire is validated by regular use in the region, but not for older hip fracture 
patients per se. 
 
Data have not been collected from proxy if the patient died during the index stay. 
 
5.7 Health economy 
i) EuroQol 
See 5.5. We will use qualys [21] as a part of our economic analysis to create a generic picture of 
cost of the interventions. 
 
ii) Use of recourses 
We have decided to use a cost utility approach[22] with measurement of direct costs of health 
services related to outcomes. As the primary outcome is difference in SPPB at 4 months, this will 
be the primary outcome in the analysis, but other significant differences between groups on 
secondary end points will also be subject of cost analysis. 
 
We have not registered indirect costs or costs outside the public health service due to 
difficulties with reliable registration of data. If there are indications of differences between 
groups i.e. a major difference regarding people living at home at 4 and 12 months after the hip 
fracture, an estimation of indirect costs based on registrations by Statistics Norway will be 
considered.  
 
Direct costs consist of: 
i) In-hospital use of resources during the index stay- 
- Length of stay including total length of stay and time from admission to registration of “ready 
for discharge”. 
- Costs per day .We will use a calculated average costs for each group per day and not the actual 
costs. Due to differences in DRG coding in the orthopedic ward versus the geriatric ward we will 
use a registration of total cost regardless of funding based on DRG. 
ii) During a 12 months follow-up use of in-hospital resources post discharge, including visits at 
specialist out patient clinics. 
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iii) Use of resources in the primary health care system 
- Time in rehabilitation facilities. We will calculate an individual average cost differentiating 
between types/level of rehabilitation. 
- Home care including nursing and home help by the municipality authorities. 
-Use of physical or occupational therapy. 
-Use of primary health care physicians (GPs)  
 
A table specifying cost categories, units, source of data, unit prices in Euro, see Addendum. 
 
5.8 Fear of falling 
i) FES-I, short form 
The original FES-I is a validated scale measuring fear of falling and the social consequences of 
fear of falling [23]. The newly developed short form is found to have a good correlation and 
similar abilities as the original FES-I [24]. A Norwegian version has recently been validated[25].    
 
ii) 4 point Likert scale of fear of falling 
The scoring 0 indicates not worried, 1- slightly worried, 2- rather worried, 3- very worried. This is 
also a part of Standardized Audit of Hip Fractures in Europe (SAHFE) protocol (5.9) 
 
5.9 SAHFE interview 
i) Pain 
a) NRS 11 
We use the NRS 11 scale for evaluation of pain. This scale is widely used for evaluation in clinical 
settings and has a good face value. We have not used it as a ratio scale, as recommended in 
literature[26]. 
 
b) Charnley hip score 
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The Charnley hip score is a grading of pain from no pain to the worst thinkable pain and is 
established and recommended by the Standardized Audit of Hip Fractures in Europe (SAHFE) 
[27]. 
 
c) SAHFE questions on pain 
Questionnaire with 6 items grading pain in operated foot from no pain, occasional light pain, 
pain in activity, moderate pain with limitation of activity, strong pain not allowing activity and 
strong pain even with no activity. 
 
ii) SAHFE questionnaire mobility 
Indoor and outdoor use of aid , 6 items from no aid, one cane/crutch, 2 canes/crutches, walker, 
wheelchair, able to walk with support and wheelchair not able to walk. 
 
Change in walking ability after fracture, 3 alternatives- no change, some negative change due to 
fracture, some negative change independent of fracture. 
 
iii) Registration of falls:  
A simple registration of number of falls, having 3 alternatives: no falls, 2 or less falls, more than 
two falls. Space for free text describing fall. 
 
iv) Fear of falling 
See 5.8 
 
5.10 Background variables 
i) Charlson score 
This is a co-morbidity score performed by evaluation of patient medical history and subsequent 
risk of complications based on a limited number of diseases[28]. The patient is scored from 1 to 
6 points if he suffers from a disease on the Charlson list. The score is cumulative. We will use the 
ICD-10 adapted scoring system.[29] 
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 5.11 Clinical variables 
i) APACHE II 
APACHE (Acute Physiology And Chronic Health Evaluation) is a scoring system for grading risk of 
morbidity and mortality for acute sick patient[30]. It consists of a mix of different variables 
including acute physiological parameters (pulse, blood pressure, temperature and respiratory 
status), Glasgow Coma Scale, lab values (oxygen saturation, hematocrite, leukocytes, sodium, 
potassium and creatinine) and evidence of chronic disease (heart-, kidney-, respiratory-, and 
liver failure) and failure of the immune-system. We have used the APACHE II version[31]. 
 
The APACHE scoring system is generally used in studies of intensive care settings, but is also 
used as a grading system of preoperative risk, and is also used to evaluate the risk of geriatric 
patients with a hip fracture[32]. 
 
5.12 Baseline and clinical variables 
i) Social status 
a) Residence- regular or sheltered housing 
b) Home care- general aid and/or in home medical care 
c) Living alone- unmarried, married, divorced, widowed 
d) Children 
e) Use of walking aids 
 
ii) Medical history at baseline 
a) Contact with hospital 12 months before fracture 
b) Fractures 10 years before hip fracture 
c) Known osteoporosis 
d) Charlson score 
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iii) Fracture type 
a) Femoral neck fracture, and using the Garden classification dichotomized in non-dislocated 
(Garden 1 and 2) or dislocated (Garden 3 and 4) 
b) Pertrochanteric fracture 
c) Subtrochanteric fracture 
 
iv) Pre-operative data 
a) Door to needle time specified as registered time of entry into hospital to start of preparation 
for surgery in the theater. 
b) Preoperative evaluation including ASA score and the need of medical evaluation other than 
surgeon and anesthesiologist (cardiologist or other) 
 
v) Periperative data 
a) Blood loss 
b) Periperative pulse and blood pressure measurements 
c) Operating time defined as time with surgeon working on patient. 
 
vi) Postoperative data 
a) Fracture related complications - infections (superficial or deep), dislocation of hip, 
reoperation 
b) General complications- death, renal failure, stroke, heart attack, pulmonary embolism 
 
vii) Mobilization 
Cumulated ambulation score (CAS) is a measurement of the degree of active mobilization during 
the index stay and is measured at day 3 to 5 during the postoperatively [33] . 
 
viii) Medication 
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a) Medication at admission 
b) Medication at discharge 
 
6 Outcome variables 
6.1 Clinical effectiveness 
In line with the aims of the study our outcome variables are as follows: 
 
i) Primary outcome 
1) Mobility  
SPPB measured as described at 4 months. 
 
ii) Secondary outcomes 
See Table 2 for time of assessment of secondary outcomes. 
 
Table 2 
OUTCOMES Prefracturefu
nction
Index stay Follow up 
1month
Follow up
4 month
Follow up
12 month
patient
proxy
M
ed. d
p-ADL
I-ADL
Barthel index
Nottingham 
ext
New mobility 
score
IPLOS
Barthel index
Nottingham 
ext.
New mobility 
sore
IPLOS
Barthel index
Nottingham 
ext.
New mobility 
score
IPLOS
Barthel index
Nottingham ext
New mobility 
score
IPLOS
X
X
X
X
X
X
 
 
 
 
X 
Gait/balance TUG
SPPB
TUG 
SPPB
Gaitrite
Biodex
TUG
SPPB
Gaitrite
Biodex
X
X
X
X
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Cognitive
function
CDR 
MMS MMS 
CDR
MMS
CDR
X
X
 
Health related 
quality of life
EQ-5D EQ-5D EQ-5D EQ-5D X  
Depression GDS 15 GDS 15 GDS 15 GDS 15 X  
Fear of falling FES-I FES-I FES-I FES-I X  
Fall SAHFE SAHFE SAHFE SAHFE X 
Activity level Active pal (Active pal) X  
Medical 
registrations
Test results
complications
treatment
Test results
complications
treatment
Test results
complications
treatment
Test results
complications
treatment
X 
Health 
economy
Place of 
residence,
home care 
services, 
institution last  
14 days
Place of 
residence,
home care 
services, 
institution/
hospitalizatio
n
EQ-5D
Place of 
residence,
home care 
services, 
institution/
hospitalization 
EQ-5D
Place of 
residence,
home care 
services, 
institution/
hospitalization 
EQ-5D
X 
Patient/proxy
experience
PasOpp Interviews of 
selected 
populations 
X X  
 
7. Data quality control 
During scanning of data we have performed a continuous control of input: random samples of 
scanned forms (10% total) are controlled afterwards to check for errors. 
Comments/supplementary information on forms are registered in a separate computer based 
log. 
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Plotting of data is performed by 2 persons working together. Control of plotted data includes 
check of 10% of the data. 
 
Complete data files are checked for errors by descriptive statistics, performing extra checks on 
outliers.   
 
8. Statistical analysis 
The data will be summarized and analyzed according to the aims of the trial and as described in 
Sletvold et al BMC Geriatrics 2011 and registered in ClinicalTrials.gov. 
 
The analysis will be performed by PASW (SPSS) version 17 or 18 from IBM and STATA by Stata 
Corp. 
 
We will use 2-sided tests with a significance level of 5%. The results will be presented as means 
and 95% confidence interval for continuous data, median and interquartile range for ordinal 
data and numbers and percentage for dichotomous data.  
   
To study differences between groups for mobility outcomes at four months we will use 
multivariate analyses by use of ANCOVA, controlling  for variables possibly influencing the 
results [34]. Outcomes at four months with available baseline values will be assessed by general 
linear modeling (GLM) for continuous variables and by logistic regression for binary variables.  
 
Change in outcomes from one to four to twelve months will be assessed by longitudinal 
ANCOVAs or by GLM. When analyzing data related to place of residence we will use survival 
analysis with Cox proportional hazard 
 
Mixed model analyses will be considered according to pattern and extent of missing data.   
 
8.1 Recruitment 
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The numbers and percentage of participants left in the study at the different stages will be 
published as shown in the CONSORT diagram in section 1.4[35]. 
 
We will analyze withdrawals and protocol violators related to randomization group. 
 
8.2 Demography/baseline 
Data will be presented as mean, median, standard deviation, interquartil range or n and 
percentages.. 
 
i) Demography  
a) Age, gender and place of residence will be reported  
a) All patients screened in the study will be reported (total population)  
b) All patients randomized including those randomized by error will be reported 
c) Eligible patients randomized and included (ITT) will be reported 
 
ii) Baseline data 
Background variables including clinical data during index stay are listed in section 7.1. will be 
reported for randomized patients. Data are not reported for ineligible patients randomized by 
mistake. 
 
8.3 Clinical effectiveness 
Analysis will be performed according to 
i) Intention to treat.  There are no data on ineligible patients. Primary analysis will be on 
observed datasets, secondary on data including imputed variables. 
 
ii) Efficacy assessment exclusive of protocol violators (Per protocol analysis). Primary analysis 
will be on observed datasets, secondary on data including imputed variables. 
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 8.3.1 Primary end point 
Difference in mobility as measured by total SPPB score at 4 months between treatment arm 
(“comprehensive geriatric care”) and standard care will be analyzed by use of ANCOVA. 
 
Baseline ADL, I-ADL, CDR, gender, age, living alone, place of residence , type of fracture, length 
of stay, baseline muscle strength and preoperative waiting time will be explored as controlling 
variables in  the analysis. 
 
If there is a difference in SPPB between groups after 4 months, we will perform a second 
analysis on the effect of  change in ADL/I-ADL, cognitive function (CDR, MMS and GDS) on SPPB 
by longitudinal ANCOVA combination approach[34]. 
 
8.3.2 Secondary end points 
i) Mobility 1, 4 and 12 months 
a) SPPB difference at 1 and 12 months between groups analyzed by ANCOVA 
b) Difference in TUG between groups after 1, 4 and 12 months by longitudinal ANCOVA 
combination approach. 
c) Difference in Gaitrite score after baseline, 4 and 12 months by longitudinal ANCOVA 
combination approach. 
 
ii) Place of residence 
Difference in place of residence after 1, 4 and 12 months will be analyzed by cox proportional 
hazard method. 
 
iii) ADL 
We will measure change in Barthel score at 1, 4 and 12 months and analyze it by longitudinal 
ANCOVA combination approach. 
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iv) iADL 
Change in Nottingham score at 1, 4 and 12 months will be analyzed by longitudinal ANCOVA 
combination approach. 
 
v) Cognitive function 
a) Change in CDR after 4 and 12 months will be analyzed by longitudinal ANCOVA combination 
approach. 
b) Change of MMS after 1, 4 and 12 months will be analyzed by longitudinal ANCOVA 
combination approach. 
c) Change in GDS after 1, 4 and 12 months will be analyzed by longitudinal ANCOVA combination 
approach. 
 
vi) Quality of life 
Change in score EQ- 5d and difference in score at 1, 4 and 12 months depending on allocation 
will be analyzed in longitudinal ANCOVA combination approach. 
 
vii) Patient /proxy satisfaction 
The results of PasOp will be analyzed by ANCOVA comparing the 2 groups.  
We will analyze whether there is a change in satisfaction after the control group (orthopedic 
department) moved from old to new department (prespesified subgroup). 
 
viii) Health economy 
Total cost at discharge will be calculated for each group and compared by ANCOVA with 
preoperative waiting time as a prespesified covariate. Both costs at date of actual discharge and 
date of “ready for discharge” will be published. 
 
We will calculate costs from the municipalities as described in 6.7 for three time periods, from 
discharge to 1 month, from one month to four months and finally from four to twelve months 
and compare the two groups by longitudinal ANCOVA. 
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 ix) Fear of falling 
a) FES-I data from 1, 4 and 12 months will be analyzed in a longitudinal ANCOVA combination 
approach. 
b) Score from the 4 item Likert scale will be analyzed in longitudinal ANCOVA combination 
approach. 
 
x) Pain 
a) The data from the questionnaire will be analyzed with a longitudinal ANCOVA combination 
approach. 
 Type of fracture, surgical complications, ability to walk and surgeon’s opinion about immediate 
postoperative stability will be included in model. 
b) Charnley hip score and NRS will be analyzed longitudinal ANCOVA combination approach. 
 
 
9. Report 
9.1 
i) All results will be published in peer reviewed international journals according to the Consort 
2010 criteria.  
ii) When publishing tables, type of data (observed or imputed) will be specified in the tables. 
 
 
10. SAP Amendments 
Copies of all forms used in collecting datasets, a table of baseline variables and cost categories 
will follow the analysis plan as amendments. 
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 25 
  
1. Sletvold, O., et al., Effect of in-hospital comprehensive geriatric assessment (CGA) in 
older people with hip fracture. The protocol of the Trondheim Hip Fracture Trial. BMC 
Geriatr, 2011. 11(1): p. 18. 
2. Twisk, J. and W. de Vente, Attrition in longitudinal studies. How to deal with missing 
data. Journal of Clinical Epidemiology, 2002. 55(4): p. 329-37. 
3. Guralnik, J.M., et al., A short physical performance battery assessing lower extremity 
function: association with self-reported disability and prediction of mortality and nursing 
home admission. Journal of Gerontology, 1994. 49(2): p. M85-94. 
4. Perera, S., et al., Meaningful change and responsiveness in common physical 
performance measures in older adults. J Am Geriatr Soc, 2006. 54(5): p. 743-9. 
5. Podsiadlo, D. and S. Richardson, The timed "Up & Go": a test of basic functional mobility 
for frail elderly persons. J Am Geriatr Soc, 1991. 39(2): p. 142-8. 
6. Okumiya, K., et al., The timed "up & go" test is a useful predictor of falls in community-
dwelling older people. J Am Geriatr Soc, 1998. 46(7): p. 928-30. 
7. Kristensen, M.T., N.B. Foss, and H. Kehlet, Timed "up & go" test as a predictor of falls 
within 6 months after hip fracture surgery. Physical Therapy, 2007. 87(1): p. 24-30. 
8. Menz, H.B., et al., Reliability of the GAITRite walkway system for the quantification of 
temporo-spatial parameters of gait in young and older people. Gait and Posture, 2004. 
20(1): p. 20-5. 
9. Grant, P.M., et al., The validation of a novel activity monitor in the measurement of 
posture and motion during everyday activities. British Journal of Sports Medicine, 2006. 
40(12): p. 992-7. 
10. Taraldsen, K., et al., Evaluation of a body-worn sensor system to measure physical 
activity in older people with impaired function. Physical Therapy, 2011. 91(2): p. 277-85. 
11. Dixon, W.G., et al., Low grip strength is associated with bone mineral density and 
vertebral fracture in women. Rheumatology (Oxford), 2005. 44(5): p. 642-6. 
12. Pluijm, S.M., et al., A risk profile for identifying community-dwelling elderly with a high 
risk of recurrent falling: results of a 3-year prospective study. Osteoporos Int, 2006. 
17(3): p. 417-25. 
13. Mahoney, F.I. and D.W. Barthel, Functional Evaluation: The Barthel Index. Maryland 
State Medical Journal, 1965. 14: p. 61-5. 
 26 
14. Lincoln, N.B. and J.R. Gladman, The Extended Activities of Daily Living scale: a further 
validation. Disabil Rehabil, 1992. 14(1): p. 41-3. 
15. Sylliaas, H., et al., Progressive strength training in older patients after hip fracture: a 
randomised controlled trial. Age Ageing, 2011. 40(2): p. 221-7. 
16. Harwood, R.H. and S. Ebrahim, The validity, reliability and responsiveness of the 
Nottingham Extended Activities of Daily Living scale in patients undergoing total hip 
replacement. Disabil Rehabil, 2002. 24(7): p. 371-7. 
17. Hughes, C.P., et al., A new clinical scale for the staging of dementia. British Journal of 
Psychiatry, 1982. 140: p. 566-72. 
18. Folstein, M.F., S.E. Folstein, and P.R. McHugh, "Mini-mental state". A practical method 
for grading the cognitive state of patients for the clinician. Journal of Psychiatric 
Research, 1975. 12(3): p. 189-98. 
19. Morghen, S., et al., Moderate to severe depressive symptoms and rehabilitation 
outcome in older adults with hip fracture. International Journal of Geriatric Psychiatry, 
2010. 
20. EuroQol--a new facility for the measurement of health-related quality of life. The 
EuroQol Group. Health Policy, 1990. 16(3): p. 199-208. 
21. Brooks, R., EuroQol: the current state of play. Health Policy, 1996. 37(1): p. 53-72. 
22. van der Roer, N., N. Boos, and M.W. van Tulder, Economic evaluations: a new avenue of 
outcome assessment in spinal disorders. European Spine Journal, 2006. 15 Suppl 1: p. 
S109-17. 
23. Yardley, L., et al., Development and initial validation of the Falls Efficacy Scale-
International (FES-I). Age Ageing, 2005. 34(6): p. 614-9. 
24. Kempen, G.I., et al., The Short FES-I: a shortened version of the falls efficacy scale-
international to assess fear of falling. Age Ageing, 2008. 37(1): p. 45-50. 
25. Helbostad, J.L., et al., Validation of the Falls Efficacy Scale-International in fall-prone 
older persons. Age Ageing, 2010. 39(2): p. 259. 
26. Hartrick, C.T., J.P. Kovan, and S. Shapiro, The numeric rating scale for clinical pain 
measurement: a ratio measure? Pain Pract, 2003. 3(4): p. 310-6. 
27. Parker, M., et al., Standardised audit of hip fracture in Europe (SAHFE). HIP International 
,:, 1998( 8): p. 10-15. 
 27 
28. Charlson, M.E., A new method of classifying prognostic comorbidity in longitudinal 
studies: Development and validation. Journal of Chronic Diseases, 1987. Volume 40( 
Issue 5): p. Pages 373-383. 
29. Sundararajana, V., New ICD-10 version of the Charlson Comorbidity Index predicted in-
hospital mortality. Journal of Clinical Epidemiology, 2004. 57: p. 1288–1294. 
30. Knaus, W.A., et al., APACHE-acute physiology and chronic health evaluation: a 
physiologically based classification system. Critical Care Medicine, 1981. 9(8): p. 591-7. 
31. Knaus, W.A., et al., APACHE II: a severity of disease classification system. Critical Care 
Medicine, 1985. 13(10): p. 818-29. 
32. Leininger, S.M., One year later: did the quality circle of geriatric hip fracture care achieve 
quality outcomes? Nursing Case Management, 1999. 4(6): p. 263-7. 
33. Foss, N.B., M.T. Kristensen, and H. Kehlet, Prediction of postoperative morbidity, 
mortality and rehabilitation in hip fracture patients: the cumulated ambulation score. 
Clinical Rehabilitation, 2006. 20(8): p. 701-8. 
34. Twisk, J.W. and W. de Vente, The analysis of randomised controlled trial data with more 
than one follow-up measurement. A comparison between different approaches. 
European Journal of Epidemiology, 2008. 23(10): p. 655-60. 
35. Schulz, K.F., D.G. Altman, and D. Moher, CONSORT 2010 statement: updated guidelines 
for reporting parallel group randomized trials. Annals of Internal Medicine, 2010. 
152(11): p. 726-32. 
 
 
 28 
